#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Evolutionary modifications in human brain connectivity associated with schizophrenia
#Text=See Vértes and Seidlitz (doi:) for a scientific commentary on this article.
1-1	0-12	Evolutionary	_	
1-2	13-26	modifications	_	
1-3	27-29	in	_	
1-4	30-35	human	_	
1-5	36-41	brain	_	
1-6	42-54	connectivity	_	
1-7	55-65	associated	_	
1-8	66-70	with	_	
1-9	71-84	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-10	85-88	See	_	
1-11	89-95	Vértes	_	
1-12	96-99	and	_	
1-13	100-108	Seidlitz	_	
1-14	109-110	(	_	
1-15	110-113	doi	_	
1-16	113-114	:	_	
1-17	114-115	)	_	
1-18	116-119	for	_	
1-19	120-121	a	_	
1-20	122-132	scientific	_	
1-21	133-143	commentary	_	
1-22	144-146	on	_	
1-23	147-151	this	_	
1-24	152-159	article	_	
1-25	159-160	.	_	

#Text=Is schizophrenia a by-product of human brain evolution?
2-1	161-163	Is	_	
2-2	164-177	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
2-3	178-179	a	_	
2-4	180-190	by-product	_	
2-5	191-193	of	_	
2-6	194-199	human	_	
2-7	200-205	brain	_	
2-8	206-215	evolution	_	
2-9	215-216	?	_	

#Text=By comparing the human and chimpanzee connectomes, van den Heuvel et al. demonstrate that connections unique to the human brain show greater involvement in schizophrenia pathology.
3-1	217-219	By	_	
3-2	220-229	comparing	_	
3-3	230-233	the	_	
3-4	234-239	human	_	
3-5	240-243	and	_	
3-6	244-254	chimpanzee	_	
3-7	255-266	connectomes	_	
3-8	266-267	,	_	
3-9	268-271	van	_	
3-10	272-275	den	_	
3-11	276-282	Heuvel	_	
3-12	283-285	et	_	
3-13	286-288	al	_	
3-14	288-289	.	_	
3-15	290-301	demonstrate	_	
3-16	302-306	that	_	
3-17	307-318	connections	_	
3-18	319-325	unique	_	
3-19	326-328	to	_	
3-20	329-332	the	_	
3-21	333-338	human	_	
3-22	339-344	brain	_	
3-23	345-349	show	_	
3-24	350-357	greater	_	
3-25	358-369	involvement	_	
3-26	370-372	in	_	
3-27	373-386	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
3-28	387-396	pathology	_	
3-29	396-397	.	_	

#Text=Modifications in service of higher-order brain functions may have rendered the brain more vulnerable to dysfunction.
4-1	398-411	Modifications	_	
4-2	412-414	in	_	
4-3	415-422	service	_	
4-4	423-425	of	_	
4-5	426-438	higher-order	_	
4-6	439-444	brain	_	
4-7	445-454	functions	_	
4-8	455-458	may	_	
4-9	459-463	have	_	
4-10	464-472	rendered	_	
4-11	473-476	the	_	
4-12	477-482	brain	_	
4-13	483-487	more	_	
4-14	488-498	vulnerable	_	
4-15	499-501	to	_	
4-16	502-513	dysfunction	_	
4-17	513-514	.	_	

#Text=Abstract
#Text=The genetic basis and human-specific character of schizophrenia has led to the hypothesis that human brain evolution may have played a role in the development of the disorder.
5-1	515-523	Abstract	_	
5-2	524-527	The	_	
5-3	528-535	genetic	_	
5-4	536-541	basis	_	
5-5	542-545	and	_	
5-6	546-560	human-specific	_	
5-7	561-570	character	_	
5-8	571-573	of	_	
5-9	574-587	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
5-10	588-591	has	_	
5-11	592-595	led	_	
5-12	596-598	to	_	
5-13	599-602	the	_	
5-14	603-613	hypothesis	_	
5-15	614-618	that	_	
5-16	619-624	human	_	
5-17	625-630	brain	_	
5-18	631-640	evolution	_	
5-19	641-644	may	_	
5-20	645-649	have	_	
5-21	650-656	played	_	
5-22	657-658	a	_	
5-23	659-663	role	_	
5-24	664-666	in	_	
5-25	667-670	the	_	
5-26	671-682	development	_	
5-27	683-685	of	_	
5-28	686-689	the	_	
5-29	690-698	disorder	_	
5-30	698-699	.	_	

#Text=We examined schizophrenia-related changes in brain connectivity in the context of evolutionary changes in human brain wiring by comparing in vivo neuroimaging data from humans and chimpanzees, one of our closest living evolutionary relatives and a species with which we share a very recent common ancestor.
6-1	700-702	We	_	
6-2	703-711	examined	_	
6-3	712-733	schizophrenia-related	_	
6-4	734-741	changes	_	
6-5	742-744	in	_	
6-6	745-750	brain	_	
6-7	751-763	connectivity	_	
6-8	764-766	in	_	
6-9	767-770	the	_	
6-10	771-778	context	_	
6-11	779-781	of	_	
6-12	782-794	evolutionary	_	
6-13	795-802	changes	_	
6-14	803-805	in	_	
6-15	806-811	human	_	
6-16	812-817	brain	_	
6-17	818-824	wiring	_	
6-18	825-827	by	_	
6-19	828-837	comparing	_	
6-20	838-840	in	_	
6-21	841-845	vivo	_	
6-22	846-858	neuroimaging	_	
6-23	859-863	data	_	
6-24	864-868	from	_	
6-25	869-875	humans	_	
6-26	876-879	and	_	
6-27	880-891	chimpanzees	_	
6-28	891-892	,	_	
6-29	893-896	one	_	
6-30	897-899	of	_	
6-31	900-903	our	_	
6-32	904-911	closest	_	
6-33	912-918	living	_	
6-34	919-931	evolutionary	_	
6-35	932-941	relatives	_	
6-36	942-945	and	_	
6-37	946-947	a	_	
6-38	948-955	species	_	
6-39	956-960	with	_	
6-40	961-966	which	_	
6-41	967-969	we	_	
6-42	970-975	share	_	
6-43	976-977	a	_	
6-44	978-982	very	_	
6-45	983-989	recent	_	
6-46	990-996	common	_	
6-47	997-1005	ancestor	_	
6-48	1005-1006	.	_	

#Text=We contrasted the connectome layout between the chimpanzee and human brain and compared differences with the pattern of schizophrenia-related changes in brain connectivity as observed in patients.
7-1	1007-1009	We	_	
7-2	1010-1020	contrasted	_	
7-3	1021-1024	the	_	
7-4	1025-1035	connectome	_	
7-5	1036-1042	layout	_	
7-6	1043-1050	between	_	
7-7	1051-1054	the	_	
7-8	1055-1065	chimpanzee	_	
7-9	1066-1069	and	_	
7-10	1070-1075	human	_	
7-11	1076-1081	brain	_	
7-12	1082-1085	and	_	
7-13	1086-1094	compared	_	
7-14	1095-1106	differences	_	
7-15	1107-1111	with	_	
7-16	1112-1115	the	_	
7-17	1116-1123	pattern	_	
7-18	1124-1126	of	_	
7-19	1127-1148	schizophrenia-related	_	
7-20	1149-1156	changes	_	
7-21	1157-1159	in	_	
7-22	1160-1165	brain	_	
7-23	1166-1178	connectivity	_	
7-24	1179-1181	as	_	
7-25	1182-1190	observed	_	
7-26	1191-1193	in	_	
7-27	1194-1202	patients	_	
7-28	1202-1203	.	_	

#Text=We show evidence of evolutionary modifications of human brain connectivity to significantly overlap with the cortical pattern of schizophrenia-related dysconnectivity (P < 0.001, permutation testing).
8-1	1204-1206	We	_	
8-2	1207-1211	show	_	
8-3	1212-1220	evidence	_	
8-4	1221-1223	of	_	
8-5	1224-1236	evolutionary	_	
8-6	1237-1250	modifications	_	
8-7	1251-1253	of	_	
8-8	1254-1259	human	_	
8-9	1260-1265	brain	_	
8-10	1266-1278	connectivity	_	
8-11	1279-1281	to	_	
8-12	1282-1295	significantly	_	
8-13	1296-1303	overlap	_	
8-14	1304-1308	with	_	
8-15	1309-1312	the	_	
8-16	1313-1321	cortical	_	
8-17	1322-1329	pattern	_	
8-18	1330-1332	of	_	
8-19	1333-1354	schizophrenia-related	_	
8-20	1355-1370	dysconnectivity	_	
8-21	1371-1372	(	_	
8-22	1372-1373	P	_	
8-23	1374-1375	<	_	
8-24	1376-1381	0.001	_	
8-25	1381-1382	,	_	
8-26	1383-1394	permutation	_	
8-27	1395-1402	testing	_	
8-28	1402-1403	)	_	
8-29	1403-1404	.	_	

#Text=We validated these effects in three additional, independent schizophrenia datasets.
9-1	1405-1407	We	_	
9-2	1408-1417	validated	_	
9-3	1418-1423	these	_	
9-4	1424-1431	effects	_	
9-5	1432-1434	in	_	
9-6	1435-1440	three	_	
9-7	1441-1451	additional	_	
9-8	1451-1452	,	_	
9-9	1453-1464	independent	_	
9-10	1465-1478	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
9-11	1479-1487	datasets	_	
9-12	1487-1488	.	_	

#Text=We further assessed the specificity of effects by examining brain dysconnectivity patterns in seven other psychiatric and neurological brain disorders (including, among others, major depressive disorder and obsessive-compulsive disorder, arguably characterized by behavioural symptoms that are less specific to humans), which showed no such associations with modifications of human brain connectivity.
10-1	1489-1491	We	_	
10-2	1492-1499	further	_	
10-3	1500-1508	assessed	_	
10-4	1509-1512	the	_	
10-5	1513-1524	specificity	_	
10-6	1525-1527	of	_	
10-7	1528-1535	effects	_	
10-8	1536-1538	by	_	
10-9	1539-1548	examining	_	
10-10	1549-1554	brain	_	
10-11	1555-1570	dysconnectivity	_	
10-12	1571-1579	patterns	_	
10-13	1580-1582	in	_	
10-14	1583-1588	seven	_	
10-15	1589-1594	other	_	
10-16	1595-1606	psychiatric	_	
10-17	1607-1610	and	_	
10-18	1611-1623	neurological	_	
10-19	1624-1629	brain	_	
10-20	1630-1639	disorders	_	
10-21	1640-1641	(	_	
10-22	1641-1650	including	_	
10-23	1650-1651	,	_	
10-24	1652-1657	among	_	
10-25	1658-1664	others	_	
10-26	1664-1665	,	_	
10-27	1666-1671	major	_	
10-28	1672-1682	depressive	_	
10-29	1683-1691	disorder	_	
10-30	1692-1695	and	_	
10-31	1696-1716	obsessive-compulsive	_	
10-32	1717-1725	disorder	_	
10-33	1725-1726	,	_	
10-34	1727-1735	arguably	_	
10-35	1736-1749	characterized	_	
10-36	1750-1752	by	_	
10-37	1753-1764	behavioural	_	
10-38	1765-1773	symptoms	_	
10-39	1774-1778	that	_	
10-40	1779-1782	are	_	
10-41	1783-1787	less	_	
10-42	1788-1796	specific	_	
10-43	1797-1799	to	_	
10-44	1800-1806	humans	_	
10-45	1806-1807	)	_	
10-46	1807-1808	,	_	
10-47	1809-1814	which	_	
10-48	1815-1821	showed	_	
10-49	1822-1824	no	_	
10-50	1825-1829	such	_	
10-51	1830-1842	associations	_	
10-52	1843-1847	with	_	
10-53	1848-1861	modifications	_	
10-54	1862-1864	of	_	
10-55	1865-1870	human	_	
10-56	1871-1876	brain	_	
10-57	1877-1889	connectivity	_	
10-58	1889-1890	.	_	

#Text=Comparisons of brain connectivity across humans, chimpanzee and macaques further suggest that features of connectivity that evolved in the human lineage showed the strongest association to the disorder, that is, brain circuits potentially related to human evolutionary specializations.
11-1	1891-1902	Comparisons	_	
11-2	1903-1905	of	_	
11-3	1906-1911	brain	_	
11-4	1912-1924	connectivity	_	
11-5	1925-1931	across	_	
11-6	1932-1938	humans	_	
11-7	1938-1939	,	_	
11-8	1940-1950	chimpanzee	_	
11-9	1951-1954	and	_	
11-10	1955-1963	macaques	_	
11-11	1964-1971	further	_	
11-12	1972-1979	suggest	_	
11-13	1980-1984	that	_	
11-14	1985-1993	features	_	
11-15	1994-1996	of	_	
11-16	1997-2009	connectivity	_	
11-17	2010-2014	that	_	
11-18	2015-2022	evolved	_	
11-19	2023-2025	in	_	
11-20	2026-2029	the	_	
11-21	2030-2035	human	_	
11-22	2036-2043	lineage	_	
11-23	2044-2050	showed	_	
11-24	2051-2054	the	_	
11-25	2055-2064	strongest	_	
11-26	2065-2076	association	_	
11-27	2077-2079	to	_	
11-28	2080-2083	the	_	
11-29	2084-2092	disorder	_	
11-30	2092-2093	,	_	
11-31	2094-2098	that	_	
11-32	2099-2101	is	_	
11-33	2101-2102	,	_	
11-34	2103-2108	brain	_	
11-35	2109-2117	circuits	_	
11-36	2118-2129	potentially	_	
11-37	2130-2137	related	_	
11-38	2138-2140	to	_	
11-39	2141-2146	human	_	
11-40	2147-2159	evolutionary	_	
11-41	2160-2175	specializations	_	
11-42	2175-2176	.	_	

#Text=Taken together, our findings suggest that human-specific features of connectome organization may be enriched for changes in brain connectivity related to schizophrenia.
12-1	2177-2182	Taken	_	
12-2	2183-2191	together	_	
12-3	2191-2192	,	_	
12-4	2193-2196	our	_	
12-5	2197-2205	findings	_	
12-6	2206-2213	suggest	_	
12-7	2214-2218	that	_	
12-8	2219-2233	human-specific	_	
12-9	2234-2242	features	_	
12-10	2243-2245	of	_	
12-11	2246-2256	connectome	_	
12-12	2257-2269	organization	_	
12-13	2270-2273	may	_	
12-14	2274-2276	be	_	
12-15	2277-2285	enriched	_	
12-16	2286-2289	for	_	
12-17	2290-2297	changes	_	
12-18	2298-2300	in	_	
12-19	2301-2306	brain	_	
12-20	2307-2319	connectivity	_	
12-21	2320-2327	related	_	
12-22	2328-2330	to	_	
12-23	2331-2344	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
12-24	2344-2345	.	_	

#Text=Modifications in human brain connectivity in service of higher order brain functions may have potentially also rendered the brain vulnerable to brain dysfunction.
13-1	2346-2359	Modifications	_	
13-2	2360-2362	in	_	
13-3	2363-2368	human	_	
13-4	2369-2374	brain	_	
13-5	2375-2387	connectivity	_	
13-6	2388-2390	in	_	
13-7	2391-2398	service	_	
13-8	2399-2401	of	_	
13-9	2402-2408	higher	_	
13-10	2409-2414	order	_	
13-11	2415-2420	brain	_	
13-12	2421-2430	functions	_	
13-13	2431-2434	may	_	
13-14	2435-2439	have	_	
13-15	2440-2451	potentially	_	
13-16	2452-2456	also	_	
13-17	2457-2465	rendered	_	
13-18	2466-2469	the	_	
13-19	2470-2475	brain	_	
13-20	2476-2486	vulnerable	_	
13-21	2487-2489	to	_	
13-22	2490-2495	brain	_	
13-23	2496-2507	dysfunction	_	
13-24	2507-2508	.	_	

#Text=Introduction
#Text=Schizophrenia is a neuropsychiatric disorder that is characterized by hallucinations, delusions, loss of initiative and general cognitive dysfunction.
14-1	2509-2521	Introduction	_	
14-2	2522-2535	Schizophrenia	_	
14-3	2536-2538	is	_	
14-4	2539-2540	a	_	
14-5	2541-2557	neuropsychiatric	_	
14-6	2558-2566	disorder	_	
14-7	2567-2571	that	_	
14-8	2572-2574	is	_	
14-9	2575-2588	characterized	_	
14-10	2589-2591	by	_	
14-11	2592-2606	hallucinations	_	
14-12	2606-2607	,	_	
14-13	2608-2617	delusions	_	
14-14	2617-2618	,	_	
14-15	2619-2623	loss	_	
14-16	2624-2626	of	_	
14-17	2627-2637	initiative	_	
14-18	2638-2641	and	_	
14-19	2642-2649	general	_	
14-20	2650-2659	cognitive	_	
14-21	2660-2671	dysfunction	_	
14-22	2671-2672	.	_	

#Text=Its human-specific character and its genetic origin, coupled with its similar prevalence across societies varying in climate, level of urbanization, culture, industrialization etc., led to the early hypothesis that human brain evolution may have played a role in vulnerability to the disorder.
15-1	2673-2676	Its	_	
15-2	2677-2691	human-specific	_	
15-3	2692-2701	character	_	
15-4	2702-2705	and	_	
15-5	2706-2709	its	_	
15-6	2710-2717	genetic	_	
15-7	2718-2724	origin	_	
15-8	2724-2725	,	_	
15-9	2726-2733	coupled	_	
15-10	2734-2738	with	_	
15-11	2739-2742	its	_	
15-12	2743-2750	similar	_	
15-13	2751-2761	prevalence	_	
15-14	2762-2768	across	_	
15-15	2769-2778	societies	_	
15-16	2779-2786	varying	_	
15-17	2787-2789	in	_	
15-18	2790-2797	climate	_	
15-19	2797-2798	,	_	
15-20	2799-2804	level	_	
15-21	2805-2807	of	_	
15-22	2808-2820	urbanization	_	
15-23	2820-2821	,	_	
15-24	2822-2829	culture	_	
15-25	2829-2830	,	_	
15-26	2831-2848	industrialization	_	
15-27	2849-2852	etc	_	
15-28	2852-2853	.	_	
15-29	2853-2854	,	_	
15-30	2855-2858	led	_	
15-31	2859-2861	to	_	
15-32	2862-2865	the	_	
15-33	2866-2871	early	_	
15-34	2872-2882	hypothesis	_	
15-35	2883-2887	that	_	
15-36	2888-2893	human	_	
15-37	2894-2899	brain	_	
15-38	2900-2909	evolution	_	
15-39	2910-2913	may	_	
15-40	2914-2918	have	_	
15-41	2919-2925	played	_	
15-42	2926-2927	a	_	
15-43	2928-2932	role	_	
15-44	2933-2935	in	_	
15-45	2936-2949	vulnerability	_	
15-46	2950-2952	to	_	
15-47	2953-2956	the	_	
15-48	2957-2965	disorder	_	
15-49	2965-2966	.	_	

#Text=The early theories of an evolutionary origin of psychosis were motivated by the observations of enhanced cerebral asymmetry in humans compared to other primates combined with observations of reduced corpus callosum connectivity and asymmetrical changes of ventricular size in patients with schizophrenia.
16-1	2967-2970	The	_	
16-2	2971-2976	early	_	
16-3	2977-2985	theories	_	
16-4	2986-2988	of	_	
16-5	2989-2991	an	_	
16-6	2992-3004	evolutionary	_	
16-7	3005-3011	origin	_	
16-8	3012-3014	of	_	
16-9	3015-3024	psychosis	_	
16-10	3025-3029	were	_	
16-11	3030-3039	motivated	_	
16-12	3040-3042	by	_	
16-13	3043-3046	the	_	
16-14	3047-3059	observations	_	
16-15	3060-3062	of	_	
16-16	3063-3071	enhanced	_	
16-17	3072-3080	cerebral	_	
16-18	3081-3090	asymmetry	_	
16-19	3091-3093	in	_	
16-20	3094-3100	humans	_	
16-21	3101-3109	compared	_	
16-22	3110-3112	to	_	
16-23	3113-3118	other	_	
16-24	3119-3127	primates	_	
16-25	3128-3136	combined	_	
16-26	3137-3141	with	_	
16-27	3142-3154	observations	_	
16-28	3155-3157	of	_	
16-29	3158-3165	reduced	_	
16-30	3166-3172	corpus	_	
16-31	3173-3181	callosum	_	
16-32	3182-3194	connectivity	_	
16-33	3195-3198	and	_	
16-34	3199-3211	asymmetrical	_	
16-35	3212-3219	changes	_	
16-36	3220-3222	of	_	
16-37	3223-3234	ventricular	_	
16-38	3235-3239	size	_	
16-39	3240-3242	in	_	
16-40	3243-3251	patients	_	
16-41	3252-3256	with	_	
16-42	3257-3270	schizophrenia	_	
16-43	3270-3271	.	_	

#Text=It was particularly hypothesized that schizophrenia may be related to the evolution of cognitive functions and complex social cognition and accompanying development of inter-regional neural connectivity in hominins, rendering the brain vulnerable to alterations within these brain circuits.
17-1	3272-3274	It	_	
17-2	3275-3278	was	_	
17-3	3279-3291	particularly	_	
17-4	3292-3304	hypothesized	_	
17-5	3305-3309	that	_	
17-6	3310-3323	schizophrenia	_	
17-7	3324-3327	may	_	
17-8	3328-3330	be	_	
17-9	3331-3338	related	_	
17-10	3339-3341	to	_	
17-11	3342-3345	the	_	
17-12	3346-3355	evolution	_	
17-13	3356-3358	of	_	
17-14	3359-3368	cognitive	_	
17-15	3369-3378	functions	_	
17-16	3379-3382	and	_	
17-17	3383-3390	complex	_	
17-18	3391-3397	social	_	
17-19	3398-3407	cognition	_	
17-20	3408-3411	and	_	
17-21	3412-3424	accompanying	_	
17-22	3425-3436	development	_	
17-23	3437-3439	of	_	
17-24	3440-3454	inter-regional	_	
17-25	3455-3461	neural	_	
17-26	3462-3474	connectivity	_	
17-27	3475-3477	in	_	
17-28	3478-3486	hominins	_	
17-29	3486-3487	,	_	
17-30	3488-3497	rendering	_	
17-31	3498-3501	the	_	
17-32	3502-3507	brain	_	
17-33	3508-3518	vulnerable	_	
17-34	3519-3521	to	_	
17-35	3522-3533	alterations	_	
17-36	3534-3540	within	_	
17-37	3541-3546	these	_	
17-38	3547-3552	brain	_	
17-39	3553-3561	circuits	_	
17-40	3561-3562	.	_	

#Text=Emerging evidence from modern-day studies of the network structure of the human brain—the human connectome—have suggested that schizophrenia may involve a disruption of the brain’s large-scale connectivity architecture (; for a review see).
18-1	3563-3571	Emerging	_	
18-2	3572-3580	evidence	_	
18-3	3581-3585	from	_	
18-4	3586-3596	modern-day	_	
18-5	3597-3604	studies	_	
18-6	3605-3607	of	_	
18-7	3608-3611	the	_	
18-8	3612-3619	network	_	
18-9	3620-3629	structure	_	
18-10	3630-3632	of	_	
18-11	3633-3636	the	_	
18-12	3637-3642	human	_	
18-13	3643-3652	brain—the	_	
18-14	3653-3658	human	_	
18-15	3659-3674	connectome—have	_	
18-16	3675-3684	suggested	_	
18-17	3685-3689	that	_	
18-18	3690-3703	schizophrenia	_	
18-19	3704-3707	may	_	
18-20	3708-3715	involve	_	
18-21	3716-3717	a	_	
18-22	3718-3728	disruption	_	
18-23	3729-3731	of	_	
18-24	3732-3735	the	_	
18-25	3736-3741	brain	_	
18-26	3741-3742	’	_	
18-27	3742-3743	s	_	
18-28	3744-3755	large-scale	_	
18-29	3756-3768	connectivity	_	
18-30	3769-3781	architecture	_	
18-31	3782-3783	(	_	
18-32	3783-3784	;	_	
18-33	3785-3788	for	_	
18-34	3789-3790	a	_	
18-35	3791-3797	review	_	
18-36	3798-3801	see	_	
18-37	3801-3802	)	_	
18-38	3802-3803	.	_	

#Text=This collectively leads to the question of whether evolutionary modifications in the human connectome played a role in the vulnerability and emergence of cerebral dysconnectivity associated with schizophrenia.
19-1	3804-3808	This	_	
19-2	3809-3821	collectively	_	
19-3	3822-3827	leads	_	
19-4	3828-3830	to	_	
19-5	3831-3834	the	_	
19-6	3835-3843	question	_	
19-7	3844-3846	of	_	
19-8	3847-3854	whether	_	
19-9	3855-3867	evolutionary	_	
19-10	3868-3881	modifications	_	
19-11	3882-3884	in	_	
19-12	3885-3888	the	_	
19-13	3889-3894	human	_	
19-14	3895-3905	connectome	_	
19-15	3906-3912	played	_	
19-16	3913-3914	a	_	
19-17	3915-3919	role	_	
19-18	3920-3922	in	_	
19-19	3923-3926	the	_	
19-20	3927-3940	vulnerability	_	
19-21	3941-3944	and	_	
19-22	3945-3954	emergence	_	
19-23	3955-3957	of	_	
19-24	3958-3966	cerebral	_	
19-25	3967-3982	dysconnectivity	_	
19-26	3983-3993	associated	_	
19-27	3994-3998	with	_	
19-28	3999-4012	schizophrenia	_	
19-29	4012-4013	.	_	

#Text=One approach to investigating the evolution of human brain connectivity and its potential relationship to psychiatric traits is to compare human brain organization with that of other living primate species, especially with our closest living primate relative, the chimpanzee.
20-1	4014-4017	One	_	
20-2	4018-4026	approach	_	
20-3	4027-4029	to	_	
20-4	4030-4043	investigating	_	
20-5	4044-4047	the	_	
20-6	4048-4057	evolution	_	
20-7	4058-4060	of	_	
20-8	4061-4066	human	_	
20-9	4067-4072	brain	_	
20-10	4073-4085	connectivity	_	
20-11	4086-4089	and	_	
20-12	4090-4093	its	_	
20-13	4094-4103	potential	_	
20-14	4104-4116	relationship	_	
20-15	4117-4119	to	_	
20-16	4120-4131	psychiatric	_	
20-17	4132-4138	traits	_	
20-18	4139-4141	is	_	
20-19	4142-4144	to	_	
20-20	4145-4152	compare	_	
20-21	4153-4158	human	_	
20-22	4159-4164	brain	_	
20-23	4165-4177	organization	_	
20-24	4178-4182	with	_	
20-25	4183-4187	that	_	
20-26	4188-4190	of	_	
20-27	4191-4196	other	_	
20-28	4197-4203	living	_	
20-29	4204-4211	primate	_	
20-30	4212-4219	species	_	
20-31	4219-4220	,	_	
20-32	4221-4231	especially	_	
20-33	4232-4236	with	_	
20-34	4237-4240	our	_	
20-35	4241-4248	closest	_	
20-36	4249-4255	living	_	
20-37	4256-4263	primate	_	
20-38	4264-4272	relative	_	
20-39	4272-4273	,	_	
20-40	4274-4277	the	_	
20-41	4278-4288	chimpanzee	_	
20-42	4288-4289	.	_	

#Text=Our two species shared a last common African ancestor from about 7–8 million years ago, making chimpanzees an ideal group to study human brain evolution.
21-1	4290-4293	Our	_	
21-2	4294-4297	two	_	
21-3	4298-4305	species	_	
21-4	4306-4312	shared	_	
21-5	4313-4314	a	_	
21-6	4315-4319	last	_	
21-7	4320-4326	common	_	
21-8	4327-4334	African	_	
21-9	4335-4343	ancestor	_	
21-10	4344-4348	from	_	
21-11	4349-4354	about	_	
21-12	4355-4356	7	_	
21-13	4356-4357	–	_	
21-14	4357-4358	8	_	
21-15	4359-4366	million	_	
21-16	4367-4372	years	_	
21-17	4373-4376	ago	_	
21-18	4376-4377	,	_	
21-19	4378-4384	making	_	
21-20	4385-4396	chimpanzees	_	
21-21	4397-4399	an	_	
21-22	4400-4405	ideal	_	
21-23	4406-4411	group	_	
21-24	4412-4414	to	_	
21-25	4415-4420	study	_	
21-26	4421-4426	human	_	
21-27	4427-4432	brain	_	
21-28	4433-4442	evolution	_	
21-29	4442-4443	.	_	

#Text=Larger brain size across primates is associated with reduced interhemispheric and increased intrahemispheric connectivity, with encephalization argued to lead to an increasing dependence of brain function on the effectiveness of evolutionarily new connectivity.
22-1	4444-4450	Larger	_	
22-2	4451-4456	brain	_	
22-3	4457-4461	size	_	
22-4	4462-4468	across	_	
22-5	4469-4477	primates	_	
22-6	4478-4480	is	_	
22-7	4481-4491	associated	_	
22-8	4492-4496	with	_	
22-9	4497-4504	reduced	_	
22-10	4505-4521	interhemispheric	_	
22-11	4522-4525	and	_	
22-12	4526-4535	increased	_	
22-13	4536-4552	intrahemispheric	_	
22-14	4553-4565	connectivity	_	
22-15	4565-4566	,	_	
22-16	4567-4571	with	_	
22-17	4572-4587	encephalization	_	
22-18	4588-4594	argued	_	
22-19	4595-4597	to	_	
22-20	4598-4602	lead	_	
22-21	4603-4605	to	_	
22-22	4606-4608	an	_	
22-23	4609-4619	increasing	_	
22-24	4620-4630	dependence	_	
22-25	4631-4633	of	_	
22-26	4634-4639	brain	_	
22-27	4640-4648	function	_	
22-28	4649-4651	on	_	
22-29	4652-4655	the	_	
22-30	4656-4669	effectiveness	_	
22-31	4670-4672	of	_	
22-32	4673-4687	evolutionarily	_	
22-33	4688-4691	new	_	
22-34	4692-4704	connectivity	_	
22-35	4704-4705	.	_	

#Text=Human-specific modifications in brain wiring of the connectome may thus support increasing efficiency of global brain network communication of multimodal association regions, arguably in service of development of more complex cognitive brain functions in humans.
23-1	4706-4720	Human-specific	_	
23-2	4721-4734	modifications	_	
23-3	4735-4737	in	_	
23-4	4738-4743	brain	_	
23-5	4744-4750	wiring	_	
23-6	4751-4753	of	_	
23-7	4754-4757	the	_	
23-8	4758-4768	connectome	_	
23-9	4769-4772	may	_	
23-10	4773-4777	thus	_	
23-11	4778-4785	support	_	
23-12	4786-4796	increasing	_	
23-13	4797-4807	efficiency	_	
23-14	4808-4810	of	_	
23-15	4811-4817	global	_	
23-16	4818-4823	brain	_	
23-17	4824-4831	network	_	
23-18	4832-4845	communication	_	
23-19	4846-4848	of	_	
23-20	4849-4859	multimodal	_	
23-21	4860-4871	association	_	
23-22	4872-4879	regions	_	
23-23	4879-4880	,	_	
23-24	4881-4889	arguably	_	
23-25	4890-4892	in	_	
23-26	4893-4900	service	_	
23-27	4901-4903	of	_	
23-28	4904-4915	development	_	
23-29	4916-4918	of	_	
23-30	4919-4923	more	_	
23-31	4924-4931	complex	_	
23-32	4932-4941	cognitive	_	
23-33	4942-4947	brain	_	
23-34	4948-4957	functions	_	
23-35	4958-4960	in	_	
23-36	4961-4967	humans	_	
23-37	4967-4968	.	_	

#Text=This selection pressure for effective information transfer between remote brain regions may have been paralleled by an increasing risk of disruption in these circuits and the cognitive brain functions they support.
24-1	4969-4973	This	_	
24-2	4974-4983	selection	_	
24-3	4984-4992	pressure	_	
24-4	4993-4996	for	_	
24-5	4997-5006	effective	_	
24-6	5007-5018	information	_	
24-7	5019-5027	transfer	_	
24-8	5028-5035	between	_	
24-9	5036-5042	remote	_	
24-10	5043-5048	brain	_	
24-11	5049-5056	regions	_	
24-12	5057-5060	may	_	
24-13	5061-5065	have	_	
24-14	5066-5070	been	_	
24-15	5071-5081	paralleled	_	
24-16	5082-5084	by	_	
24-17	5085-5087	an	_	
24-18	5088-5098	increasing	_	
24-19	5099-5103	risk	_	
24-20	5104-5106	of	_	
24-21	5107-5117	disruption	_	
24-22	5118-5120	in	_	
24-23	5121-5126	these	_	
24-24	5127-5135	circuits	_	
24-25	5136-5139	and	_	
24-26	5140-5143	the	_	
24-27	5144-5153	cognitive	_	
24-28	5154-5159	brain	_	
24-29	5160-5169	functions	_	
24-30	5170-5174	they	_	
24-31	5175-5182	support	_	
24-32	5182-5183	.	_	

#Text=Modifications in human brain connectivity may as such have played a role in a higher risk of emergence of human-unique brain disorders like schizophrenia.
25-1	5184-5197	Modifications	_	
25-2	5198-5200	in	_	
25-3	5201-5206	human	_	
25-4	5207-5212	brain	_	
25-5	5213-5225	connectivity	_	
25-6	5226-5229	may	_	
25-7	5230-5232	as	_	
25-8	5233-5237	such	_	
25-9	5238-5242	have	_	
25-10	5243-5249	played	_	
25-11	5250-5251	a	_	
25-12	5252-5256	role	_	
25-13	5257-5259	in	_	
25-14	5260-5261	a	_	
25-15	5262-5268	higher	_	
25-16	5269-5273	risk	_	
25-17	5274-5276	of	_	
25-18	5277-5286	emergence	_	
25-19	5287-5289	of	_	
25-20	5290-5302	human-unique	_	
25-21	5303-5308	brain	_	
25-22	5309-5318	disorders	_	
25-23	5319-5323	like	_	
25-24	5324-5337	schizophrenia	_	
25-25	5337-5338	.	_	

#Text=We used the framework of comparative connectomics —the field that studies commonalities and differences in the topological organization of brain circuits across species—to evaluate the proposed role of brain connectivity evolution in the hominid group in the context of vulnerability for schizophrenia.
26-1	5339-5341	We	_	
26-2	5342-5346	used	_	
26-3	5347-5350	the	_	
26-4	5351-5360	framework	_	
26-5	5361-5363	of	_	
26-6	5364-5375	comparative	_	
26-7	5376-5388	connectomics	_	
26-8	5389-5390	—	_	
26-9	5390-5393	the	_	
26-10	5394-5399	field	_	
26-11	5400-5404	that	_	
26-12	5405-5412	studies	_	
26-13	5413-5426	commonalities	_	
26-14	5427-5430	and	_	
26-15	5431-5442	differences	_	
26-16	5443-5445	in	_	
26-17	5446-5449	the	_	
26-18	5450-5461	topological	_	
26-19	5462-5474	organization	_	
26-20	5475-5477	of	_	
26-21	5478-5483	brain	_	
26-22	5484-5492	circuits	_	
26-23	5493-5499	across	_	
26-24	5500-5510	species—to	_	
26-25	5511-5519	evaluate	_	
26-26	5520-5523	the	_	
26-27	5524-5532	proposed	_	
26-28	5533-5537	role	_	
26-29	5538-5540	of	_	
26-30	5541-5546	brain	_	
26-31	5547-5559	connectivity	_	
26-32	5560-5569	evolution	_	
26-33	5570-5572	in	_	
26-34	5573-5576	the	_	
26-35	5577-5584	hominid	_	
26-36	5585-5590	group	_	
26-37	5591-5593	in	_	
26-38	5594-5597	the	_	
26-39	5598-5605	context	_	
26-40	5606-5608	of	_	
26-41	5609-5622	vulnerability	_	
26-42	5623-5626	for	_	
26-43	5627-5640	schizophrenia	_	
26-44	5640-5641	.	_	

#Text=We compare human and chimpanzee brain network organization and provide evidence that the pattern of schizophrenia brain dysconnectivity overlaps with recent evolutionary changes to human brain connectivity.
27-1	5642-5644	We	_	
27-2	5645-5652	compare	_	
27-3	5653-5658	human	_	
27-4	5659-5662	and	_	
27-5	5663-5673	chimpanzee	_	
27-6	5674-5679	brain	_	
27-7	5680-5687	network	_	
27-8	5688-5700	organization	_	
27-9	5701-5704	and	_	
27-10	5705-5712	provide	_	
27-11	5713-5721	evidence	_	
27-12	5722-5726	that	_	
27-13	5727-5730	the	_	
27-14	5731-5738	pattern	_	
27-15	5739-5741	of	_	
27-16	5742-5755	schizophrenia	_	
27-17	5756-5761	brain	_	
27-18	5762-5777	dysconnectivity	_	
27-19	5778-5786	overlaps	_	
27-20	5787-5791	with	_	
27-21	5792-5798	recent	_	
27-22	5799-5811	evolutionary	_	
27-23	5812-5819	changes	_	
27-24	5820-5822	to	_	
27-25	5823-5828	human	_	
27-26	5829-5834	brain	_	
27-27	5835-5847	connectivity	_	
27-28	5847-5848	.	_	

#Text=Materials and methods
#Text=Subjects and data acquisition
#Text=Principal schizophrenia dataset
#Text=MRI data of the principal schizophrenia dataset included the examination of 3 T T1 and diffusion-weighted imaging (DWI) data of 48 patients with schizophrenia and 43 age- and gender-matched healthy control subjects (demographics listed in Supplementary Table 2 and).
28-1	5849-5858	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[1]	
28-2	5859-5862	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[1]	
28-3	5863-5870	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[1]	
28-4	5871-5879	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-5	5880-5883	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-6	5884-5888	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-7	5889-5900	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-8	5901-5910	Principal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-9	5911-5924	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-10	5925-5932	dataset	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-11	5933-5936	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[3]	
28-12	5937-5941	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-13	5942-5944	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-14	5945-5948	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-15	5949-5958	principal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-16	5959-5972	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[4]	
28-17	5973-5980	dataset	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-18	5981-5989	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-19	5990-5993	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-20	5994-6005	examination	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-21	6006-6008	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-22	6009-6010	3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-23	6011-6012	T	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-24	6013-6015	T1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-25	6016-6019	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-26	6020-6038	diffusion-weighted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[5]	
28-27	6039-6046	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[5]	
28-28	6047-6048	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[5]	
28-29	6048-6051	DWI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[5]	
28-30	6051-6052	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[5]	
28-31	6053-6057	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-32	6058-6060	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-33	6061-6063	48	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-34	6064-6072	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-35	6073-6077	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-36	6078-6091	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
28-37	6092-6095	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-38	6096-6098	43	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-39	6099-6102	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-40	6102-6103	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-41	6104-6107	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-42	6108-6122	gender-matched	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-43	6123-6130	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
28-44	6131-6138	control	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
28-45	6139-6147	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-46	6148-6149	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-47	6149-6161	demographics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-48	6162-6168	listed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-49	6169-6171	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-50	6172-6185	Supplementary	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-51	6186-6191	Table	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-52	6192-6193	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-53	6194-6197	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-54	6197-6198	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
28-55	6198-6199	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	

#Text=All participants provided informed consent as approved by the local medical ethics committee for research in humans (METC), with procedures carried out according to the directives of the Declaration of Helsinki (amendment of Edinburgh, 2000).
29-1	6200-6203	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-2	6204-6216	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-3	6217-6225	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-4	6226-6234	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-5	6235-6242	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-6	6243-6245	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-7	6246-6254	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-8	6255-6257	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-9	6258-6261	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-10	6262-6267	local	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-11	6268-6275	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-12	6276-6282	ethics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-13	6283-6292	committee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-14	6293-6296	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-15	6297-6305	research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-16	6306-6308	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-17	6309-6315	humans	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-18	6316-6317	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-19	6317-6321	METC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-20	6321-6322	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-21	6322-6323	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-22	6324-6328	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-23	6329-6339	procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-24	6340-6347	carried	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-25	6348-6351	out	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-26	6352-6361	according	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-27	6362-6364	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-28	6365-6368	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-29	6369-6379	directives	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-30	6380-6382	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-31	6383-6386	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-32	6387-6398	Declaration	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-33	6399-6401	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-34	6402-6410	Helsinki	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-35	6411-6412	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-36	6412-6421	amendment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-37	6422-6424	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-38	6425-6434	Edinburgh	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-39	6434-6435	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-40	6436-6440	2000	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-41	6440-6441	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
29-42	6441-6442	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	

#Text=MRI data were acquired on a clinical Philips MRI scanner and included the acquisition of a T1 scan and a DWI scan (Supplementary material).
30-1	6443-6446	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
30-2	6447-6451	data	_	
30-3	6452-6456	were	_	
30-4	6457-6465	acquired	_	
30-5	6466-6468	on	_	
30-6	6469-6470	a	_	
30-7	6471-6479	clinical	_	
30-8	6480-6487	Philips	_	
30-9	6488-6491	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
30-10	6492-6499	scanner	_	
30-11	6500-6503	and	_	
30-12	6504-6512	included	_	
30-13	6513-6516	the	_	
30-14	6517-6528	acquisition	_	
30-15	6529-6531	of	_	
30-16	6532-6533	a	_	
30-17	6534-6536	T1	_	
30-18	6537-6541	scan	_	
30-19	6542-6545	and	_	
30-20	6546-6547	a	_	
30-21	6548-6551	DWI	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging	
30-22	6552-6556	scan	_	
30-23	6557-6558	(	_	
30-24	6558-6571	Supplementary	_	
30-25	6572-6580	material	_	
30-26	6580-6581	)	_	
30-27	6581-6582	.	_	

#Text=Schizophrenia validation datasets
#Text=Effects were validated in two additional, independent schizophrenia validation datasets (datasets acquired on 3 T scanner with the same imaging protocol as the principal dataset), including 40 patients and 37 healthy controls and 30 patients and 33 healthy controls, respectively (Supplementary Table 3).
31-1	6583-6596	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
31-2	6597-6607	validation	_	
31-3	6608-6616	datasets	_	
31-4	6617-6624	Effects	_	
31-5	6625-6629	were	_	
31-6	6630-6639	validated	_	
31-7	6640-6642	in	_	
31-8	6643-6646	two	_	
31-9	6647-6657	additional	_	
31-10	6657-6658	,	_	
31-11	6659-6670	independent	_	
31-12	6671-6684	schizophrenia	_	
31-13	6685-6695	validation	_	
31-14	6696-6704	datasets	_	
31-15	6705-6706	(	_	
31-16	6706-6714	datasets	_	
31-17	6715-6723	acquired	_	
31-18	6724-6726	on	_	
31-19	6727-6728	3	_	
31-20	6729-6730	T	_	
31-21	6731-6738	scanner	_	
31-22	6739-6743	with	_	
31-23	6744-6747	the	_	
31-24	6748-6752	same	_	
31-25	6753-6760	imaging	_	
31-26	6761-6769	protocol	_	
31-27	6770-6772	as	_	
31-28	6773-6776	the	_	
31-29	6777-6786	principal	_	
31-30	6787-6794	dataset	_	
31-31	6794-6795	)	_	
31-32	6795-6796	,	_	
31-33	6797-6806	including	_	
31-34	6807-6809	40	_	
31-35	6810-6818	patients	_	
31-36	6819-6822	and	_	
31-37	6823-6825	37	_	
31-38	6826-6833	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[9]	
31-39	6834-6842	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[9]	
31-40	6843-6846	and	_	
31-41	6847-6849	30	_	
31-42	6850-6858	patients	_	
31-43	6859-6862	and	_	
31-44	6863-6865	33	_	
31-45	6866-6873	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[10]	
31-46	6874-6882	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[10]	
31-47	6882-6883	,	_	
31-48	6884-6896	respectively	_	
31-49	6897-6898	(	_	
31-50	6898-6911	Supplementary	_	
31-51	6912-6917	Table	_	
31-52	6918-6919	3	_	
31-53	6919-6920	)	_	
31-54	6920-6921	.	_	

#Text=Other disorders
#Text=To examine specificity in brain connectivity effects to schizophrenia, we additionally included T1 and DWI data of seven other brain conditions (all in their own way related to changes to white matter connectivity), including major depressive disorder (MDD, patients/matched controls n = 211/476), obsessive-compulsive disorder (OCD, n = 36/42), bipolar disorder (n = 147/477), autism spectrum disorder (ASD, n = 73/64, ABIDE dataset), behavioural variant frontotemporal dementia (bvFTD, n = 20/20), Alzheimer’s disease (n = 20/20) and mild cognitive impairment (MCI, n = 28/28).
32-1	6922-6927	Other	_	
32-2	6928-6937	disorders	_	
32-3	6938-6940	To	_	
32-4	6941-6948	examine	_	
32-5	6949-6960	specificity	_	
32-6	6961-6963	in	_	
32-7	6964-6969	brain	_	
32-8	6970-6982	connectivity	_	
32-9	6983-6990	effects	_	
32-10	6991-6993	to	_	
32-11	6994-7007	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
32-12	7007-7008	,	_	
32-13	7009-7011	we	_	
32-14	7012-7024	additionally	_	
32-15	7025-7033	included	_	
32-16	7034-7036	T1	_	
32-17	7037-7040	and	_	
32-18	7041-7044	DWI	_	
32-19	7045-7049	data	_	
32-20	7050-7052	of	_	
32-21	7053-7058	seven	_	
32-22	7059-7064	other	_	
32-23	7065-7070	brain	_	
32-24	7071-7081	conditions	_	
32-25	7082-7083	(	_	
32-26	7083-7086	all	_	
32-27	7087-7089	in	_	
32-28	7090-7095	their	_	
32-29	7096-7099	own	_	
32-30	7100-7103	way	_	
32-31	7104-7111	related	_	
32-32	7112-7114	to	_	
32-33	7115-7122	changes	_	
32-34	7123-7125	to	_	
32-35	7126-7131	white	_	
32-36	7132-7138	matter	_	
32-37	7139-7151	connectivity	_	
32-38	7151-7152	)	_	
32-39	7152-7153	,	_	
32-40	7154-7163	including	_	
32-41	7164-7169	major	_	
32-42	7170-7180	depressive	_	
32-43	7181-7189	disorder	_	
32-44	7190-7191	(	_	
32-45	7191-7194	MDD	_	
32-46	7194-7195	,	_	
32-47	7196-7204	patients	_	
32-48	7204-7205	/	_	
32-49	7205-7212	matched	_	
32-50	7213-7221	controls	_	
32-51	7222-7223	n	_	
32-52	7224-7225	=	_	
32-53	7226-7229	211	_	
32-54	7229-7230	/	_	
32-55	7230-7233	476	_	
32-56	7233-7234	)	_	
32-57	7234-7235	,	_	
32-58	7236-7256	obsessive-compulsive	_	
32-59	7257-7265	disorder	_	
32-60	7266-7267	(	_	
32-61	7267-7270	OCD	_	
32-62	7270-7271	,	_	
32-63	7272-7273	n	_	
32-64	7274-7275	=	_	
32-65	7276-7278	36	_	
32-66	7278-7279	/	_	
32-67	7279-7281	42	_	
32-68	7281-7282	)	_	
32-69	7282-7283	,	_	
32-70	7284-7291	bipolar	_	
32-71	7292-7300	disorder	_	
32-72	7301-7302	(	_	
32-73	7302-7303	n	_	
32-74	7304-7305	=	_	
32-75	7306-7309	147	_	
32-76	7309-7310	/	_	
32-77	7310-7313	477	_	
32-78	7313-7314	)	_	
32-79	7314-7315	,	_	
32-80	7316-7322	autism	_	
32-81	7323-7331	spectrum	_	
32-82	7332-7340	disorder	_	
32-83	7341-7342	(	_	
32-84	7342-7345	ASD	_	
32-85	7345-7346	,	_	
32-86	7347-7348	n	_	
32-87	7349-7350	=	_	
32-88	7351-7353	73	_	
32-89	7353-7354	/	_	
32-90	7354-7356	64	_	
32-91	7356-7357	,	_	
32-92	7358-7363	ABIDE	_	
32-93	7364-7371	dataset	_	
32-94	7371-7372	)	_	
32-95	7372-7373	,	_	
32-96	7374-7385	behavioural	_	
32-97	7386-7393	variant	_	
32-98	7394-7408	frontotemporal	_	
32-99	7409-7417	dementia	_	
32-100	7418-7419	(	_	
32-101	7419-7424	bvFTD	_	
32-102	7424-7425	,	_	
32-103	7426-7427	n	_	
32-104	7428-7429	=	_	
32-105	7430-7432	20	_	
32-106	7432-7433	/	_	
32-107	7433-7435	20	_	
32-108	7435-7436	)	_	
32-109	7436-7437	,	_	
32-110	7438-7447	Alzheimer	_	
32-111	7447-7448	’	_	
32-112	7448-7449	s	_	
32-113	7450-7457	disease	_	
32-114	7458-7459	(	_	
32-115	7459-7460	n	_	
32-116	7461-7462	=	_	
32-117	7463-7465	20	_	
32-118	7465-7466	/	_	
32-119	7466-7468	20	_	
32-120	7468-7469	)	_	
32-121	7470-7473	and	_	
32-122	7474-7478	mild	_	
32-123	7479-7488	cognitive	_	
32-124	7489-7499	impairment	_	
32-125	7500-7501	(	_	
32-126	7501-7504	MCI	_	
32-127	7504-7505	,	_	
32-128	7506-7507	n	_	
32-129	7508-7509	=	_	
32-130	7510-7512	28	_	
32-131	7512-7513	/	_	
32-132	7513-7515	28	_	
32-133	7515-7516	)	_	
32-134	7516-7517	.	_	

#Text=Details on these datasets are provided in the Supplementary material and Supplementary Tables 6 and 7 and.
33-1	7518-7525	Details	_	
33-2	7526-7528	on	_	
33-3	7529-7534	these	_	
33-4	7535-7543	datasets	_	
33-5	7544-7547	are	_	
33-6	7548-7556	provided	_	
33-7	7557-7559	in	_	
33-8	7560-7563	the	_	
33-9	7564-7577	Supplementary	_	
33-10	7578-7586	material	_	
33-11	7587-7590	and	_	
33-12	7591-7604	Supplementary	_	
33-13	7605-7611	Tables	_	
33-14	7612-7613	6	_	
33-15	7614-7617	and	_	
33-16	7618-7619	7	_	
33-17	7620-7623	and	_	
33-18	7623-7624	.	_	

#Text=To validate that observed schizophrenia effects were independent of acquisition method, a fourth dataset of patients with schizophrenia was included by means of the open SchizoConnect COBRE dataset (SCZcobre, n = 65/75).
34-1	7625-7627	To	_	
34-2	7628-7636	validate	_	
34-3	7637-7641	that	_	
34-4	7642-7650	observed	_	
34-5	7651-7664	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
34-6	7665-7672	effects	_	
34-7	7673-7677	were	_	
34-8	7678-7689	independent	_	
34-9	7690-7692	of	_	
34-10	7693-7704	acquisition	_	
34-11	7705-7711	method	_	
34-12	7711-7712	,	_	
34-13	7713-7714	a	_	
34-14	7715-7721	fourth	_	
34-15	7722-7729	dataset	_	
34-16	7730-7732	of	_	
34-17	7733-7741	patients	_	
34-18	7742-7746	with	_	
34-19	7747-7760	schizophrenia	_	
34-20	7761-7764	was	_	
34-21	7765-7773	included	_	
34-22	7774-7776	by	_	
34-23	7777-7782	means	_	
34-24	7783-7785	of	_	
34-25	7786-7789	the	_	
34-26	7790-7794	open	_	
34-27	7795-7808	SchizoConnect	_	
34-28	7809-7814	COBRE	_	
34-29	7815-7822	dataset	_	
34-30	7823-7824	(	_	
34-31	7824-7832	SCZcobre	_	
34-32	7832-7833	,	_	
34-33	7834-7835	n	_	
34-34	7836-7837	=	_	
34-35	7838-7840	65	_	
34-36	7840-7841	/	_	
34-37	7841-7843	75	_	
34-38	7843-7844	)	_	
34-39	7844-7845	.	_	

#Text=Primates and human dataset
#Text=T1 and DWI from 22 adult chimpanzees (Pan troglodytes, 29.4 ± 12.8 years) and 58 adult age-matched human subjects were included (Homo sapiens, 42.5 ± 9.8 years) (Supplementary material).
35-1	7846-7854	Primates	_	
35-2	7855-7858	and	_	
35-3	7859-7864	human	_	
35-4	7865-7872	dataset	_	
35-5	7873-7875	T1	_	
35-6	7876-7879	and	_	
35-7	7880-7883	DWI	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging	
35-8	7884-7888	from	_	
35-9	7889-7891	22	_	
35-10	7892-7897	adult	_	
35-11	7898-7909	chimpanzees	_	
35-12	7910-7911	(	_	
35-13	7911-7914	Pan	_	
35-14	7915-7926	troglodytes	_	
35-15	7926-7927	,	_	
35-16	7928-7932	29.4	_	
35-17	7933-7934	±	_	
35-18	7935-7939	12.8	_	
35-19	7940-7945	years	_	
35-20	7945-7946	)	_	
35-21	7947-7950	and	_	
35-22	7951-7953	58	_	
35-23	7954-7959	adult	_	
35-24	7960-7971	age-matched	_	
35-25	7972-7977	human	_	
35-26	7978-7986	subjects	_	
35-27	7987-7991	were	_	
35-28	7992-8000	included	_	
35-29	8001-8002	(	_	
35-30	8002-8006	Homo	_	
35-31	8007-8014	sapiens	_	
35-32	8014-8015	,	_	
35-33	8016-8020	42.5	_	
35-34	8021-8022	±	_	
35-35	8023-8026	9.8	_	
35-36	8027-8032	years	_	
35-37	8032-8033	)	_	
35-38	8034-8035	(	_	
35-39	8035-8048	Supplementary	_	
35-40	8049-8057	material	_	
35-41	8057-8058	)	_	
35-42	8058-8059	.	_	

#Text=No new chimpanzee MRI data were acquired for this study.
36-1	8060-8062	No	_	
36-2	8063-8066	new	_	
36-3	8067-8077	chimpanzee	_	
36-4	8078-8081	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
36-5	8082-8086	data	_	
36-6	8087-8091	were	_	
36-7	8092-8100	acquired	_	
36-8	8101-8104	for	_	
36-9	8105-8109	this	_	
36-10	8110-8115	study	_	
36-11	8115-8116	.	_	

#Text=All chimpanzee MRIs were obtained from a data archive of scans obtained prior to the 2015 implementation of US Fish and Wildlife Service and National Institutes of Health regulations governing research with chimpanzees, with all chimpanzee scans completed by the end of 2012.
37-1	8117-8120	All	_	
37-2	8121-8131	chimpanzee	_	
37-3	8132-8136	MRIs	_	
37-4	8137-8141	were	_	
37-5	8142-8150	obtained	_	
37-6	8151-8155	from	_	
37-7	8156-8157	a	_	
37-8	8158-8162	data	_	
37-9	8163-8170	archive	_	
37-10	8171-8173	of	_	
37-11	8174-8179	scans	_	
37-12	8180-8188	obtained	_	
37-13	8189-8194	prior	_	
37-14	8195-8197	to	_	
37-15	8198-8201	the	_	
37-16	8202-8206	2015	_	
37-17	8207-8221	implementation	_	
37-18	8222-8224	of	_	
37-19	8225-8227	US	_	
37-20	8228-8232	Fish	_	
37-21	8233-8236	and	_	
37-22	8237-8245	Wildlife	_	
37-23	8246-8253	Service	_	
37-24	8254-8257	and	_	
37-25	8258-8266	National	_	
37-26	8267-8277	Institutes	_	
37-27	8278-8280	of	_	
37-28	8281-8287	Health	_	
37-29	8288-8299	regulations	_	
37-30	8300-8309	governing	_	
37-31	8310-8318	research	_	
37-32	8319-8323	with	_	
37-33	8324-8335	chimpanzees	_	
37-34	8335-8336	,	_	
37-35	8337-8341	with	_	
37-36	8342-8345	all	_	
37-37	8346-8356	chimpanzee	_	
37-38	8357-8362	scans	_	
37-39	8363-8372	completed	_	
37-40	8373-8375	by	_	
37-41	8376-8379	the	_	
37-42	8380-8383	end	_	
37-43	8384-8386	of	_	
37-44	8387-8391	2012	_	
37-45	8391-8392	.	_	

#Text=Data are archived in the National Chimpanzee Brain Resource (https://www.chimpanzeebrain.org).
38-1	8393-8397	Data	_	
38-2	8398-8401	are	_	
38-3	8402-8410	archived	_	
38-4	8411-8413	in	_	
38-5	8414-8417	the	_	
38-6	8418-8426	National	_	
38-7	8427-8437	Chimpanzee	_	
38-8	8438-8443	Brain	_	
38-9	8444-8452	Resource	_	
38-10	8453-8454	(	_	
38-11	8454-8459	https	_	
38-12	8459-8460	:	_	
38-13	8460-8461	/	_	
38-14	8461-8462	/	_	
38-15	8462-8485	www.chimpanzeebrain.org	_	
38-16	8485-8486	)	_	
38-17	8486-8487	.	_	

#Text=T1 and DWI data of eight rhesus macaques (Macaca mulatta, 14 ± 6.7 years) were included as an outgroup.
39-1	8488-8490	T1	_	
39-2	8491-8494	and	_	
39-3	8495-8498	DWI	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging	
39-4	8499-8503	data	_	
39-5	8504-8506	of	_	
39-6	8507-8512	eight	_	
39-7	8513-8519	rhesus	_	
39-8	8520-8528	macaques	_	
39-9	8529-8530	(	_	
39-10	8530-8536	Macaca	_	
39-11	8537-8544	mulatta	_	
39-12	8544-8545	,	_	
39-13	8546-8548	14	_	
39-14	8549-8550	±	_	
39-15	8551-8554	6.7	_	
39-16	8555-8560	years	_	
39-17	8560-8561	)	_	
39-18	8562-8566	were	_	
39-19	8567-8575	included	_	
39-20	8576-8578	as	_	
39-21	8579-8581	an	_	
39-22	8582-8590	outgroup	_	
39-23	8590-8591	.	_	

#Text=MRI data were acquired on Siemens 3 T Trio Tim Scanners and included the acquisition of a structural T1 scan and a diffusion MRI scan.
40-1	8592-8595	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
40-2	8596-8600	data	_	
40-3	8601-8605	were	_	
40-4	8606-8614	acquired	_	
40-5	8615-8617	on	_	
40-6	8618-8625	Siemens	_	
40-7	8626-8627	3	_	
40-8	8628-8629	T	_	
40-9	8630-8634	Trio	_	
40-10	8635-8638	Tim	_	
40-11	8639-8647	Scanners	_	
40-12	8648-8651	and	_	
40-13	8652-8660	included	_	
40-14	8661-8664	the	_	
40-15	8665-8676	acquisition	_	
40-16	8677-8679	of	_	
40-17	8680-8681	a	_	
40-18	8682-8692	structural	_	
40-19	8693-8695	T1	_	
40-20	8696-8700	scan	_	
40-21	8701-8704	and	_	
40-22	8705-8706	a	_	
40-23	8707-8716	diffusion	_	
40-24	8717-8720	MRI	_	
40-25	8721-8725	scan	_	
40-26	8725-8726	.	_	

#Text=Macroscale diffusion-weighted imaging connectome construction
#Text=For each subject, the T1 image was processed using FreeSurfer, followed by parcellation of the cortex using a 114-area subdivision of the Desikan-Killiany atlas (DK-114) of cortical structures (Supplementary material).
41-1	8727-8737	Macroscale	_	
41-2	8738-8756	diffusion-weighted	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[11]	
41-3	8757-8764	imaging	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[11]	
41-4	8765-8775	connectome	_	
41-5	8776-8788	construction	_	
41-6	8789-8792	For	_	
41-7	8793-8797	each	_	
41-8	8798-8805	subject	_	
41-9	8805-8806	,	_	
41-10	8807-8810	the	_	
41-11	8811-8813	T1	_	
41-12	8814-8819	image	_	
41-13	8820-8823	was	_	
41-14	8824-8833	processed	_	
41-15	8834-8839	using	_	
41-16	8840-8850	FreeSurfer	_	
41-17	8850-8851	,	_	
41-18	8852-8860	followed	_	
41-19	8861-8863	by	_	
41-20	8864-8876	parcellation	_	
41-21	8877-8879	of	_	
41-22	8880-8883	the	_	
41-23	8884-8890	cortex	_	
41-24	8891-8896	using	_	
41-25	8897-8898	a	_	
41-26	8899-8902	114	_	
41-27	8902-8903	-	_	
41-28	8903-8907	area	_	
41-29	8908-8919	subdivision	_	
41-30	8920-8922	of	_	
41-31	8923-8926	the	_	
41-32	8927-8943	Desikan-Killiany	_	
41-33	8944-8949	atlas	_	
41-34	8950-8951	(	_	
41-35	8951-8953	DK	_	
41-36	8953-8954	-	_	
41-37	8954-8957	114	_	
41-38	8957-8958	)	_	
41-39	8959-8961	of	_	
41-40	8962-8970	cortical	_	
41-41	8971-8981	structures	_	
41-42	8982-8983	(	_	
41-43	8983-8996	Supplementary	_	
41-44	8997-9005	material	_	
41-45	9005-9006	)	_	
41-46	9006-9007	.	_	

#Text=Deterministic fibre tracking was used to reconstruct cortico-cortical connections, with the cortico-cortical connectivity matrix reconstructed by determining for each pair of cortical regions whether the two regions were interconnected by DWI streamlines [see Supplementary material for details of preprocessing and fibre tracking, including robustness analyses validating effects of movement, group-consensus masking, fibre thresholding, fibre length and validation by means of the high-resolution data from the Human Connectome Project ].
42-1	9008-9021	Deterministic	_	
42-2	9022-9027	fibre	_	
42-3	9028-9036	tracking	_	
42-4	9037-9040	was	_	
42-5	9041-9045	used	_	
42-6	9046-9048	to	_	
42-7	9049-9060	reconstruct	_	
42-8	9061-9077	cortico-cortical	_	
42-9	9078-9089	connections	_	
42-10	9089-9090	,	_	
42-11	9091-9095	with	_	
42-12	9096-9099	the	_	
42-13	9100-9116	cortico-cortical	_	
42-14	9117-9129	connectivity	_	
42-15	9130-9136	matrix	_	
42-16	9137-9150	reconstructed	_	
42-17	9151-9153	by	_	
42-18	9154-9165	determining	_	
42-19	9166-9169	for	_	
42-20	9170-9174	each	_	
42-21	9175-9179	pair	_	
42-22	9180-9182	of	_	
42-23	9183-9191	cortical	_	
42-24	9192-9199	regions	_	
42-25	9200-9207	whether	_	
42-26	9208-9211	the	_	
42-27	9212-9215	two	_	
42-28	9216-9223	regions	_	
42-29	9224-9228	were	_	
42-30	9229-9243	interconnected	_	
42-31	9244-9246	by	_	
42-32	9247-9250	DWI	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging	
42-33	9251-9262	streamlines	_	
42-34	9263-9264	[	_	
42-35	9264-9267	see	_	
42-36	9268-9281	Supplementary	_	
42-37	9282-9290	material	_	
42-38	9291-9294	for	_	
42-39	9295-9302	details	_	
42-40	9303-9305	of	_	
42-41	9306-9319	preprocessing	_	
42-42	9320-9323	and	_	
42-43	9324-9329	fibre	_	
42-44	9330-9338	tracking	_	
42-45	9338-9339	,	_	
42-46	9340-9349	including	_	
42-47	9350-9360	robustness	_	
42-48	9361-9369	analyses	_	
42-49	9370-9380	validating	_	
42-50	9381-9388	effects	_	
42-51	9389-9391	of	_	
42-52	9392-9400	movement	_	
42-53	9400-9401	,	_	
42-54	9402-9417	group-consensus	_	
42-55	9418-9425	masking	_	
42-56	9425-9426	,	_	
42-57	9427-9432	fibre	_	
42-58	9433-9445	thresholding	_	
42-59	9445-9446	,	_	
42-60	9447-9452	fibre	_	
42-61	9453-9459	length	_	
42-62	9460-9463	and	_	
42-63	9464-9474	validation	_	
42-64	9475-9477	by	_	
42-65	9478-9483	means	_	
42-66	9484-9486	of	_	
42-67	9487-9490	the	_	
42-68	9491-9506	high-resolution	_	
42-69	9507-9511	data	_	
42-70	9512-9516	from	_	
42-71	9517-9520	the	_	
42-72	9521-9526	Human	_	
42-73	9527-9537	Connectome	_	
42-74	9538-9545	Project	_	
42-75	9546-9547	]	_	
42-76	9547-9548	.	_	

#Text=We used fractional anisotropy as a metric of connectivity strength of reconstructed connections, a metric often suggested to relate to tract integrity and myelination levels and often used to examine case-control differences in connectivity strength.
43-1	9549-9551	We	_	
43-2	9552-9556	used	_	
43-3	9557-9567	fractional	_	
43-4	9568-9578	anisotropy	_	
43-5	9579-9581	as	_	
43-6	9582-9583	a	_	
43-7	9584-9590	metric	_	
43-8	9591-9593	of	_	
43-9	9594-9606	connectivity	_	
43-10	9607-9615	strength	_	
43-11	9616-9618	of	_	
43-12	9619-9632	reconstructed	_	
43-13	9633-9644	connections	_	
43-14	9644-9645	,	_	
43-15	9646-9647	a	_	
43-16	9648-9654	metric	_	
43-17	9655-9660	often	_	
43-18	9661-9670	suggested	_	
43-19	9671-9673	to	_	
43-20	9674-9680	relate	_	
43-21	9681-9683	to	_	
43-22	9684-9689	tract	_	
43-23	9690-9699	integrity	_	
43-24	9700-9703	and	_	
43-25	9704-9715	myelination	_	
43-26	9716-9722	levels	_	
43-27	9723-9726	and	_	
43-28	9727-9732	often	_	
43-29	9733-9737	used	_	
43-30	9738-9740	to	_	
43-31	9741-9748	examine	_	
43-32	9749-9761	case-control	_	
43-33	9762-9773	differences	_	
43-34	9774-9776	in	_	
43-35	9777-9789	connectivity	_	
43-36	9790-9798	strength	_	
43-37	9798-9799	.	_	

#Text=Fractional anisotropy weights were resampled in the comparative dataset to a Gaussian distribution (mean = 0.5, standard deviation = 0.15) to allow for cross-species comparison and to rule out global differences (Supplementary material).
44-1	9800-9810	Fractional	_	
44-2	9811-9821	anisotropy	_	
44-3	9822-9829	weights	_	
44-4	9830-9834	were	_	
44-5	9835-9844	resampled	_	
44-6	9845-9847	in	_	
44-7	9848-9851	the	_	
44-8	9852-9863	comparative	_	
44-9	9864-9871	dataset	_	
44-10	9872-9874	to	_	
44-11	9875-9876	a	_	
44-12	9877-9885	Gaussian	_	
44-13	9886-9898	distribution	_	
44-14	9899-9900	(	_	
44-15	9900-9904	mean	_	
44-16	9905-9906	=	_	
44-17	9907-9910	0.5	_	
44-18	9910-9911	,	_	
44-19	9912-9920	standard	_	
44-20	9921-9930	deviation	_	
44-21	9931-9932	=	_	
44-22	9933-9937	0.15	_	
44-23	9937-9938	)	_	
44-24	9939-9941	to	_	
44-25	9942-9947	allow	_	
44-26	9948-9951	for	_	
44-27	9952-9965	cross-species	_	
44-28	9966-9976	comparison	_	
44-29	9977-9980	and	_	
44-30	9981-9983	to	_	
44-31	9984-9988	rule	_	
44-32	9989-9992	out	_	
44-33	9993-9999	global	_	
44-34	10000-10011	differences	_	
44-35	10012-10013	(	_	
44-36	10013-10026	Supplementary	_	
44-37	10027-10035	material	_	
44-38	10035-10036	)	_	
44-39	10036-10037	.	_	

#Text=Analysis of number of streamlines and volume-normalized streamline density as an alternative metric of connectivity strength did not show overlap with patient effects, so we further focused on fractional anisotropy in our analysis.
45-1	10038-10046	Analysis	_	
45-2	10047-10049	of	_	
45-3	10050-10056	number	_	
45-4	10057-10059	of	_	
45-5	10060-10071	streamlines	_	
45-6	10072-10075	and	_	
45-7	10076-10093	volume-normalized	_	
45-8	10094-10104	streamline	_	
45-9	10105-10112	density	_	
45-10	10113-10115	as	_	
45-11	10116-10118	an	_	
45-12	10119-10130	alternative	_	
45-13	10131-10137	metric	_	
45-14	10138-10140	of	_	
45-15	10141-10153	connectivity	_	
45-16	10154-10162	strength	_	
45-17	10163-10166	did	_	
45-18	10167-10170	not	_	
45-19	10171-10175	show	_	
45-20	10176-10183	overlap	_	
45-21	10184-10188	with	_	
45-22	10189-10196	patient	_	
45-23	10197-10204	effects	_	
45-24	10204-10205	,	_	
45-25	10206-10208	so	_	
45-26	10209-10211	we	_	
45-27	10212-10219	further	_	
45-28	10220-10227	focused	_	
45-29	10228-10230	on	_	
45-30	10231-10241	fractional	_	
45-31	10242-10252	anisotropy	_	
45-32	10253-10255	in	_	
45-33	10256-10259	our	_	
45-34	10260-10268	analysis	_	
45-35	10268-10269	.	_	

#Text=Brain dysconnectivity
#Text=Schizophrenia brain dysconnectivity was assessed by performing edgewise comparison of the reconstructed connections between patient and control connectome maps.
46-1	10270-10275	Brain	_	
46-2	10276-10291	dysconnectivity	_	
46-3	10292-10305	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
46-4	10306-10311	brain	_	
46-5	10312-10327	dysconnectivity	_	
46-6	10328-10331	was	_	
46-7	10332-10340	assessed	_	
46-8	10341-10343	by	_	
46-9	10344-10354	performing	_	
46-10	10355-10363	edgewise	_	
46-11	10364-10374	comparison	_	
46-12	10375-10377	of	_	
46-13	10378-10381	the	_	
46-14	10382-10395	reconstructed	_	
46-15	10396-10407	connections	_	
46-16	10408-10415	between	_	
46-17	10416-10423	patient	_	
46-18	10424-10427	and	_	
46-19	10428-10435	control	_	
46-20	10436-10446	connectome	_	
46-21	10447-10451	maps	_	
46-22	10451-10452	.	_	

#Text=Between-group difference was taken as the t-statistic of a two-sample t-test comparison between edgewise fractional anisotropy values of the patients and control subjects, with higher t-statistics indicating greater dysconnectivity in schizophrenia patients (Supplementary material).
47-1	10453-10466	Between-group	_	
47-2	10467-10477	difference	_	
47-3	10478-10481	was	_	
47-4	10482-10487	taken	_	
47-5	10488-10490	as	_	
47-6	10491-10494	the	_	
47-7	10495-10506	t-statistic	_	
47-8	10507-10509	of	_	
47-9	10510-10511	a	_	
47-10	10512-10522	two-sample	_	
47-11	10523-10529	t-test	_	
47-12	10530-10540	comparison	_	
47-13	10541-10548	between	_	
47-14	10549-10557	edgewise	_	
47-15	10558-10568	fractional	_	
47-16	10569-10579	anisotropy	_	
47-17	10580-10586	values	_	
47-18	10587-10589	of	_	
47-19	10590-10593	the	_	
47-20	10594-10602	patients	_	
47-21	10603-10606	and	_	
47-22	10607-10614	control	_	
47-23	10615-10623	subjects	_	
47-24	10623-10624	,	_	
47-25	10625-10629	with	_	
47-26	10630-10636	higher	_	
47-27	10637-10649	t-statistics	_	
47-28	10650-10660	indicating	_	
47-29	10661-10668	greater	_	
47-30	10669-10684	dysconnectivity	_	
47-31	10685-10687	in	_	
47-32	10688-10701	schizophrenia	_	
47-33	10702-10710	patients	_	
47-34	10711-10712	(	_	
47-35	10712-10725	Supplementary	_	
47-36	10726-10734	material	_	
47-37	10734-10735	)	_	
47-38	10735-10736	.	_	

#Text=Dysconnectivity maps for the other disorder datasets were derived using the same procedure.
48-1	10737-10752	Dysconnectivity	_	
48-2	10753-10757	maps	_	
48-3	10758-10761	for	_	
48-4	10762-10765	the	_	
48-5	10766-10771	other	_	
48-6	10772-10780	disorder	_	
48-7	10781-10789	datasets	_	
48-8	10790-10794	were	_	
48-9	10795-10802	derived	_	
48-10	10803-10808	using	_	
48-11	10809-10812	the	_	
48-12	10813-10817	same	_	
48-13	10818-10827	procedure	_	
48-14	10827-10828	.	_	

#Text=Human modifications to brain connectivity
#Text=Human-specific connections
#Text=Human-specific connections were selected as the set of connections that were observed in ≥60% of the human subjects and in none of the chimpanzee connectome maps (i.e. 0% of the chimpanzee subjects).
49-1	10829-10834	Human	_	
49-2	10835-10848	modifications	_	
49-3	10849-10851	to	_	
49-4	10852-10857	brain	_	
49-5	10858-10870	connectivity	_	
49-6	10871-10885	Human-specific	_	
49-7	10886-10897	connections	_	
49-8	10898-10912	Human-specific	_	
49-9	10913-10924	connections	_	
49-10	10925-10929	were	_	
49-11	10930-10938	selected	_	
49-12	10939-10941	as	_	
49-13	10942-10945	the	_	
49-14	10946-10949	set	_	
49-15	10950-10952	of	_	
49-16	10953-10964	connections	_	
49-17	10965-10969	that	_	
49-18	10970-10974	were	_	
49-19	10975-10983	observed	_	
49-20	10984-10986	in	_	
49-21	10987-10988	≥	_	
49-22	10988-10991	60%	_	
49-23	10992-10994	of	_	
49-24	10995-10998	the	_	
49-25	10999-11004	human	_	
49-26	11005-11013	subjects	_	
49-27	11014-11017	and	_	
49-28	11018-11020	in	_	
49-29	11021-11025	none	_	
49-30	11026-11028	of	_	
49-31	11029-11032	the	_	
49-32	11033-11043	chimpanzee	_	
49-33	11044-11054	connectome	_	
49-34	11055-11059	maps	_	
49-35	11060-11061	(	_	
49-36	11061-11064	i.e	_	
49-37	11064-11065	.	_	
49-38	11066-11068	0%	_	
49-39	11069-11071	of	_	
49-40	11072-11075	the	_	
49-41	11076-11086	chimpanzee	_	
49-42	11087-11095	subjects	_	
49-43	11095-11096	)	_	
49-44	11096-11097	.	_	

#Text=We used this strict prevalence group threshold of 60% (human) and exclusion threshold of 0% (chimpanzee) to reduce the inclusion of false-positive reconstructions at the group level and to include a conservative definition of human-specific tracts (Supplementary material).
50-1	11098-11100	We	_	
50-2	11101-11105	used	_	
50-3	11106-11110	this	_	
50-4	11111-11117	strict	_	
50-5	11118-11128	prevalence	_	
50-6	11129-11134	group	_	
50-7	11135-11144	threshold	_	
50-8	11145-11147	of	_	
50-9	11148-11151	60%	_	
50-10	11152-11153	(	_	
50-11	11153-11158	human	_	
50-12	11158-11159	)	_	
50-13	11160-11163	and	_	
50-14	11164-11173	exclusion	_	
50-15	11174-11183	threshold	_	
50-16	11184-11186	of	_	
50-17	11187-11189	0%	_	
50-18	11190-11191	(	_	
50-19	11191-11201	chimpanzee	_	
50-20	11201-11202	)	_	
50-21	11203-11205	to	_	
50-22	11206-11212	reduce	_	
50-23	11213-11216	the	_	
50-24	11217-11226	inclusion	_	
50-25	11227-11229	of	_	
50-26	11230-11244	false-positive	_	
50-27	11245-11260	reconstructions	_	
50-28	11261-11263	at	_	
50-29	11264-11267	the	_	
50-30	11268-11273	group	_	
50-31	11274-11279	level	_	
50-32	11280-11283	and	_	
50-33	11284-11286	to	_	
50-34	11287-11294	include	_	
50-35	11295-11296	a	_	
50-36	11297-11309	conservative	_	
50-37	11310-11320	definition	_	
50-38	11321-11323	of	_	
50-39	11324-11338	human-specific	_	
50-40	11339-11345	tracts	_	
50-41	11346-11347	(	_	
50-42	11347-11360	Supplementary	_	
50-43	11361-11369	material	_	
50-44	11369-11370	)	_	
50-45	11370-11371	.	_	

#Text=We use the term ‘human-specific’ for these connections, but we note that with this term, we are not directly implying that humans are necessarily the only primate species to possess these connections.
51-1	11372-11374	We	_	
51-2	11375-11378	use	_	
51-3	11379-11382	the	_	
51-4	11383-11387	term	_	
51-5	11388-11389	‘	_	
51-6	11389-11403	human-specific	_	
51-7	11403-11404	’	_	
51-8	11405-11408	for	_	
51-9	11409-11414	these	_	
51-10	11415-11426	connections	_	
51-11	11426-11427	,	_	
51-12	11428-11431	but	_	
51-13	11432-11434	we	_	
51-14	11435-11439	note	_	
51-15	11440-11444	that	_	
51-16	11445-11449	with	_	
51-17	11450-11454	this	_	
51-18	11455-11459	term	_	
51-19	11459-11460	,	_	
51-20	11461-11463	we	_	
51-21	11464-11467	are	_	
51-22	11468-11471	not	_	
51-23	11472-11480	directly	_	
51-24	11481-11489	implying	_	
51-25	11490-11494	that	_	
51-26	11495-11501	humans	_	
51-27	11502-11505	are	_	
51-28	11506-11517	necessarily	_	
51-29	11518-11521	the	_	
51-30	11522-11526	only	_	
51-31	11527-11534	primate	_	
51-32	11535-11542	species	_	
51-33	11543-11545	to	_	
51-34	11546-11553	possess	_	
51-35	11554-11559	these	_	
51-36	11560-11571	connections	_	
51-37	11571-11572	.	_	

#Text=Human-chimpanzee-shared connections were selected as the subset of cortico-cortical connections that were consistently observed in both species (≥60% of humans and ≥60% of chimpanzees).
52-1	11573-11596	Human-chimpanzee-shared	_	
52-2	11597-11608	connections	_	
52-3	11609-11613	were	_	
52-4	11614-11622	selected	_	
52-5	11623-11625	as	_	
52-6	11626-11629	the	_	
52-7	11630-11636	subset	_	
52-8	11637-11639	of	_	
52-9	11640-11656	cortico-cortical	_	
52-10	11657-11668	connections	_	
52-11	11669-11673	that	_	
52-12	11674-11678	were	_	
52-13	11679-11691	consistently	_	
52-14	11692-11700	observed	_	
52-15	11701-11703	in	_	
52-16	11704-11708	both	_	
52-17	11709-11716	species	_	
52-18	11717-11718	(	_	
52-19	11718-11719	≥	_	
52-20	11719-11722	60%	_	
52-21	11723-11725	of	_	
52-22	11726-11732	humans	_	
52-23	11733-11736	and	_	
52-24	11737-11738	≥	_	
52-25	11738-11741	60%	_	
52-26	11742-11744	of	_	
52-27	11745-11756	chimpanzees	_	
52-28	11756-11757	)	_	
52-29	11757-11758	.	_	

#Text=Results were verified using other threshold settings (Supplementary material).
53-1	11759-11766	Results	_	
53-2	11767-11771	were	_	
53-3	11772-11780	verified	_	
53-4	11781-11786	using	_	
53-5	11787-11792	other	_	
53-6	11793-11802	threshold	_	
53-7	11803-11811	settings	_	
53-8	11812-11813	(	_	
53-9	11813-11826	Supplementary	_	
53-10	11827-11835	material	_	
53-11	11835-11836	)	_	
53-12	11836-11837	.	_	

#Text=For the class of shared connections, the level of species difference was computed as the between-group t-statistic between the normalized fractional anisotropy values of the constructed connections of the group of chimpanzees and the group of humans (Supplementary material).
54-1	11838-11841	For	_	
54-2	11842-11845	the	_	
54-3	11846-11851	class	_	
54-4	11852-11854	of	_	
54-5	11855-11861	shared	_	
54-6	11862-11873	connections	_	
54-7	11873-11874	,	_	
54-8	11875-11878	the	_	
54-9	11879-11884	level	_	
54-10	11885-11887	of	_	
54-11	11888-11895	species	_	
54-12	11896-11906	difference	_	
54-13	11907-11910	was	_	
54-14	11911-11919	computed	_	
54-15	11920-11922	as	_	
54-16	11923-11926	the	_	
54-17	11927-11940	between-group	_	
54-18	11941-11952	t-statistic	_	
54-19	11953-11960	between	_	
54-20	11961-11964	the	_	
54-21	11965-11975	normalized	_	
54-22	11976-11986	fractional	_	
54-23	11987-11997	anisotropy	_	
54-24	11998-12004	values	_	
54-25	12005-12007	of	_	
54-26	12008-12011	the	_	
54-27	12012-12023	constructed	_	
54-28	12024-12035	connections	_	
54-29	12036-12038	of	_	
54-30	12039-12042	the	_	
54-31	12043-12048	group	_	
54-32	12049-12051	of	_	
54-33	12052-12063	chimpanzees	_	
54-34	12064-12067	and	_	
54-35	12068-12071	the	_	
54-36	12072-12077	group	_	
54-37	12078-12080	of	_	
54-38	12081-12087	humans	_	
54-39	12088-12089	(	_	
54-40	12089-12102	Supplementary	_	
54-41	12103-12111	material	_	
54-42	12111-12112	)	_	
54-43	12112-12113	.	_	

#Text=Validation chimpanzee-human homologous BB38
#Text=We opted for the use of the Desikan-Killiany brain atlas to be in line with previous connectome studies of brain disorders, including those in schizophrenia.
55-1	12114-12124	Validation	_	
55-2	12125-12141	chimpanzee-human	_	
55-3	12142-12152	homologous	_	
55-4	12153-12157	BB38	_	
55-5	12158-12160	We	_	
55-6	12161-12166	opted	_	
55-7	12167-12170	for	_	
55-8	12171-12174	the	_	
55-9	12175-12178	use	_	
55-10	12179-12181	of	_	
55-11	12182-12185	the	_	
55-12	12186-12202	Desikan-Killiany	_	
55-13	12203-12208	brain	_	
55-14	12209-12214	atlas	_	
55-15	12215-12217	to	_	
55-16	12218-12220	be	_	
55-17	12221-12223	in	_	
55-18	12224-12228	line	_	
55-19	12229-12233	with	_	
55-20	12234-12242	previous	_	
55-21	12243-12253	connectome	_	
55-22	12254-12261	studies	_	
55-23	12262-12264	of	_	
55-24	12265-12270	brain	_	
55-25	12271-12280	disorders	_	
55-26	12280-12281	,	_	
55-27	12282-12291	including	_	
55-28	12292-12297	those	_	
55-29	12298-12300	in	_	
55-30	12301-12314	schizophrenia	_	
55-31	12314-12315	.	_	

#Text=However, the Desikan-Killiany atlas is designed to map the gyri and sulci patterning of the human cortical mantle and a disadvantage of using this atlas in a human-primate neuroimaging study is thus that it does not necessarily describe homologous cytoarchitectonic regions across the two species.
56-1	12316-12323	However	_	
56-2	12323-12324	,	_	
56-3	12325-12328	the	_	
56-4	12329-12345	Desikan-Killiany	_	
56-5	12346-12351	atlas	_	
56-6	12352-12354	is	_	
56-7	12355-12363	designed	_	
56-8	12364-12366	to	_	
56-9	12367-12370	map	_	
56-10	12371-12374	the	_	
56-11	12375-12379	gyri	_	
56-12	12380-12383	and	_	
56-13	12384-12389	sulci	_	
56-14	12390-12400	patterning	_	
56-15	12401-12403	of	_	
56-16	12404-12407	the	_	
56-17	12408-12413	human	_	
56-18	12414-12422	cortical	_	
56-19	12423-12429	mantle	_	
56-20	12430-12433	and	_	
56-21	12434-12435	a	_	
56-22	12436-12448	disadvantage	_	
56-23	12449-12451	of	_	
56-24	12452-12457	using	_	
56-25	12458-12462	this	_	
56-26	12463-12468	atlas	_	
56-27	12469-12471	in	_	
56-28	12472-12473	a	_	
56-29	12474-12487	human-primate	_	
56-30	12488-12500	neuroimaging	_	
56-31	12501-12506	study	_	
56-32	12507-12509	is	_	
56-33	12510-12514	thus	_	
56-34	12515-12519	that	_	
56-35	12520-12522	it	_	
56-36	12523-12527	does	_	
56-37	12528-12531	not	_	
56-38	12532-12543	necessarily	_	
56-39	12544-12552	describe	_	
56-40	12553-12563	homologous	_	
56-41	12564-12581	cytoarchitectonic	_	
56-42	12582-12589	regions	_	
56-43	12590-12596	across	_	
56-44	12597-12600	the	_	
56-45	12601-12604	two	_	
56-46	12605-12612	species	_	
56-47	12612-12613	.	_	

#Text=We therefore validated our findings using data from the von Bonin and Bailey (BB38) cortical atlas designed to map homologous regions across humans and chimpanzees.
57-1	12614-12616	We	_	
57-2	12617-12626	therefore	_	
57-3	12627-12636	validated	_	
57-4	12637-12640	our	_	
57-5	12641-12649	findings	_	
57-6	12650-12655	using	_	
57-7	12656-12660	data	_	
57-8	12661-12665	from	_	
57-9	12666-12669	the	_	
57-10	12670-12673	von	_	
57-11	12674-12679	Bonin	_	
57-12	12680-12683	and	_	
57-13	12684-12690	Bailey	_	
57-14	12691-12692	(	_	
57-15	12692-12696	BB38	_	
57-16	12696-12697	)	_	
57-17	12698-12706	cortical	_	
57-18	12707-12712	atlas	_	
57-19	12713-12721	designed	_	
57-20	12722-12724	to	_	
57-21	12725-12728	map	_	
57-22	12729-12739	homologous	_	
57-23	12740-12747	regions	_	
57-24	12748-12754	across	_	
57-25	12755-12761	humans	_	
57-26	12762-12765	and	_	
57-27	12766-12777	chimpanzees	_	
57-28	12777-12778	.	_	

#Text=This atlas describes 38 homologous cortical areas per hemisphere across humans and chimpanzees based on cytoarchitectonic similarity of cortical areas (Supplementary material and Supplementary Fig. 3).
58-1	12779-12783	This	_	
58-2	12784-12789	atlas	_	
58-3	12790-12799	describes	_	
58-4	12800-12802	38	_	
58-5	12803-12813	homologous	_	
58-6	12814-12822	cortical	_	
58-7	12823-12828	areas	_	
58-8	12829-12832	per	_	
58-9	12833-12843	hemisphere	_	
58-10	12844-12850	across	_	
58-11	12851-12857	humans	_	
58-12	12858-12861	and	_	
58-13	12862-12873	chimpanzees	_	
58-14	12874-12879	based	_	
58-15	12880-12882	on	_	
58-16	12883-12900	cytoarchitectonic	_	
58-17	12901-12911	similarity	_	
58-18	12912-12914	of	_	
58-19	12915-12923	cortical	_	
58-20	12924-12929	areas	_	
58-21	12930-12931	(	_	
58-22	12931-12944	Supplementary	_	
58-23	12945-12953	material	_	
58-24	12954-12957	and	_	
58-25	12958-12971	Supplementary	_	
58-26	12972-12975	Fig	_	
58-27	12975-12976	.	_	
58-28	12977-12978	3	_	
58-29	12978-12979	)	_	
58-30	12979-12980	.	_	

#Text=Data availability
#Text=Chimpanzee MRIs are archived in the National Chimpanzee Brain Resource (data available at https://www.chimpanzeebrain.org).
59-1	12981-12985	Data	_	
59-2	12986-12998	availability	_	
59-3	12999-13009	Chimpanzee	_	
59-4	13010-13014	MRIs	_	
59-5	13015-13018	are	_	
59-6	13019-13027	archived	_	
59-7	13028-13030	in	_	
59-8	13031-13034	the	_	
59-9	13035-13043	National	_	
59-10	13044-13054	Chimpanzee	_	
59-11	13055-13060	Brain	_	
59-12	13061-13069	Resource	_	
59-13	13070-13071	(	_	
59-14	13071-13075	data	_	
59-15	13076-13085	available	_	
59-16	13086-13088	at	_	
59-17	13089-13094	https	_	
59-18	13094-13095	:	_	
59-19	13095-13096	/	_	
59-20	13096-13097	/	_	
59-21	13097-13120	www.chimpanzeebrain.org	_	
59-22	13120-13121	)	_	
59-23	13121-13122	.	_	

#Text=Species connectivity matrices are available at the USC Multimodal Connectivity Database (UMCD), http://umcd.humanconnectomeproject.org (ID 3036, 3037, 3038, 3039).
60-1	13123-13130	Species	_	
60-2	13131-13143	connectivity	_	
60-3	13144-13152	matrices	_	
60-4	13153-13156	are	_	
60-5	13157-13166	available	_	
60-6	13167-13169	at	_	
60-7	13170-13173	the	_	
60-8	13174-13177	USC	_	
60-9	13178-13188	Multimodal	_	
60-10	13189-13201	Connectivity	_	
60-11	13202-13210	Database	_	
60-12	13211-13212	(	_	
60-13	13212-13216	UMCD	_	
60-14	13216-13217	)	_	
60-15	13217-13218	,	_	
60-16	13219-13223	http	_	
60-17	13223-13224	:	_	
60-18	13224-13225	/	_	
60-19	13225-13226	/	_	
60-20	13226-13257	umcd.humanconnectomeproject.org	_	
60-21	13258-13259	(	_	
60-22	13259-13261	ID	_	
60-23	13262-13266	3036	_	
60-24	13266-13267	,	_	
60-25	13268-13272	3037	_	
60-26	13272-13273	,	_	
60-27	13274-13278	3038	_	
60-28	13278-13279	,	_	
60-29	13280-13284	3039	_	
60-30	13284-13285	)	_	
60-31	13285-13286	.	_	

#Text=Healthy human connectome data from the Human Connectome Project are available through the Human Connectome Project data portal (https://www.humanconnectome.org).
61-1	13287-13294	Healthy	_	
61-2	13295-13300	human	_	
61-3	13301-13311	connectome	_	
61-4	13312-13316	data	_	
61-5	13317-13321	from	_	
61-6	13322-13325	the	_	
61-7	13326-13331	Human	_	
61-8	13332-13342	Connectome	_	
61-9	13343-13350	Project	_	
61-10	13351-13354	are	_	
61-11	13355-13364	available	_	
61-12	13365-13372	through	_	
61-13	13373-13376	the	_	
61-14	13377-13382	Human	_	
61-15	13383-13393	Connectome	_	
61-16	13394-13401	Project	_	
61-17	13402-13406	data	_	
61-18	13407-13413	portal	_	
61-19	13414-13415	(	_	
61-20	13415-13420	https	_	
61-21	13420-13421	:	_	
61-22	13421-13422	/	_	
61-23	13422-13423	/	_	
61-24	13423-13446	www.humanconnectome.org	_	
61-25	13446-13447	)	_	
61-26	13447-13448	.	_	

#Text=Patient dysconnectivity maps are available on reasonable request to the corresponding author.
62-1	13449-13456	Patient	_	
62-2	13457-13472	dysconnectivity	_	
62-3	13473-13477	maps	_	
62-4	13478-13481	are	_	
62-5	13482-13491	available	_	
62-6	13492-13494	on	_	
62-7	13495-13505	reasonable	_	
62-8	13506-13513	request	_	
62-9	13514-13516	to	_	
62-10	13517-13520	the	_	
62-11	13521-13534	corresponding	_	
62-12	13535-13541	author	_	
62-13	13541-13542	.	_	

#Text=Results
#Text=Schizophrenia brain dysconnectivity
#Text=We first analysed the pattern of brain dysconnectivity related to schizophrenia, assessed by edgewise statistical comparison of connectivity strength (fractional anisotropy-weighted) across the principal set of n = 48 schizophrenia patients and n = 43 matched healthy control subjects.
63-1	13544-13551	Results	_	
63-2	13552-13565	Schizophrenia	_	
63-3	13566-13571	brain	_	
63-4	13572-13587	dysconnectivity	_	
63-5	13588-13590	We	_	
63-6	13591-13596	first	_	
63-7	13597-13605	analysed	_	
63-8	13606-13609	the	_	
63-9	13610-13617	pattern	_	
63-10	13618-13620	of	_	
63-11	13621-13626	brain	_	
63-12	13627-13642	dysconnectivity	_	
63-13	13643-13650	related	_	
63-14	13651-13653	to	_	
63-15	13654-13667	schizophrenia	_	
63-16	13667-13668	,	_	
63-17	13669-13677	assessed	_	
63-18	13678-13680	by	_	
63-19	13681-13689	edgewise	_	
63-20	13690-13701	statistical	_	
63-21	13702-13712	comparison	_	
63-22	13713-13715	of	_	
63-23	13716-13728	connectivity	_	
63-24	13729-13737	strength	_	
63-25	13738-13739	(	_	
63-26	13739-13749	fractional	_	
63-27	13750-13769	anisotropy-weighted	_	
63-28	13769-13770	)	_	
63-29	13771-13777	across	_	
63-30	13778-13781	the	_	
63-31	13782-13791	principal	_	
63-32	13792-13795	set	_	
63-33	13796-13798	of	_	
63-34	13799-13800	n	_	
63-35	13801-13802	=	_	
63-36	13803-13805	48	_	
63-37	13806-13819	schizophrenia	_	
63-38	13820-13828	patients	_	
63-39	13829-13832	and	_	
63-40	13833-13834	n	_	
63-41	13835-13836	=	_	
63-42	13837-13839	43	_	
63-43	13840-13847	matched	_	
63-44	13848-13855	healthy	_	
63-45	13856-13863	control	_	
63-46	13864-13872	subjects	_	
63-47	13872-13873	.	_	

#Text=Strongest patient-control differences of lower fractional anisotropy were observed around connections of the ventral part of the posterior cingulate cortex (isthmus), inferior and superior parietal and inferior and superior temporal cortex, frontal pole, insular cortex, rostral middle frontal cortex, precuneus, supramarginal gyrus and post and precentral gyrus (Network Based Statistics, NBS; P = 0.024) (Fig. 1); findings consistent with previous schizophrenia connectome studies.
64-1	13874-13883	Strongest	_	
64-2	13884-13899	patient-control	_	
64-3	13900-13911	differences	_	
64-4	13912-13914	of	_	
64-5	13915-13920	lower	_	
64-6	13921-13931	fractional	_	
64-7	13932-13942	anisotropy	_	
64-8	13943-13947	were	_	
64-9	13948-13956	observed	_	
64-10	13957-13963	around	_	
64-11	13964-13975	connections	_	
64-12	13976-13978	of	_	
64-13	13979-13982	the	_	
64-14	13983-13990	ventral	_	
64-15	13991-13995	part	_	
64-16	13996-13998	of	_	
64-17	13999-14002	the	_	
64-18	14003-14012	posterior	_	
64-19	14013-14022	cingulate	_	
64-20	14023-14029	cortex	_	
64-21	14030-14031	(	_	
64-22	14031-14038	isthmus	_	
64-23	14038-14039	)	_	
64-24	14039-14040	,	_	
64-25	14041-14049	inferior	_	
64-26	14050-14053	and	_	
64-27	14054-14062	superior	_	
64-28	14063-14071	parietal	_	
64-29	14072-14075	and	_	
64-30	14076-14084	inferior	_	
64-31	14085-14088	and	_	
64-32	14089-14097	superior	_	
64-33	14098-14106	temporal	_	
64-34	14107-14113	cortex	_	
64-35	14113-14114	,	_	
64-36	14115-14122	frontal	_	
64-37	14123-14127	pole	_	
64-38	14127-14128	,	_	
64-39	14129-14136	insular	_	
64-40	14137-14143	cortex	_	
64-41	14143-14144	,	_	
64-42	14145-14152	rostral	_	
64-43	14153-14159	middle	_	
64-44	14160-14167	frontal	_	
64-45	14168-14174	cortex	_	
64-46	14174-14175	,	_	
64-47	14176-14185	precuneus	_	
64-48	14185-14186	,	_	
64-49	14187-14200	supramarginal	_	
64-50	14201-14206	gyrus	_	
64-51	14207-14210	and	_	
64-52	14211-14215	post	_	
64-53	14216-14219	and	_	
64-54	14220-14230	precentral	_	
64-55	14231-14236	gyrus	_	
64-56	14237-14238	(	_	
64-57	14238-14245	Network	_	
64-58	14246-14251	Based	_	
64-59	14252-14262	Statistics	_	
64-60	14262-14263	,	_	
64-61	14264-14267	NBS	_	
64-62	14267-14268	;	_	
64-63	14269-14270	P	_	
64-64	14271-14272	=	_	
64-65	14273-14278	0.024	_	
64-66	14278-14279	)	_	
64-67	14280-14281	(	_	
64-68	14281-14284	Fig	_	
64-69	14284-14285	.	_	
64-70	14286-14287	1	_	
64-71	14287-14288	)	_	
64-72	14288-14289	;	_	
64-73	14290-14298	findings	_	
64-74	14299-14309	consistent	_	
64-75	14310-14314	with	_	
64-76	14315-14323	previous	_	
64-77	14324-14337	schizophrenia	_	
64-78	14338-14348	connectome	_	
64-79	14349-14356	studies	_	
64-80	14356-14357	.	_	

#Text=Schizophrenia dysconnectivity.
65-1	14360-14373	Schizophrenia	_	
65-2	14374-14389	dysconnectivity	_	
65-3	14389-14390	.	_	

#Text=(A) The cortico-cortical fibre connections of the group average human connectome (group threshold 60%) with level of dysconnectivity (fractional anisotropy weighted) as measured between n = 48 schizophrenia patients and n = 43 matched healthy control subjects.
66-1	14391-14392	(	_	
66-2	14392-14393	A	_	
66-3	14393-14394	)	_	
66-4	14395-14398	The	_	
66-5	14399-14415	cortico-cortical	_	
66-6	14416-14421	fibre	_	
66-7	14422-14433	connections	_	
66-8	14434-14436	of	_	
66-9	14437-14440	the	_	
66-10	14441-14446	group	_	
66-11	14447-14454	average	_	
66-12	14455-14460	human	_	
66-13	14461-14471	connectome	_	
66-14	14472-14473	(	_	
66-15	14473-14478	group	_	
66-16	14479-14488	threshold	_	
66-17	14489-14492	60%	_	
66-18	14492-14493	)	_	
66-19	14494-14498	with	_	
66-20	14499-14504	level	_	
66-21	14505-14507	of	_	
66-22	14508-14523	dysconnectivity	_	
66-23	14524-14525	(	_	
66-24	14525-14535	fractional	_	
66-25	14536-14546	anisotropy	_	
66-26	14547-14555	weighted	_	
66-27	14555-14556	)	_	
66-28	14557-14559	as	_	
66-29	14560-14568	measured	_	
66-30	14569-14576	between	_	
66-31	14577-14578	n	_	
66-32	14579-14580	=	_	
66-33	14581-14583	48	_	
66-34	14584-14597	schizophrenia	_	
66-35	14598-14606	patients	_	
66-36	14607-14610	and	_	
66-37	14611-14612	n	_	
66-38	14613-14614	=	_	
66-39	14615-14617	43	_	
66-40	14618-14625	matched	_	
66-41	14626-14633	healthy	_	
66-42	14634-14641	control	_	
66-43	14642-14650	subjects	_	
66-44	14650-14651	.	_	

#Text=Dysconnectivity levels are indicated from light blue (no patient-control difference) to dark blue (patients showing significantly lower fractional anisotropy than controls) NBS, P = 0.024.
67-1	14652-14667	Dysconnectivity	_	
67-2	14668-14674	levels	_	
67-3	14675-14678	are	_	
67-4	14679-14688	indicated	_	
67-5	14689-14693	from	_	
67-6	14694-14699	light	_	
67-7	14700-14704	blue	_	
67-8	14705-14706	(	_	
67-9	14706-14708	no	_	
67-10	14709-14724	patient-control	_	
67-11	14725-14735	difference	_	
67-12	14735-14736	)	_	
67-13	14737-14739	to	_	
67-14	14740-14744	dark	_	
67-15	14745-14749	blue	_	
67-16	14750-14751	(	_	
67-17	14751-14759	patients	_	
67-18	14760-14767	showing	_	
67-19	14768-14781	significantly	_	
67-20	14782-14787	lower	_	
67-21	14788-14798	fractional	_	
67-22	14799-14809	anisotropy	_	
67-23	14810-14814	than	_	
67-24	14815-14823	controls	_	
67-25	14823-14824	)	_	
67-26	14825-14828	NBS	_	
67-27	14828-14829	,	_	
67-28	14830-14831	P	_	
67-29	14832-14833	=	_	
67-30	14834-14839	0.024	_	
67-31	14839-14840	.	_	

#Text=(B) Cortical regions involved in the NBS subnetwork showing significantly reduced white matter connectivity in patients.
68-1	14841-14842	(	_	
68-2	14842-14843	B	_	
68-3	14843-14844	)	_	
68-4	14845-14853	Cortical	_	
68-5	14854-14861	regions	_	
68-6	14862-14870	involved	_	
68-7	14871-14873	in	_	
68-8	14874-14877	the	_	
68-9	14878-14881	NBS	_	
68-10	14882-14892	subnetwork	_	
68-11	14893-14900	showing	_	
68-12	14901-14914	significantly	_	
68-13	14915-14922	reduced	_	
68-14	14923-14928	white	_	
68-15	14929-14935	matter	_	
68-16	14936-14948	connectivity	_	
68-17	14949-14951	in	_	
68-18	14952-14960	patients	_	
68-19	14960-14961	.	_	

#Text=Chimpanzee-human network comparison
#Text=The chimpanzee and human brain networks showed large overlap in their overall connectome layouts, with a binary overlap of 94% (P < 0.001, Mantel test) and a strong overall correlation in connectivity strength (r = 0.93, P < 0.001) (Fig. 2).
69-1	14962-14978	Chimpanzee-human	_	
69-2	14979-14986	network	_	
69-3	14987-14997	comparison	_	
69-4	14998-15001	The	_	
69-5	15002-15012	chimpanzee	_	
69-6	15013-15016	and	_	
69-7	15017-15022	human	_	
69-8	15023-15028	brain	_	
69-9	15029-15037	networks	_	
69-10	15038-15044	showed	_	
69-11	15045-15050	large	_	
69-12	15051-15058	overlap	_	
69-13	15059-15061	in	_	
69-14	15062-15067	their	_	
69-15	15068-15075	overall	_	
69-16	15076-15086	connectome	_	
69-17	15087-15094	layouts	_	
69-18	15094-15095	,	_	
69-19	15096-15100	with	_	
69-20	15101-15102	a	_	
69-21	15103-15109	binary	_	
69-22	15110-15117	overlap	_	
69-23	15118-15120	of	_	
69-24	15121-15124	94%	_	
69-25	15125-15126	(	_	
69-26	15126-15127	P	_	
69-27	15128-15129	<	_	
69-28	15130-15135	0.001	_	
69-29	15135-15136	,	_	
69-30	15137-15143	Mantel	_	
69-31	15144-15148	test	_	
69-32	15148-15149	)	_	
69-33	15150-15153	and	_	
69-34	15154-15155	a	_	
69-35	15156-15162	strong	_	
69-36	15163-15170	overall	_	
69-37	15171-15182	correlation	_	
69-38	15183-15185	in	_	
69-39	15186-15198	connectivity	_	
69-40	15199-15207	strength	_	
69-41	15208-15209	(	_	
69-42	15209-15210	r	_	
69-43	15211-15212	=	_	
69-44	15213-15217	0.93	_	
69-45	15217-15218	,	_	
69-46	15219-15220	P	_	
69-47	15221-15222	<	_	
69-48	15223-15228	0.001	_	
69-49	15228-15229	)	_	
69-50	15230-15231	(	_	
69-51	15231-15234	Fig	_	
69-52	15234-15235	.	_	
69-53	15236-15237	2	_	
69-54	15237-15238	)	_	
69-55	15238-15239	.	_	

#Text=Twenty-seven human-specific connections in the human connectome were observed (3.5% of total connections), including cortico-cortical connections of the posterior bank of the left superior temporal sulcus (bank), left inferior and middle temporal gyri, left posterior inferior parietal cortex, left caudal anterior cingulate cortex and lateral orbitofrontal cortex, ventral part of the right and left precentral gyrus, left pars opercularis, left paracentral cortex, left precuneus, right cuneus, right insula, right superior frontal cortex, right medial orbitofrontal and pars orbitalis and right inferior and superior parietal cortex (Fig. 3 and Supplementary Table 1).
70-1	15240-15252	Twenty-seven	_	
70-2	15253-15267	human-specific	_	
70-3	15268-15279	connections	_	
70-4	15280-15282	in	_	
70-5	15283-15286	the	_	
70-6	15287-15292	human	_	
70-7	15293-15303	connectome	_	
70-8	15304-15308	were	_	
70-9	15309-15317	observed	_	
70-10	15318-15319	(	_	
70-11	15319-15323	3.5%	_	
70-12	15324-15326	of	_	
70-13	15327-15332	total	_	
70-14	15333-15344	connections	_	
70-15	15344-15345	)	_	
70-16	15345-15346	,	_	
70-17	15347-15356	including	_	
70-18	15357-15373	cortico-cortical	_	
70-19	15374-15385	connections	_	
70-20	15386-15388	of	_	
70-21	15389-15392	the	_	
70-22	15393-15402	posterior	_	
70-23	15403-15407	bank	_	
70-24	15408-15410	of	_	
70-25	15411-15414	the	_	
70-26	15415-15419	left	_	
70-27	15420-15428	superior	_	
70-28	15429-15437	temporal	_	
70-29	15438-15444	sulcus	_	
70-30	15445-15446	(	_	
70-31	15446-15450	bank	_	
70-32	15450-15451	)	_	
70-33	15451-15452	,	_	
70-34	15453-15457	left	_	
70-35	15458-15466	inferior	_	
70-36	15467-15470	and	_	
70-37	15471-15477	middle	_	
70-38	15478-15486	temporal	_	
70-39	15487-15491	gyri	_	
70-40	15491-15492	,	_	
70-41	15493-15497	left	_	
70-42	15498-15507	posterior	_	
70-43	15508-15516	inferior	_	
70-44	15517-15525	parietal	_	
70-45	15526-15532	cortex	_	
70-46	15532-15533	,	_	
70-47	15534-15538	left	_	
70-48	15539-15545	caudal	_	
70-49	15546-15554	anterior	_	
70-50	15555-15564	cingulate	_	
70-51	15565-15571	cortex	_	
70-52	15572-15575	and	_	
70-53	15576-15583	lateral	_	
70-54	15584-15597	orbitofrontal	_	
70-55	15598-15604	cortex	_	
70-56	15604-15605	,	_	
70-57	15606-15613	ventral	_	
70-58	15614-15618	part	_	
70-59	15619-15621	of	_	
70-60	15622-15625	the	_	
70-61	15626-15631	right	_	
70-62	15632-15635	and	_	
70-63	15636-15640	left	_	
70-64	15641-15651	precentral	_	
70-65	15652-15657	gyrus	_	
70-66	15657-15658	,	_	
70-67	15659-15663	left	_	
70-68	15664-15668	pars	_	
70-69	15669-15680	opercularis	_	
70-70	15680-15681	,	_	
70-71	15682-15686	left	_	
70-72	15687-15698	paracentral	_	
70-73	15699-15705	cortex	_	
70-74	15705-15706	,	_	
70-75	15707-15711	left	_	
70-76	15712-15721	precuneus	_	
70-77	15721-15722	,	_	
70-78	15723-15728	right	_	
70-79	15729-15735	cuneus	_	
70-80	15735-15736	,	_	
70-81	15737-15742	right	_	
70-82	15743-15749	insula	_	
70-83	15749-15750	,	_	
70-84	15751-15756	right	_	
70-85	15757-15765	superior	_	
70-86	15766-15773	frontal	_	
70-87	15774-15780	cortex	_	
70-88	15780-15781	,	_	
70-89	15782-15787	right	_	
70-90	15788-15794	medial	_	
70-91	15795-15808	orbitofrontal	_	
70-92	15809-15812	and	_	
70-93	15813-15817	pars	_	
70-94	15818-15827	orbitalis	_	
70-95	15828-15831	and	_	
70-96	15832-15837	right	_	
70-97	15838-15846	inferior	_	
70-98	15847-15850	and	_	
70-99	15851-15859	superior	_	
70-100	15860-15868	parietal	_	
70-101	15869-15875	cortex	_	
70-102	15876-15877	(	_	
70-103	15877-15880	Fig	_	
70-104	15880-15881	.	_	
70-105	15882-15883	3	_	
70-106	15884-15887	and	_	
70-107	15888-15901	Supplementary	_	
70-108	15902-15907	Table	_	
70-109	15908-15909	1	_	
70-110	15909-15910	)	_	
70-111	15910-15911	.	_	

#Text=For contrast, chimpanzee-specific connections (i.e. reconstructed pathways observed in at least 60% of chimpanzees, but not in humans) yielded only seven connections (1.1% of the chimpanzee connectome).
71-1	15912-15915	For	_	
71-2	15916-15924	contrast	_	
71-3	15924-15925	,	_	
71-4	15926-15945	chimpanzee-specific	_	
71-5	15946-15957	connections	_	
71-6	15958-15959	(	_	
71-7	15959-15962	i.e	_	
71-8	15962-15963	.	_	
71-9	15964-15977	reconstructed	_	
71-10	15978-15986	pathways	_	
71-11	15987-15995	observed	_	
71-12	15996-15998	in	_	
71-13	15999-16001	at	_	
71-14	16002-16007	least	_	
71-15	16008-16011	60%	_	
71-16	16012-16014	of	_	
71-17	16015-16026	chimpanzees	_	
71-18	16026-16027	,	_	
71-19	16028-16031	but	_	
71-20	16032-16035	not	_	
71-21	16036-16038	in	_	
71-22	16039-16045	humans	_	
71-23	16045-16046	)	_	
71-24	16047-16054	yielded	_	
71-25	16055-16059	only	_	
71-26	16060-16065	seven	_	
71-27	16066-16077	connections	_	
71-28	16078-16079	(	_	
71-29	16079-16083	1.1%	_	
71-30	16084-16086	of	_	
71-31	16087-16090	the	_	
71-32	16091-16101	chimpanzee	_	
71-33	16102-16112	connectome	_	
71-34	16112-16113	)	_	
71-35	16113-16114	.	_	

#Text=Comparison revealed 428 human-chimpanzee shared connections, taken as the set of connections that were observed in at least 60% of both the groups of humans and chimpanzees (56% of the human connectome, 72% of the chimpanzee connectome).
72-1	16115-16125	Comparison	_	
72-2	16126-16134	revealed	_	
72-3	16135-16138	428	_	
72-4	16139-16155	human-chimpanzee	_	
72-5	16156-16162	shared	_	
72-6	16163-16174	connections	_	
72-7	16174-16175	,	_	
72-8	16176-16181	taken	_	
72-9	16182-16184	as	_	
72-10	16185-16188	the	_	
72-11	16189-16192	set	_	
72-12	16193-16195	of	_	
72-13	16196-16207	connections	_	
72-14	16208-16212	that	_	
72-15	16213-16217	were	_	
72-16	16218-16226	observed	_	
72-17	16227-16229	in	_	
72-18	16230-16232	at	_	
72-19	16233-16238	least	_	
72-20	16239-16242	60%	_	
72-21	16243-16245	of	_	
72-22	16246-16250	both	_	
72-23	16251-16254	the	_	
72-24	16255-16261	groups	_	
72-25	16262-16264	of	_	
72-26	16265-16271	humans	_	
72-27	16272-16275	and	_	
72-28	16276-16287	chimpanzees	_	
72-29	16288-16289	(	_	
72-30	16289-16292	56%	_	
72-31	16293-16295	of	_	
72-32	16296-16299	the	_	
72-33	16300-16305	human	_	
72-34	16306-16316	connectome	_	
72-35	16316-16317	,	_	
72-36	16318-16321	72%	_	
72-37	16322-16324	of	_	
72-38	16325-16328	the	_	
72-39	16329-16339	chimpanzee	_	
72-40	16340-16350	connectome	_	
72-41	16350-16351	)	_	
72-42	16351-16352	.	_	

#Text=We particularly focused our analysis on these connections consistently observed in both species, with connections less consistently observed (i.e. connections observed in <60%) excluded from analysis.
73-1	16353-16355	We	_	
73-2	16356-16368	particularly	_	
73-3	16369-16376	focused	_	
73-4	16377-16380	our	_	
73-5	16381-16389	analysis	_	
73-6	16390-16392	on	_	
73-7	16393-16398	these	_	
73-8	16399-16410	connections	_	
73-9	16411-16423	consistently	_	
73-10	16424-16432	observed	_	
73-11	16433-16435	in	_	
73-12	16436-16440	both	_	
73-13	16441-16448	species	_	
73-14	16448-16449	,	_	
73-15	16450-16454	with	_	
73-16	16455-16466	connections	_	
73-17	16467-16471	less	_	
73-18	16472-16484	consistently	_	
73-19	16485-16493	observed	_	
73-20	16494-16495	(	_	
73-21	16495-16498	i.e	_	
73-22	16498-16499	.	_	
73-23	16500-16511	connections	_	
73-24	16512-16520	observed	_	
73-25	16521-16523	in	_	
73-26	16524-16525	<	_	
73-27	16525-16528	60%	_	
73-28	16528-16529	)	_	
73-29	16530-16538	excluded	_	
73-30	16539-16543	from	_	
73-31	16544-16552	analysis	_	
73-32	16552-16553	.	_	

#Text=Chimpanzee and human connectome.
74-1	16556-16566	Chimpanzee	_	
74-2	16567-16570	and	_	
74-3	16571-16576	human	_	
74-4	16577-16587	connectome	_	
74-5	16587-16588	.	_	

#Text=(A and B) Fibre reconstruction of an exemplary chimpanzee and human subject.
75-1	16589-16590	(	_	
75-2	16590-16591	A	_	
75-3	16592-16595	and	_	
75-4	16596-16597	B	_	
75-5	16597-16598	)	_	
75-6	16599-16604	Fibre	_	
75-7	16605-16619	reconstruction	_	
75-8	16620-16622	of	_	
75-9	16623-16625	an	_	
75-10	16626-16635	exemplary	_	
75-11	16636-16646	chimpanzee	_	
75-12	16647-16650	and	_	
75-13	16651-16656	human	_	
75-14	16657-16664	subject	_	
75-15	16664-16665	.	_	

#Text=Lower right images show the DK-114 parcellation for an exemplary chimpanzee and human brain subject.
76-1	16666-16671	Lower	_	
76-2	16672-16677	right	_	
76-3	16678-16684	images	_	
76-4	16685-16689	show	_	
76-5	16690-16693	the	_	
76-6	16694-16696	DK	_	
76-7	16696-16697	-	_	
76-8	16697-16700	114	_	
76-9	16701-16713	parcellation	_	
76-10	16714-16717	for	_	
76-11	16718-16720	an	_	
76-12	16721-16730	exemplary	_	
76-13	16731-16741	chimpanzee	_	
76-14	16742-16745	and	_	
76-15	16746-16751	human	_	
76-16	16752-16757	brain	_	
76-17	16758-16765	subject	_	
76-18	16765-16766	.	_	

#Text=(C) The group averaged chimpanzee (n = 22, 60% group threshold) and human connectome (n = 58, 60% threshold group connectome).
77-1	16767-16768	(	_	
77-2	16768-16769	C	_	
77-3	16769-16770	)	_	
77-4	16771-16774	The	_	
77-5	16775-16780	group	_	
77-6	16781-16789	averaged	_	
77-7	16790-16800	chimpanzee	_	
77-8	16801-16802	(	_	
77-9	16802-16803	n	_	
77-10	16804-16805	=	_	
77-11	16806-16808	22	_	
77-12	16808-16809	,	_	
77-13	16810-16813	60%	_	
77-14	16814-16819	group	_	
77-15	16820-16829	threshold	_	
77-16	16829-16830	)	_	
77-17	16831-16834	and	_	
77-18	16835-16840	human	_	
77-19	16841-16851	connectome	_	
77-20	16852-16853	(	_	
77-21	16853-16854	n	_	
77-22	16855-16856	=	_	
77-23	16857-16859	58	_	
77-24	16859-16860	,	_	
77-25	16861-16864	60%	_	
77-26	16865-16874	threshold	_	
77-27	16875-16880	group	_	
77-28	16881-16891	connectome	_	
77-29	16891-16892	)	_	
77-30	16892-16893	.	_	

#Text=Coloured values show (normalized) fractional anisotropy values of the chimpanzee and human connectome from low (blue) to high (red).
78-1	16894-16902	Coloured	_	
78-2	16903-16909	values	_	
78-3	16910-16914	show	_	
78-4	16915-16916	(	_	
78-5	16916-16926	normalized	_	
78-6	16926-16927	)	_	
78-7	16928-16938	fractional	_	
78-8	16939-16949	anisotropy	_	
78-9	16950-16956	values	_	
78-10	16957-16959	of	_	
78-11	16960-16963	the	_	
78-12	16964-16974	chimpanzee	_	
78-13	16975-16978	and	_	
78-14	16979-16984	human	_	
78-15	16985-16995	connectome	_	
78-16	16996-17000	from	_	
78-17	17001-17004	low	_	
78-18	17005-17006	(	_	
78-19	17006-17010	blue	_	
78-20	17010-17011	)	_	
78-21	17012-17014	to	_	
78-22	17015-17019	high	_	
78-23	17020-17021	(	_	
78-24	17021-17024	red	_	
78-25	17024-17025	)	_	
78-26	17025-17026	.	_	

#Text=Non-coloured pixels represent no connection present.
79-1	17027-17039	Non-coloured	_	
79-2	17040-17046	pixels	_	
79-3	17047-17056	represent	_	
79-4	17057-17059	no	_	
79-5	17060-17070	connection	_	
79-6	17071-17078	present	_	
79-7	17078-17079	.	_	

#Text=(D) Correlation between fractional anisotropy (FA) values of all shared connections of the two species (r = 0.93, P < 0.001).
80-1	17080-17081	(	_	
80-2	17081-17082	D	_	
80-3	17082-17083	)	_	
80-4	17084-17095	Correlation	_	
80-5	17096-17103	between	_	
80-6	17104-17114	fractional	_	
80-7	17115-17125	anisotropy	_	
80-8	17126-17127	(	_	
80-9	17127-17129	FA	_	
80-10	17129-17130	)	_	
80-11	17131-17137	values	_	
80-12	17138-17140	of	_	
80-13	17141-17144	all	_	
80-14	17145-17151	shared	_	
80-15	17152-17163	connections	_	
80-16	17164-17166	of	_	
80-17	17167-17170	the	_	
80-18	17171-17174	two	_	
80-19	17175-17182	species	_	
80-20	17183-17184	(	_	
80-21	17184-17185	r	_	
80-22	17186-17187	=	_	
80-23	17188-17192	0.93	_	
80-24	17192-17193	,	_	
80-25	17194-17195	P	_	
80-26	17196-17197	<	_	
80-27	17198-17203	0.001	_	
80-28	17203-17204	)	_	
80-29	17204-17205	.	_	

#Text=Human-specific connections and association to disease.
81-1	17207-17221	Human-specific	_	
81-2	17222-17233	connections	_	
81-3	17234-17237	and	_	
81-4	17238-17249	association	_	
81-5	17250-17252	to	_	
81-6	17253-17260	disease	_	
81-7	17260-17261	.	_	

#Text=(A) Identified cortico-cortical connections of the human cerebral connectome.
82-1	17262-17263	(	_	
82-2	17263-17264	A	_	
82-3	17264-17265	)	_	
82-4	17266-17276	Identified	_	
82-5	17277-17293	cortico-cortical	_	
82-6	17294-17305	connections	_	
82-7	17306-17308	of	_	
82-8	17309-17312	the	_	
82-9	17313-17318	human	_	
82-10	17319-17327	cerebral	_	
82-11	17328-17338	connectome	_	
82-12	17338-17339	.	_	

#Text=Red connections identify human-specific connections, orange connections show human-chimpanzee shared connections showing significant positive human enhancement (normalized fractional anisotropy, P < 0.05 FDR).
83-1	17340-17343	Red	_	
83-2	17344-17355	connections	_	
83-3	17356-17364	identify	_	
83-4	17365-17379	human-specific	_	
83-5	17380-17391	connections	_	
83-6	17391-17392	,	_	
83-7	17393-17399	orange	_	
83-8	17400-17411	connections	_	
83-9	17412-17416	show	_	
83-10	17417-17433	human-chimpanzee	_	
83-11	17434-17440	shared	_	
83-12	17441-17452	connections	_	
83-13	17453-17460	showing	_	
83-14	17461-17472	significant	_	
83-15	17473-17481	positive	_	
83-16	17482-17487	human	_	
83-17	17488-17499	enhancement	_	
83-18	17500-17501	(	_	
83-19	17501-17511	normalized	_	
83-20	17512-17522	fractional	_	
83-21	17523-17533	anisotropy	_	
83-22	17533-17534	,	_	
83-23	17535-17536	P	_	
83-24	17537-17538	<	_	
83-25	17539-17543	0.05	_	
83-26	17544-17547	FDR	_	
83-27	17547-17548	)	_	
83-28	17548-17549	.	_	

#Text=Green connections indicate remaining human-chimpanzee shared connections showing no species difference and connections of the group average connectome.
84-1	17550-17555	Green	_	
84-2	17556-17567	connections	_	
84-3	17568-17576	indicate	_	
84-4	17577-17586	remaining	_	
84-5	17587-17603	human-chimpanzee	_	
84-6	17604-17610	shared	_	
84-7	17611-17622	connections	_	
84-8	17623-17630	showing	_	
84-9	17631-17633	no	_	
84-10	17634-17641	species	_	
84-11	17642-17652	difference	_	
84-12	17653-17656	and	_	
84-13	17657-17668	connections	_	
84-14	17669-17671	of	_	
84-15	17672-17675	the	_	
84-16	17676-17681	group	_	
84-17	17682-17689	average	_	
84-18	17690-17700	connectome	_	
84-19	17700-17701	.	_	

#Text=(B) Subset of cortical regions that displayed one or more human-specific cortico-cortical connections.
85-1	17702-17703	(	_	
85-2	17703-17704	B	_	
85-3	17704-17705	)	_	
85-4	17706-17712	Subset	_	
85-5	17713-17715	of	_	
85-6	17716-17724	cortical	_	
85-7	17725-17732	regions	_	
85-8	17733-17737	that	_	
85-9	17738-17747	displayed	_	
85-10	17748-17751	one	_	
85-11	17752-17754	or	_	
85-12	17755-17759	more	_	
85-13	17760-17774	human-specific	_	
85-14	17775-17791	cortico-cortical	_	
85-15	17792-17803	connections	_	
85-16	17803-17804	.	_	

#Text=(C) Schizophrenia effects (y-axis: t-statistic of fractional anisotropy values controls versus patients) across human-specific (red) and connections shared between humans and chimpanzees.
86-1	17805-17806	(	_	
86-2	17806-17807	C	_	
86-3	17807-17808	)	_	
86-4	17809-17822	Schizophrenia	_	
86-5	17823-17830	effects	_	
86-6	17831-17832	(	_	
86-7	17832-17838	y-axis	_	
86-8	17838-17839	:	_	
86-9	17840-17851	t-statistic	_	
86-10	17852-17854	of	_	
86-11	17855-17865	fractional	_	
86-12	17866-17876	anisotropy	_	
86-13	17877-17883	values	_	
86-14	17884-17892	controls	_	
86-15	17893-17899	versus	_	
86-16	17900-17908	patients	_	
86-17	17908-17909	)	_	
86-18	17910-17916	across	_	
86-19	17917-17931	human-specific	_	
86-20	17932-17933	(	_	
86-21	17933-17936	red	_	
86-22	17936-17937	)	_	
86-23	17938-17941	and	_	
86-24	17942-17953	connections	_	
86-25	17954-17960	shared	_	
86-26	17961-17968	between	_	
86-27	17969-17975	humans	_	
86-28	17976-17979	and	_	
86-29	17980-17991	chimpanzees	_	
86-30	17991-17992	.	_	

#Text=Effects in shared connections were further decomposed into connections showing enhanced human development as compared to chimpanzees (chimpanzee-human difference FDR P < 0.05) and connections that showed no positive difference in normalized fractional anisotropy between chimpanzees and humans (P > 0.05).
87-1	17993-18000	Effects	_	
87-2	18001-18003	in	_	
87-3	18004-18010	shared	_	
87-4	18011-18022	connections	_	
87-5	18023-18027	were	_	
87-6	18028-18035	further	_	
87-7	18036-18046	decomposed	_	
87-8	18047-18051	into	_	
87-9	18052-18063	connections	_	
87-10	18064-18071	showing	_	
87-11	18072-18080	enhanced	_	
87-12	18081-18086	human	_	
87-13	18087-18098	development	_	
87-14	18099-18101	as	_	
87-15	18102-18110	compared	_	
87-16	18111-18113	to	_	
87-17	18114-18125	chimpanzees	_	
87-18	18126-18127	(	_	
87-19	18127-18143	chimpanzee-human	_	
87-20	18144-18154	difference	_	
87-21	18155-18158	FDR	_	
87-22	18159-18160	P	_	
87-23	18161-18162	<	_	
87-24	18163-18167	0.05	_	
87-25	18167-18168	)	_	
87-26	18169-18172	and	_	
87-27	18173-18184	connections	_	
87-28	18185-18189	that	_	
87-29	18190-18196	showed	_	
87-30	18197-18199	no	_	
87-31	18200-18208	positive	_	
87-32	18209-18219	difference	_	
87-33	18220-18222	in	_	
87-34	18223-18233	normalized	_	
87-35	18234-18244	fractional	_	
87-36	18245-18255	anisotropy	_	
87-37	18256-18263	between	_	
87-38	18264-18275	chimpanzees	_	
87-39	18276-18279	and	_	
87-40	18280-18286	humans	_	
87-41	18287-18288	(	_	
87-42	18288-18289	P	_	
87-43	18290-18291	>	_	
87-44	18292-18296	0.05	_	
87-45	18296-18297	)	_	
87-46	18297-18298	.	_	

#Text=Human-specific connections showed the largest effect, with human enhanced connections in second place (Jonckheere-Terpstra P = 0.002).
88-1	18299-18313	Human-specific	_	
88-2	18314-18325	connections	_	
88-3	18326-18332	showed	_	
88-4	18333-18336	the	_	
88-5	18337-18344	largest	_	
88-6	18345-18351	effect	_	
88-7	18351-18352	,	_	
88-8	18353-18357	with	_	
88-9	18358-18363	human	_	
88-10	18364-18372	enhanced	_	
88-11	18373-18384	connections	_	
88-12	18385-18387	in	_	
88-13	18388-18394	second	_	
88-14	18395-18400	place	_	
88-15	18401-18402	(	_	
88-16	18402-18421	Jonckheere-Terpstra	_	
88-17	18422-18423	P	_	
88-18	18424-18425	=	_	
88-19	18426-18431	0.002	_	
88-20	18431-18432	)	_	
88-21	18432-18433	.	_	

#Text=Boxes display the interval between 25th and 75th percentiles (q1 and q3); white lines indicate median values, white circles indicate mean values; whiskers indicate the interval between q1−1.5×(q3−q1) and q3+1.5×(q3−q1); violin plots show the distribution of values (smoothed for visualization with a 0.4 kernel).
89-1	18434-18439	Boxes	_	
89-2	18440-18447	display	_	
89-3	18448-18451	the	_	
89-4	18452-18460	interval	_	
89-5	18461-18468	between	_	
89-6	18469-18473	25th	_	
89-7	18474-18477	and	_	
89-8	18478-18482	75th	_	
89-9	18483-18494	percentiles	_	
89-10	18495-18496	(	_	
89-11	18496-18498	q1	_	
89-12	18499-18502	and	_	
89-13	18503-18505	q3	_	
89-14	18505-18506	)	_	
89-15	18506-18507	;	_	
89-16	18508-18513	white	_	
89-17	18514-18519	lines	_	
89-18	18520-18528	indicate	_	
89-19	18529-18535	median	_	
89-20	18536-18542	values	_	
89-21	18542-18543	,	_	
89-22	18544-18549	white	_	
89-23	18550-18557	circles	_	
89-24	18558-18566	indicate	_	
89-25	18567-18571	mean	_	
89-26	18572-18578	values	_	
89-27	18578-18579	;	_	
89-28	18580-18588	whiskers	_	
89-29	18589-18597	indicate	_	
89-30	18598-18601	the	_	
89-31	18602-18610	interval	_	
89-32	18611-18618	between	_	
89-33	18619-18621	q1	_	
89-34	18621-18622	−	_	
89-35	18622-18625	1.5	_	
89-36	18625-18626	×	_	
89-37	18626-18627	(	_	
89-38	18627-18629	q3	_	
89-39	18629-18630	−	_	
89-40	18630-18632	q1	_	
89-41	18632-18633	)	_	
89-42	18634-18637	and	_	
89-43	18638-18640	q3	_	
89-44	18640-18641	+	_	
89-45	18641-18644	1.5	_	
89-46	18644-18645	×	_	
89-47	18645-18646	(	_	
89-48	18646-18648	q3	_	
89-49	18648-18649	−	_	
89-50	18649-18651	q1	_	
89-51	18651-18652	)	_	
89-52	18652-18653	;	_	
89-53	18654-18660	violin	_	
89-54	18661-18666	plots	_	
89-55	18667-18671	show	_	
89-56	18672-18675	the	_	
89-57	18676-18688	distribution	_	
89-58	18689-18691	of	_	
89-59	18692-18698	values	_	
89-60	18699-18700	(	_	
89-61	18700-18708	smoothed	_	
89-62	18709-18712	for	_	
89-63	18713-18726	visualization	_	
89-64	18727-18731	with	_	
89-65	18732-18733	a	_	
89-66	18734-18737	0.4	_	
89-67	18738-18744	kernel	_	
89-68	18744-18745	)	_	
89-69	18745-18746	.	_	

#Text=Human connectome modifications and dysconnectivity
#Text=We then examined the main hypothesis of our study, comparing the observed effects in schizophrenia with human evolutionary modifications of brain connectivity.
90-1	18747-18752	Human	_	
90-2	18753-18763	connectome	_	
90-3	18764-18777	modifications	_	
90-4	18778-18781	and	_	
90-5	18782-18797	dysconnectivity	_	
90-6	18798-18800	We	_	
90-7	18801-18805	then	_	
90-8	18806-18814	examined	_	
90-9	18815-18818	the	_	
90-10	18819-18823	main	_	
90-11	18824-18834	hypothesis	_	
90-12	18835-18837	of	_	
90-13	18838-18841	our	_	
90-14	18842-18847	study	_	
90-15	18847-18848	,	_	
90-16	18849-18858	comparing	_	
90-17	18859-18862	the	_	
90-18	18863-18871	observed	_	
90-19	18872-18879	effects	_	
90-20	18880-18882	in	_	
90-21	18883-18896	schizophrenia	_	
90-22	18897-18901	with	_	
90-23	18902-18907	human	_	
90-24	18908-18920	evolutionary	_	
90-25	18921-18934	modifications	_	
90-26	18935-18937	of	_	
90-27	18938-18943	brain	_	
90-28	18944-18956	connectivity	_	
90-29	18956-18957	.	_	

#Text=Human-specific connections (Fig. 3A) showed a significantly higher level of congruence with the pattern of schizophrenia dysconnectivity as compared to the set of shared connections (permutation testing with 10 000 permutations, P = 0.019).
91-1	18958-18972	Human-specific	_	
91-2	18973-18984	connections	_	
91-3	18985-18986	(	_	
91-4	18986-18989	Fig	_	
91-5	18989-18990	.	_	
91-6	18991-18993	3A	_	
91-7	18993-18994	)	_	
91-8	18995-19001	showed	_	
91-9	19002-19003	a	_	
91-10	19004-19017	significantly	_	
91-11	19018-19024	higher	_	
91-12	19025-19030	level	_	
91-13	19031-19033	of	_	
91-14	19034-19044	congruence	_	
91-15	19045-19049	with	_	
91-16	19050-19053	the	_	
91-17	19054-19061	pattern	_	
91-18	19062-19064	of	_	
91-19	19065-19078	schizophrenia	_	
91-20	19079-19094	dysconnectivity	_	
91-21	19095-19097	as	_	
91-22	19098-19106	compared	_	
91-23	19107-19109	to	_	
91-24	19110-19113	the	_	
91-25	19114-19117	set	_	
91-26	19118-19120	of	_	
91-27	19121-19127	shared	_	
91-28	19128-19139	connections	_	
91-29	19140-19141	(	_	
91-30	19141-19152	permutation	_	
91-31	19153-19160	testing	_	
91-32	19161-19165	with	_	
91-33	19166-19168	10	_	
91-34	19169-19172	000	_	
91-35	19173-19185	permutations	_	
91-36	19185-19186	,	_	
91-37	19187-19188	P	_	
91-38	19189-19190	=	_	
91-39	19191-19196	0.019	_	
91-40	19196-19197	)	_	
91-41	19197-19198	.	_	

#Text=Similar to the principal dataset, both schizophrenia validation datasets (n = 40 patients and n = 37 matched healthy controls, and n = 30 and n = 33, respectively) showed human-specific connections to display higher levels of schizophrenia involvement as compared to the set of connections shared between humans and chimpanzees (P = 0.012, P = 0.005).
92-1	19199-19206	Similar	_	
92-2	19207-19209	to	_	
92-3	19210-19213	the	_	
92-4	19214-19223	principal	_	
92-5	19224-19231	dataset	_	
92-6	19231-19232	,	_	
92-7	19233-19237	both	_	
92-8	19238-19251	schizophrenia	_	
92-9	19252-19262	validation	_	
92-10	19263-19271	datasets	_	
92-11	19272-19273	(	_	
92-12	19273-19274	n	_	
92-13	19275-19276	=	_	
92-14	19277-19279	40	_	
92-15	19280-19288	patients	_	
92-16	19289-19292	and	_	
92-17	19293-19294	n	_	
92-18	19295-19296	=	_	
92-19	19297-19299	37	_	
92-20	19300-19307	matched	_	
92-21	19308-19315	healthy	_	
92-22	19316-19324	controls	_	
92-23	19324-19325	,	_	
92-24	19326-19329	and	_	
92-25	19330-19331	n	_	
92-26	19332-19333	=	_	
92-27	19334-19336	30	_	
92-28	19337-19340	and	_	
92-29	19341-19342	n	_	
92-30	19343-19344	=	_	
92-31	19345-19347	33	_	
92-32	19347-19348	,	_	
92-33	19349-19361	respectively	_	
92-34	19361-19362	)	_	
92-35	19363-19369	showed	_	
92-36	19370-19384	human-specific	_	
92-37	19385-19396	connections	_	
92-38	19397-19399	to	_	
92-39	19400-19407	display	_	
92-40	19408-19414	higher	_	
92-41	19415-19421	levels	_	
92-42	19422-19424	of	_	
92-43	19425-19438	schizophrenia	_	
92-44	19439-19450	involvement	_	
92-45	19451-19453	as	_	
92-46	19454-19462	compared	_	
92-47	19463-19465	to	_	
92-48	19466-19469	the	_	
92-49	19470-19473	set	_	
92-50	19474-19476	of	_	
92-51	19477-19488	connections	_	
92-52	19489-19495	shared	_	
92-53	19496-19503	between	_	
92-54	19504-19510	humans	_	
92-55	19511-19514	and	_	
92-56	19515-19526	chimpanzees	_	
92-57	19527-19528	(	_	
92-58	19528-19529	P	_	
92-59	19530-19531	=	_	
92-60	19532-19537	0.012	_	
92-61	19537-19538	,	_	
92-62	19539-19540	P	_	
92-63	19541-19542	=	_	
92-64	19543-19548	0.005	_	
92-65	19548-19549	)	_	
92-66	19549-19550	.	_	

#Text=No significant associations were observed with clinical Positive and Negative Syndrome Scale (PANSS) scores (all P > 0.05).
93-1	19551-19553	No	_	
93-2	19554-19565	significant	_	
93-3	19566-19578	associations	_	
93-4	19579-19583	were	_	
93-5	19584-19592	observed	_	
93-6	19593-19597	with	_	
93-7	19598-19606	clinical	_	
93-8	19607-19615	Positive	_	
93-9	19616-19619	and	_	
93-10	19620-19628	Negative	_	
93-11	19629-19637	Syndrome	_	
93-12	19638-19643	Scale	_	
93-13	19644-19645	(	_	
93-14	19645-19650	PANSS	_	
93-15	19650-19651	)	_	
93-16	19652-19658	scores	_	
93-17	19659-19660	(	_	
93-18	19660-19663	all	_	
93-19	19664-19665	P	_	
93-20	19666-19667	>	_	
93-21	19668-19672	0.05	_	
93-22	19672-19673	)	_	
93-23	19673-19674	.	_	

#Text=Human and chimpanzee shared connections
#Text=We further examined the set of shared connections between chimpanzees and humans in context of schizophrenia effects in more detail.
94-1	19675-19680	Human	_	
94-2	19681-19684	and	_	
94-3	19685-19695	chimpanzee	_	
94-4	19696-19702	shared	_	
94-5	19703-19714	connections	_	
94-6	19715-19717	We	_	
94-7	19718-19725	further	_	
94-8	19726-19734	examined	_	
94-9	19735-19738	the	_	
94-10	19739-19742	set	_	
94-11	19743-19745	of	_	
94-12	19746-19752	shared	_	
94-13	19753-19764	connections	_	
94-14	19765-19772	between	_	
94-15	19773-19784	chimpanzees	_	
94-16	19785-19788	and	_	
94-17	19789-19795	humans	_	
94-18	19796-19798	in	_	
94-19	19799-19806	context	_	
94-20	19807-19809	of	_	
94-21	19810-19823	schizophrenia	_	
94-22	19824-19831	effects	_	
94-23	19832-19834	in	_	
94-24	19835-19839	more	_	
94-25	19840-19846	detail	_	
94-26	19846-19847	.	_	

#Text=Examining the shared connections showed that the level of connectivity difference between chimpanzees and humans was moderately correlated with the level of schizophrenia dysconnectivity (r = 0.17, P = 0.021).
95-1	19848-19857	Examining	_	
95-2	19858-19861	the	_	
95-3	19862-19868	shared	_	
95-4	19869-19880	connections	_	
95-5	19881-19887	showed	_	
95-6	19888-19892	that	_	
95-7	19893-19896	the	_	
95-8	19897-19902	level	_	
95-9	19903-19905	of	_	
95-10	19906-19918	connectivity	_	
95-11	19919-19929	difference	_	
95-12	19930-19937	between	_	
95-13	19938-19949	chimpanzees	_	
95-14	19950-19953	and	_	
95-15	19954-19960	humans	_	
95-16	19961-19964	was	_	
95-17	19965-19975	moderately	_	
95-18	19976-19986	correlated	_	
95-19	19987-19991	with	_	
95-20	19992-19995	the	_	
95-21	19996-20001	level	_	
95-22	20002-20004	of	_	
95-23	20005-20018	schizophrenia	_	
95-24	20019-20034	dysconnectivity	_	
95-25	20035-20036	(	_	
95-26	20036-20037	r	_	
95-27	20038-20039	=	_	
95-28	20040-20044	0.17	_	
95-29	20044-20045	,	_	
95-30	20046-20047	P	_	
95-31	20048-20049	=	_	
95-32	20050-20055	0.021	_	
95-33	20055-20056	)	_	
95-34	20056-20057	.	_	

#Text=The same effect was found in the validation datasets (r = 0.22, P = 0.001 and r = 0.17, P = 0.034), potentially suggesting that connections showing the largest differences between chimpanzees and humans showed on average higher involvement in the disorder, second to the class of human-specific connections.
96-1	20058-20061	The	_	
96-2	20062-20066	same	_	
96-3	20067-20073	effect	_	
96-4	20074-20077	was	_	
96-5	20078-20083	found	_	
96-6	20084-20086	in	_	
96-7	20087-20090	the	_	
96-8	20091-20101	validation	_	
96-9	20102-20110	datasets	_	
96-10	20111-20112	(	_	
96-11	20112-20113	r	_	
96-12	20114-20115	=	_	
96-13	20116-20120	0.22	_	
96-14	20120-20121	,	_	
96-15	20122-20123	P	_	
96-16	20124-20125	=	_	
96-17	20126-20131	0.001	_	
96-18	20132-20135	and	_	
96-19	20136-20137	r	_	
96-20	20138-20139	=	_	
96-21	20140-20144	0.17	_	
96-22	20144-20145	,	_	
96-23	20146-20147	P	_	
96-24	20148-20149	=	_	
96-25	20150-20155	0.034	_	
96-26	20155-20156	)	_	
96-27	20156-20157	,	_	
96-28	20158-20169	potentially	_	
96-29	20170-20180	suggesting	_	
96-30	20181-20185	that	_	
96-31	20186-20197	connections	_	
96-32	20198-20205	showing	_	
96-33	20206-20209	the	_	
96-34	20210-20217	largest	_	
96-35	20218-20229	differences	_	
96-36	20230-20237	between	_	
96-37	20238-20249	chimpanzees	_	
96-38	20250-20253	and	_	
96-39	20254-20260	humans	_	
96-40	20261-20267	showed	_	
96-41	20268-20270	on	_	
96-42	20271-20278	average	_	
96-43	20279-20285	higher	_	
96-44	20286-20297	involvement	_	
96-45	20298-20300	in	_	
96-46	20301-20304	the	_	
96-47	20305-20313	disorder	_	
96-48	20313-20314	,	_	
96-49	20315-20321	second	_	
96-50	20322-20324	to	_	
96-51	20325-20328	the	_	
96-52	20329-20334	class	_	
96-53	20335-20337	of	_	
96-54	20338-20352	human-specific	_	
96-55	20353-20364	connections	_	
96-56	20364-20365	.	_	

#Text=To illustrate this, we divided the class of shared connections into a class of human modified shared-connections (human > chimpanzee, FDR P < 0.05) and the rest.
97-1	20366-20368	To	_	
97-2	20369-20379	illustrate	_	
97-3	20380-20384	this	_	
97-4	20384-20385	,	_	
97-5	20386-20388	we	_	
97-6	20389-20396	divided	_	
97-7	20397-20400	the	_	
97-8	20401-20406	class	_	
97-9	20407-20409	of	_	
97-10	20410-20416	shared	_	
97-11	20417-20428	connections	_	
97-12	20429-20433	into	_	
97-13	20434-20435	a	_	
97-14	20436-20441	class	_	
97-15	20442-20444	of	_	
97-16	20445-20450	human	_	
97-17	20451-20459	modified	_	
97-18	20460-20478	shared-connections	_	
97-19	20479-20480	(	_	
97-20	20480-20485	human	_	
97-21	20486-20487	>	_	
97-22	20488-20498	chimpanzee	_	
97-23	20498-20499	,	_	
97-24	20500-20503	FDR	_	
97-25	20504-20505	P	_	
97-26	20506-20507	<	_	
97-27	20508-20512	0.05	_	
97-28	20512-20513	)	_	
97-29	20514-20517	and	_	
97-30	20518-20521	the	_	
97-31	20522-20526	rest	_	
97-32	20526-20527	.	_	

#Text=Across the three connection categories, human-specific connections displayed the highest level of schizophrenia dysconnectivity with the human-enhanced shared connections in second place (P = 0.0020, Jonckheere-Terpstra test) (Fig. 3C).
98-1	20528-20534	Across	_	
98-2	20535-20538	the	_	
98-3	20539-20544	three	_	
98-4	20545-20555	connection	_	
98-5	20556-20566	categories	_	
98-6	20566-20567	,	_	
98-7	20568-20582	human-specific	_	
98-8	20583-20594	connections	_	
98-9	20595-20604	displayed	_	
98-10	20605-20608	the	_	
98-11	20609-20616	highest	_	
98-12	20617-20622	level	_	
98-13	20623-20625	of	_	
98-14	20626-20639	schizophrenia	_	
98-15	20640-20655	dysconnectivity	_	
98-16	20656-20660	with	_	
98-17	20661-20664	the	_	
98-18	20665-20679	human-enhanced	_	
98-19	20680-20686	shared	_	
98-20	20687-20698	connections	_	
98-21	20699-20701	in	_	
98-22	20702-20708	second	_	
98-23	20709-20714	place	_	
98-24	20715-20716	(	_	
98-25	20716-20717	P	_	
98-26	20718-20719	=	_	
98-27	20720-20726	0.0020	_	
98-28	20726-20727	,	_	
98-29	20728-20747	Jonckheere-Terpstra	_	
98-30	20748-20752	test	_	
98-31	20752-20753	)	_	
98-32	20754-20755	(	_	
98-33	20755-20758	Fig	_	
98-34	20758-20759	.	_	
98-35	20760-20762	3C	_	
98-36	20762-20763	)	_	
98-37	20763-20764	.	_	

#Text=This effect was also observed in the patient validation datasets (P = 0.004, P = 0.010).
99-1	20765-20769	This	_	
99-2	20770-20776	effect	_	
99-3	20777-20780	was	_	
99-4	20781-20785	also	_	
99-5	20786-20794	observed	_	
99-6	20795-20797	in	_	
99-7	20798-20801	the	_	
99-8	20802-20809	patient	_	
99-9	20810-20820	validation	_	
99-10	20821-20829	datasets	_	
99-11	20830-20831	(	_	
99-12	20831-20832	P	_	
99-13	20833-20834	=	_	
99-14	20835-20840	0.004	_	
99-15	20840-20841	,	_	
99-16	20842-20843	P	_	
99-17	20844-20845	=	_	
99-18	20846-20851	0.010	_	
99-19	20851-20852	)	_	
99-20	20852-20853	.	_	

#Text=Other disorders
#Text=In contrast to the increased involvement of human-specific connections in schizophrenia (P < 0.01, schizophrenia datasets combined, Bonferroni corrected for multiple testing) (Fig. 4, left), no such effects were observed in the ASD [P > 0.05, not significant (n.s.)], bvFTD (P > 0.05 n.s.), MCI (P > 0.05 n.s.), Alzheimer’s disease (P > 0.05 n.s.), OCD (P > 0.05. n.s.) and MDD (P > 0.05 n.s.) datasets (Fig. 4 and Supplementary Fig. 4).
100-1	20854-20859	Other	_	
100-2	20860-20869	disorders	_	
100-3	20870-20872	In	_	
100-4	20873-20881	contrast	_	
100-5	20882-20884	to	_	
100-6	20885-20888	the	_	
100-7	20889-20898	increased	_	
100-8	20899-20910	involvement	_	
100-9	20911-20913	of	_	
100-10	20914-20928	human-specific	_	
100-11	20929-20940	connections	_	
100-12	20941-20943	in	_	
100-13	20944-20957	schizophrenia	_	
100-14	20958-20959	(	_	
100-15	20959-20960	P	_	
100-16	20961-20962	<	_	
100-17	20963-20967	0.01	_	
100-18	20967-20968	,	_	
100-19	20969-20982	schizophrenia	_	
100-20	20983-20991	datasets	_	
100-21	20992-21000	combined	_	
100-22	21000-21001	,	_	
100-23	21002-21012	Bonferroni	_	
100-24	21013-21022	corrected	_	
100-25	21023-21026	for	_	
100-26	21027-21035	multiple	_	
100-27	21036-21043	testing	_	
100-28	21043-21044	)	_	
100-29	21045-21046	(	_	
100-30	21046-21049	Fig	_	
100-31	21049-21050	.	_	
100-32	21051-21052	4	_	
100-33	21052-21053	,	_	
100-34	21054-21058	left	_	
100-35	21058-21059	)	_	
100-36	21059-21060	,	_	
100-37	21061-21063	no	_	
100-38	21064-21068	such	_	
100-39	21069-21076	effects	_	
100-40	21077-21081	were	_	
100-41	21082-21090	observed	_	
100-42	21091-21093	in	_	
100-43	21094-21097	the	_	
100-44	21098-21101	ASD	_	
100-45	21102-21103	[	_	
100-46	21103-21104	P	_	
100-47	21105-21106	>	_	
100-48	21107-21111	0.05	_	
100-49	21111-21112	,	_	
100-50	21113-21116	not	_	
100-51	21117-21128	significant	_	
100-52	21129-21130	(	_	
100-53	21130-21133	n.s	_	
100-54	21133-21134	.	_	
100-55	21134-21135	)	_	
100-56	21135-21136	]	_	
100-57	21136-21137	,	_	
100-58	21138-21143	bvFTD	_	
100-59	21144-21145	(	_	
100-60	21145-21146	P	_	
100-61	21147-21148	>	_	
100-62	21149-21153	0.05	_	
100-63	21154-21157	n.s	_	
100-64	21157-21158	.	_	
100-65	21158-21159	)	_	
100-66	21159-21160	,	_	
100-67	21161-21164	MCI	_	
100-68	21165-21166	(	_	
100-69	21166-21167	P	_	
100-70	21168-21169	>	_	
100-71	21170-21174	0.05	_	
100-72	21175-21178	n.s	_	
100-73	21178-21179	.	_	
100-74	21179-21180	)	_	
100-75	21180-21181	,	_	
100-76	21182-21191	Alzheimer	_	
100-77	21191-21192	’	_	
100-78	21192-21193	s	_	
100-79	21194-21201	disease	_	
100-80	21202-21203	(	_	
100-81	21203-21204	P	_	
100-82	21205-21206	>	_	
100-83	21207-21211	0.05	_	
100-84	21212-21215	n.s	_	
100-85	21215-21216	.	_	
100-86	21216-21217	)	_	
100-87	21217-21218	,	_	
100-88	21219-21222	OCD	_	
100-89	21223-21224	(	_	
100-90	21224-21225	P	_	
100-91	21226-21227	>	_	
100-92	21228-21232	0.05	_	
100-93	21232-21233	.	_	
100-94	21234-21237	n.s	_	
100-95	21237-21238	.	_	
100-96	21238-21239	)	_	
100-97	21240-21243	and	_	
100-98	21244-21247	MDD	_	
100-99	21248-21249	(	_	
100-100	21249-21250	P	_	
100-101	21251-21252	>	_	
100-102	21253-21257	0.05	_	
100-103	21258-21261	n.s	_	
100-104	21261-21262	.	_	
100-105	21262-21263	)	_	
100-106	21264-21272	datasets	_	
100-107	21273-21274	(	_	
100-108	21274-21277	Fig	_	
100-109	21277-21278	.	_	
100-110	21279-21280	4	_	
100-111	21281-21284	and	_	
100-112	21285-21298	Supplementary	_	
100-113	21299-21302	Fig	_	
100-114	21302-21303	.	_	
100-115	21304-21305	4	_	
100-116	21305-21306	)	_	
100-117	21306-21307	.	_	

#Text=A potential trend-level moderate effect could be observed in the bipolar disorder population (P = 0.058, not reaching significance after correction for multiple testing).
101-1	21308-21309	A	_	
101-2	21310-21319	potential	_	
101-3	21320-21331	trend-level	_	
101-4	21332-21340	moderate	_	
101-5	21341-21347	effect	_	
101-6	21348-21353	could	_	
101-7	21354-21356	be	_	
101-8	21357-21365	observed	_	
101-9	21366-21368	in	_	
101-10	21369-21372	the	_	
101-11	21373-21380	bipolar	_	
101-12	21381-21389	disorder	_	
101-13	21390-21400	population	_	
101-14	21401-21402	(	_	
101-15	21402-21403	P	_	
101-16	21404-21405	=	_	
101-17	21406-21411	0.058	_	
101-18	21411-21412	,	_	
101-19	21413-21416	not	_	
101-20	21417-21425	reaching	_	
101-21	21426-21438	significance	_	
101-22	21439-21444	after	_	
101-23	21445-21455	correction	_	
101-24	21456-21459	for	_	
101-25	21460-21468	multiple	_	
101-26	21469-21476	testing	_	
101-27	21476-21477	)	_	
101-28	21477-21478	.	_	

#Text=To validate that these null findings were not related to analysing datasets with other acquisition protocols we analysed the open COBRE dataset (SCZcobre).
102-1	21479-21481	To	_	
102-2	21482-21490	validate	_	
102-3	21491-21495	that	_	
102-4	21496-21501	these	_	
102-5	21502-21506	null	_	
102-6	21507-21515	findings	_	
102-7	21516-21520	were	_	
102-8	21521-21524	not	_	
102-9	21525-21532	related	_	
102-10	21533-21535	to	_	
102-11	21536-21545	analysing	_	
102-12	21546-21554	datasets	_	
102-13	21555-21559	with	_	
102-14	21560-21565	other	_	
102-15	21566-21577	acquisition	_	
102-16	21578-21587	protocols	_	
102-17	21588-21590	we	_	
102-18	21591-21599	analysed	_	
102-19	21600-21603	the	_	
102-20	21604-21608	open	_	
102-21	21609-21614	COBRE	_	
102-22	21615-21622	dataset	_	
102-23	21623-21624	(	_	
102-24	21624-21632	SCZcobre	_	
102-25	21632-21633	)	_	
102-26	21633-21634	.	_	

#Text=In contrast to these other conditions, SCZcobre again showed significant enriched involvement of human-specific connections in schizophrenia dysconnectivity (P = 0.014, Bonferroni corrected) (Fig. 4).
103-1	21635-21637	In	_	
103-2	21638-21646	contrast	_	
103-3	21647-21649	to	_	
103-4	21650-21655	these	_	
103-5	21656-21661	other	_	
103-6	21662-21672	conditions	_	
103-7	21672-21673	,	_	
103-8	21674-21682	SCZcobre	_	
103-9	21683-21688	again	_	
103-10	21689-21695	showed	_	
103-11	21696-21707	significant	_	
103-12	21708-21716	enriched	_	
103-13	21717-21728	involvement	_	
103-14	21729-21731	of	_	
103-15	21732-21746	human-specific	_	
103-16	21747-21758	connections	_	
103-17	21759-21761	in	_	
103-18	21762-21775	schizophrenia	_	
103-19	21776-21791	dysconnectivity	_	
103-20	21792-21793	(	_	
103-21	21793-21794	P	_	
103-22	21795-21796	=	_	
103-23	21797-21802	0.014	_	
103-24	21802-21803	,	_	
103-25	21804-21814	Bonferroni	_	
103-26	21815-21824	corrected	_	
103-27	21824-21825	)	_	
103-28	21826-21827	(	_	
103-29	21827-21830	Fig	_	
103-30	21830-21831	.	_	
103-31	21832-21833	4	_	
103-32	21833-21834	)	_	
103-33	21834-21835	.	_	

#Text=Cross-disorder comparison.
104-1	21838-21852	Cross-disorder	_	
104-2	21853-21863	comparison	_	
104-3	21863-21864	.	_	

#Text=Schizophrenia effects were compared to other brain disorders to assess the level of specificity to schizophrenia.
105-1	21865-21878	Schizophrenia	_	
105-2	21879-21886	effects	_	
105-3	21887-21891	were	_	
105-4	21892-21900	compared	_	
105-5	21901-21903	to	_	
105-6	21904-21909	other	_	
105-7	21910-21915	brain	_	
105-8	21916-21925	disorders	_	
105-9	21926-21928	to	_	
105-10	21929-21935	assess	_	
105-11	21936-21939	the	_	
105-12	21940-21945	level	_	
105-13	21946-21948	of	_	
105-14	21949-21960	specificity	_	
105-15	21961-21963	to	_	
105-16	21964-21977	schizophrenia	_	
105-17	21977-21978	.	_	

#Text=Figure shows the difference in overlap of disease dysconnectivity between human-specific versus species-shared connections (y-axis) for schizophrenia (three datasets combined) and seven other brain disorders (x-axis) associated with connectome alterations in the literature, together with effects in the schizophrenia COBRE dataset.
106-1	21979-21985	Figure	_	
106-2	21986-21991	shows	_	
106-3	21992-21995	the	_	
106-4	21996-22006	difference	_	
106-5	22007-22009	in	_	
106-6	22010-22017	overlap	_	
106-7	22018-22020	of	_	
106-8	22021-22028	disease	_	
106-9	22029-22044	dysconnectivity	_	
106-10	22045-22052	between	_	
106-11	22053-22067	human-specific	_	
106-12	22068-22074	versus	_	
106-13	22075-22089	species-shared	_	
106-14	22090-22101	connections	_	
106-15	22102-22103	(	_	
106-16	22103-22109	y-axis	_	
106-17	22109-22110	)	_	
106-18	22111-22114	for	_	
106-19	22115-22128	schizophrenia	_	
106-20	22129-22130	(	_	
106-21	22130-22135	three	_	
106-22	22136-22144	datasets	_	
106-23	22145-22153	combined	_	
106-24	22153-22154	)	_	
106-25	22155-22158	and	_	
106-26	22159-22164	seven	_	
106-27	22165-22170	other	_	
106-28	22171-22176	brain	_	
106-29	22177-22186	disorders	_	
106-30	22187-22188	(	_	
106-31	22188-22194	x-axis	_	
106-32	22194-22195	)	_	
106-33	22196-22206	associated	_	
106-34	22207-22211	with	_	
106-35	22212-22222	connectome	_	
106-36	22223-22234	alterations	_	
106-37	22235-22237	in	_	
106-38	22238-22241	the	_	
106-39	22242-22252	literature	_	
106-40	22252-22253	,	_	
106-41	22254-22262	together	_	
106-42	22263-22267	with	_	
106-43	22268-22275	effects	_	
106-44	22276-22278	in	_	
106-45	22279-22282	the	_	
106-46	22283-22296	schizophrenia	_	
106-47	22297-22302	COBRE	_	
106-48	22303-22310	dataset	_	
106-49	22310-22311	.	_	

#Text=*P < 0.05 human-specific versus human-shared connections, FDR corrected.
107-1	22312-22313	*	_	
107-2	22313-22314	P	_	
107-3	22315-22316	<	_	
107-4	22317-22321	0.05	_	
107-5	22322-22336	human-specific	_	
107-6	22337-22343	versus	_	
107-7	22344-22356	human-shared	_	
107-8	22357-22368	connections	_	
107-9	22368-22369	,	_	
107-10	22370-22373	FDR	_	
107-11	22374-22383	corrected	_	
107-12	22383-22384	.	_	

#Text=SCZ = schizophrenia, combined effect of the principal and two validation schizophrenia sets (see Supplementary Fig. 4 for effects in all datasets separately); BP = bipolar disorder; ASD = autism spectrum disorder, combined effect of three ASD ABIDE-II datasets; MDD = major depressive disorder; OCD = obsessive-compulsive disorder; bvFTD = behavioural variant frontotemporal dementia; AD = Alzheimer’s disease; MCI = mild cognitive impairment; SCZcobre = shizophrenia COBRE dataset.
108-1	22385-22388	SCZ	_	
108-2	22389-22390	=	_	
108-3	22391-22404	schizophrenia	_	
108-4	22404-22405	,	_	
108-5	22406-22414	combined	_	
108-6	22415-22421	effect	_	
108-7	22422-22424	of	_	
108-8	22425-22428	the	_	
108-9	22429-22438	principal	_	
108-10	22439-22442	and	_	
108-11	22443-22446	two	_	
108-12	22447-22457	validation	_	
108-13	22458-22471	schizophrenia	_	
108-14	22472-22476	sets	_	
108-15	22477-22478	(	_	
108-16	22478-22481	see	_	
108-17	22482-22495	Supplementary	_	
108-18	22496-22499	Fig	_	
108-19	22499-22500	.	_	
108-20	22501-22502	4	_	
108-21	22503-22506	for	_	
108-22	22507-22514	effects	_	
108-23	22515-22517	in	_	
108-24	22518-22521	all	_	
108-25	22522-22530	datasets	_	
108-26	22531-22541	separately	_	
108-27	22541-22542	)	_	
108-28	22542-22543	;	_	
108-29	22544-22546	BP	_	
108-30	22547-22548	=	_	
108-31	22549-22556	bipolar	_	
108-32	22557-22565	disorder	_	
108-33	22565-22566	;	_	
108-34	22567-22570	ASD	_	
108-35	22571-22572	=	_	
108-36	22573-22579	autism	_	
108-37	22580-22588	spectrum	_	
108-38	22589-22597	disorder	_	
108-39	22597-22598	,	_	
108-40	22599-22607	combined	_	
108-41	22608-22614	effect	_	
108-42	22615-22617	of	_	
108-43	22618-22623	three	_	
108-44	22624-22627	ASD	_	
108-45	22628-22636	ABIDE-II	_	
108-46	22637-22645	datasets	_	
108-47	22645-22646	;	_	
108-48	22647-22650	MDD	_	
108-49	22651-22652	=	_	
108-50	22653-22658	major	_	
108-51	22659-22669	depressive	_	
108-52	22670-22678	disorder	_	
108-53	22678-22679	;	_	
108-54	22680-22683	OCD	_	
108-55	22684-22685	=	_	
108-56	22686-22706	obsessive-compulsive	_	
108-57	22707-22715	disorder	_	
108-58	22715-22716	;	_	
108-59	22717-22722	bvFTD	_	
108-60	22723-22724	=	_	
108-61	22725-22736	behavioural	_	
108-62	22737-22744	variant	_	
108-63	22745-22759	frontotemporal	_	
108-64	22760-22768	dementia	_	
108-65	22768-22769	;	_	
108-66	22770-22772	AD	_	
108-67	22773-22774	=	_	
108-68	22775-22784	Alzheimer	_	
108-69	22784-22785	’	_	
108-70	22785-22786	s	_	
108-71	22787-22794	disease	_	
108-72	22794-22795	;	_	
108-73	22796-22799	MCI	_	
108-74	22800-22801	=	_	
108-75	22802-22806	mild	_	
108-76	22807-22816	cognitive	_	
108-77	22817-22827	impairment	_	
108-78	22827-22828	;	_	
108-79	22829-22837	SCZcobre	_	
108-80	22838-22839	=	_	
108-81	22840-22852	shizophrenia	_	
108-82	22853-22858	COBRE	_	
108-83	22859-22866	dataset	_	
108-84	22866-22867	.	_	

#Text=Inset depicts the number of patient datasets included in each disorder dataset (Supplementary Tables 6 and 7).
109-1	22868-22873	Inset	_	
109-2	22874-22881	depicts	_	
109-3	22882-22885	the	_	
109-4	22886-22892	number	_	
109-5	22893-22895	of	_	
109-6	22896-22903	patient	_	
109-7	22904-22912	datasets	_	
109-8	22913-22921	included	_	
109-9	22922-22924	in	_	
109-10	22925-22929	each	_	
109-11	22930-22938	disorder	_	
109-12	22939-22946	dataset	_	
109-13	22947-22948	(	_	
109-14	22948-22961	Supplementary	_	
109-15	22962-22968	Tables	_	
109-16	22969-22970	6	_	
109-17	22971-22974	and	_	
109-18	22975-22976	7	_	
109-19	22976-22977	)	_	
109-20	22977-22978	.	_	

#Text=Boxes display the interval between 25th and 75th percentiles (q1 and q3); white lines indicate median values, white circles indicate mean values; whiskers indicate the interval between q1−1.5×(q3−q1) and q3+1.5×(q3−q1); violin plots show the distribution of values (smoothed for visualization with a 0.4 kernel).
110-1	22979-22984	Boxes	_	
110-2	22985-22992	display	_	
110-3	22993-22996	the	_	
110-4	22997-23005	interval	_	
110-5	23006-23013	between	_	
110-6	23014-23018	25th	_	
110-7	23019-23022	and	_	
110-8	23023-23027	75th	_	
110-9	23028-23039	percentiles	_	
110-10	23040-23041	(	_	
110-11	23041-23043	q1	_	
110-12	23044-23047	and	_	
110-13	23048-23050	q3	_	
110-14	23050-23051	)	_	
110-15	23051-23052	;	_	
110-16	23053-23058	white	_	
110-17	23059-23064	lines	_	
110-18	23065-23073	indicate	_	
110-19	23074-23080	median	_	
110-20	23081-23087	values	_	
110-21	23087-23088	,	_	
110-22	23089-23094	white	_	
110-23	23095-23102	circles	_	
110-24	23103-23111	indicate	_	
110-25	23112-23116	mean	_	
110-26	23117-23123	values	_	
110-27	23123-23124	;	_	
110-28	23125-23133	whiskers	_	
110-29	23134-23142	indicate	_	
110-30	23143-23146	the	_	
110-31	23147-23155	interval	_	
110-32	23156-23163	between	_	
110-33	23164-23166	q1	_	
110-34	23166-23167	−	_	
110-35	23167-23170	1.5	_	
110-36	23170-23171	×	_	
110-37	23171-23172	(	_	
110-38	23172-23174	q3	_	
110-39	23174-23175	−	_	
110-40	23175-23177	q1	_	
110-41	23177-23178	)	_	
110-42	23179-23182	and	_	
110-43	23183-23185	q3	_	
110-44	23185-23186	+	_	
110-45	23186-23189	1.5	_	
110-46	23189-23190	×	_	
110-47	23190-23191	(	_	
110-48	23191-23193	q3	_	
110-49	23193-23194	−	_	
110-50	23194-23196	q1	_	
110-51	23196-23197	)	_	
110-52	23197-23198	;	_	
110-53	23199-23205	violin	_	
110-54	23206-23211	plots	_	
110-55	23212-23216	show	_	
110-56	23217-23220	the	_	
110-57	23221-23233	distribution	_	
110-58	23234-23236	of	_	
110-59	23237-23243	values	_	
110-60	23244-23245	(	_	
110-61	23245-23253	smoothed	_	
110-62	23254-23257	for	_	
110-63	23258-23271	visualization	_	
110-64	23272-23276	with	_	
110-65	23277-23278	a	_	
110-66	23279-23282	0.4	_	
110-67	23283-23289	kernel	_	
110-68	23289-23290	)	_	
110-69	23290-23291	.	_	

#Text=Human, chimpanzee and macaque comparison
#Text=To investigate whether the human-specific connections would represent potential ‘human-unique’ connections and with that reflect human evolutionary specializations, we carried out post hoc analyses in which we further compared human and chimpanzee connections with brain connectivity as reconstructed in eight rhesus macaques, a more distantly related primate species (Supplementary material).
111-1	23292-23297	Human	_	
111-2	23297-23298	,	_	
111-3	23299-23309	chimpanzee	_	
111-4	23310-23313	and	_	
111-5	23314-23321	macaque	_	
111-6	23322-23332	comparison	_	
111-7	23333-23335	To	_	
111-8	23336-23347	investigate	_	
111-9	23348-23355	whether	_	
111-10	23356-23359	the	_	
111-11	23360-23374	human-specific	_	
111-12	23375-23386	connections	_	
111-13	23387-23392	would	_	
111-14	23393-23402	represent	_	
111-15	23403-23412	potential	_	
111-16	23413-23414	‘	_	
111-17	23414-23426	human-unique	_	
111-18	23426-23427	’	_	
111-19	23428-23439	connections	_	
111-20	23440-23443	and	_	
111-21	23444-23448	with	_	
111-22	23449-23453	that	_	
111-23	23454-23461	reflect	_	
111-24	23462-23467	human	_	
111-25	23468-23480	evolutionary	_	
111-26	23481-23496	specializations	_	
111-27	23496-23497	,	_	
111-28	23498-23500	we	_	
111-29	23501-23508	carried	_	
111-30	23509-23512	out	_	
111-31	23513-23517	post	_	
111-32	23518-23521	hoc	_	
111-33	23522-23530	analyses	_	
111-34	23531-23533	in	_	
111-35	23534-23539	which	_	
111-36	23540-23542	we	_	
111-37	23543-23550	further	_	
111-38	23551-23559	compared	_	
111-39	23560-23565	human	_	
111-40	23566-23569	and	_	
111-41	23570-23580	chimpanzee	_	
111-42	23581-23592	connections	_	
111-43	23593-23597	with	_	
111-44	23598-23603	brain	_	
111-45	23604-23616	connectivity	_	
111-46	23617-23619	as	_	
111-47	23620-23633	reconstructed	_	
111-48	23634-23636	in	_	
111-49	23637-23642	eight	_	
111-50	23643-23649	rhesus	_	
111-51	23650-23658	macaques	_	
111-52	23658-23659	,	_	
111-53	23660-23661	a	_	
111-54	23662-23666	more	_	
111-55	23667-23676	distantly	_	
111-56	23677-23684	related	_	
111-57	23685-23692	primate	_	
111-58	23693-23700	species	_	
111-59	23701-23702	(	_	
111-60	23702-23715	Supplementary	_	
111-61	23716-23724	material	_	
111-62	23724-23725	)	_	
111-63	23725-23726	.	_	

#Text=We again found the set of connections unique to humans to show significantly greater involvement as compared to the set of species-shared connections (permutation testing, P < 0.001, replication datasets, P = 0.031, P = 0.0020).
112-1	23727-23729	We	_	
112-2	23730-23735	again	_	
112-3	23736-23741	found	_	
112-4	23742-23745	the	_	
112-5	23746-23749	set	_	
112-6	23750-23752	of	_	
112-7	23753-23764	connections	_	
112-8	23765-23771	unique	_	
112-9	23772-23774	to	_	
112-10	23775-23781	humans	_	
112-11	23782-23784	to	_	
112-12	23785-23789	show	_	
112-13	23790-23803	significantly	_	
112-14	23804-23811	greater	_	
112-15	23812-23823	involvement	_	
112-16	23824-23826	as	_	
112-17	23827-23835	compared	_	
112-18	23836-23838	to	_	
112-19	23839-23842	the	_	
112-20	23843-23846	set	_	
112-21	23847-23849	of	_	
112-22	23850-23864	species-shared	_	
112-23	23865-23876	connections	_	
112-24	23877-23878	(	_	
112-25	23878-23889	permutation	_	
112-26	23890-23897	testing	_	
112-27	23897-23898	,	_	
112-28	23899-23900	P	_	
112-29	23901-23902	<	_	
112-30	23903-23908	0.001	_	
112-31	23908-23909	,	_	
112-32	23910-23921	replication	_	
112-33	23922-23930	datasets	_	
112-34	23930-23931	,	_	
112-35	23932-23933	P	_	
112-36	23934-23935	=	_	
112-37	23936-23941	0.031	_	
112-38	23941-23942	,	_	
112-39	23943-23944	P	_	
112-40	23945-23946	=	_	
112-41	23947-23953	0.0020	_	
112-42	23953-23954	)	_	
112-43	23954-23955	.	_	

#Text=To contrast, we also examined the class of chimpanzee-specific connections as compared to the group of macaques, which provided indications of specificity of the observed dysconnectivity effects to human evolutionary specializations.
113-1	23956-23958	To	_	
113-2	23959-23967	contrast	_	
113-3	23967-23968	,	_	
113-4	23969-23971	we	_	
113-5	23972-23976	also	_	
113-6	23977-23985	examined	_	
113-7	23986-23989	the	_	
113-8	23990-23995	class	_	
113-9	23996-23998	of	_	
113-10	23999-24018	chimpanzee-specific	_	
113-11	24019-24030	connections	_	
113-12	24031-24033	as	_	
113-13	24034-24042	compared	_	
113-14	24043-24045	to	_	
113-15	24046-24049	the	_	
113-16	24050-24055	group	_	
113-17	24056-24058	of	_	
113-18	24059-24067	macaques	_	
113-19	24067-24068	,	_	
113-20	24069-24074	which	_	
113-21	24075-24083	provided	_	
113-22	24084-24095	indications	_	
113-23	24096-24098	of	_	
113-24	24099-24110	specificity	_	
113-25	24111-24113	of	_	
113-26	24114-24117	the	_	
113-27	24118-24126	observed	_	
113-28	24127-24142	dysconnectivity	_	
113-29	24143-24150	effects	_	
113-30	24151-24153	to	_	
113-31	24154-24159	human	_	
113-32	24160-24172	evolutionary	_	
113-33	24173-24188	specializations	_	
113-34	24188-24189	.	_	

#Text=First, while human-specific connections showed involvement in schizophrenia dysconnectivity as compared to species-shared connections, no such effect was found for the class of human-chimpanzee-specific [i.e. connections found in chimpanzees (and humans), not in macaques] (P > 0.05, Fig. 5).
114-1	24190-24195	First	_	
114-2	24195-24196	,	_	
114-3	24197-24202	while	_	
114-4	24203-24217	human-specific	_	
114-5	24218-24229	connections	_	
114-6	24230-24236	showed	_	
114-7	24237-24248	involvement	_	
114-8	24249-24251	in	_	
114-9	24252-24265	schizophrenia	_	
114-10	24266-24281	dysconnectivity	_	
114-11	24282-24284	as	_	
114-12	24285-24293	compared	_	
114-13	24294-24296	to	_	
114-14	24297-24311	species-shared	_	
114-15	24312-24323	connections	_	
114-16	24323-24324	,	_	
114-17	24325-24327	no	_	
114-18	24328-24332	such	_	
114-19	24333-24339	effect	_	
114-20	24340-24343	was	_	
114-21	24344-24349	found	_	
114-22	24350-24353	for	_	
114-23	24354-24357	the	_	
114-24	24358-24363	class	_	
114-25	24364-24366	of	_	
114-26	24367-24392	human-chimpanzee-specific	_	
114-27	24393-24394	[	_	
114-28	24394-24397	i.e	_	
114-29	24397-24398	.	_	
114-30	24399-24410	connections	_	
114-31	24411-24416	found	_	
114-32	24417-24419	in	_	
114-33	24420-24431	chimpanzees	_	
114-34	24432-24433	(	_	
114-35	24433-24436	and	_	
114-36	24437-24443	humans	_	
114-37	24443-24444	)	_	
114-38	24444-24445	,	_	
114-39	24446-24449	not	_	
114-40	24450-24452	in	_	
114-41	24453-24461	macaques	_	
114-42	24461-24462	]	_	
114-43	24463-24464	(	_	
114-44	24464-24465	P	_	
114-45	24466-24467	>	_	
114-46	24468-24472	0.05	_	
114-47	24472-24473	,	_	
114-48	24474-24477	Fig	_	
114-49	24477-24478	.	_	
114-50	24479-24480	5	_	
114-51	24480-24481	)	_	
114-52	24481-24482	.	_	

#Text=The differential levels of overlap with schizophrenia dysconnectivity for the three classes shown in Fig. 5 suggest a ‘step-off’ effect between human and chimpanzees, rather than a ‘step-wise’ effect of schizophrenia dysconnectivity across the three species.
115-1	24483-24486	The	_	
115-2	24487-24499	differential	_	
115-3	24500-24506	levels	_	
115-4	24507-24509	of	_	
115-5	24510-24517	overlap	_	
115-6	24518-24522	with	_	
115-7	24523-24536	schizophrenia	_	
115-8	24537-24552	dysconnectivity	_	
115-9	24553-24556	for	_	
115-10	24557-24560	the	_	
115-11	24561-24566	three	_	
115-12	24567-24574	classes	_	
115-13	24575-24580	shown	_	
115-14	24581-24583	in	_	
115-15	24584-24587	Fig	_	
115-16	24587-24588	.	_	
115-17	24589-24590	5	_	
115-18	24591-24598	suggest	_	
115-19	24599-24600	a	_	
115-20	24601-24602	‘	_	
115-21	24602-24610	step-off	_	
115-22	24610-24611	’	_	
115-23	24612-24618	effect	_	
115-24	24619-24626	between	_	
115-25	24627-24632	human	_	
115-26	24633-24636	and	_	
115-27	24637-24648	chimpanzees	_	
115-28	24648-24649	,	_	
115-29	24650-24656	rather	_	
115-30	24657-24661	than	_	
115-31	24662-24663	a	_	
115-32	24664-24665	‘	_	
115-33	24665-24674	step-wise	_	
115-34	24674-24675	’	_	
115-35	24676-24682	effect	_	
115-36	24683-24685	of	_	
115-37	24686-24699	schizophrenia	_	
115-38	24700-24715	dysconnectivity	_	
115-39	24716-24722	across	_	
115-40	24723-24726	the	_	
115-41	24727-24732	three	_	
115-42	24733-24740	species	_	
115-43	24740-24741	.	_	

#Text=Second, examining the subset of species-shared connections of which humans showed higher fractional anisotropy compared to chimpanzees (i.e. human > chimpanzee, P < 0.05) showed a significantly higher level of schizophrenia dysconnectivity (P = 0.0014) compared to species-shared connections, but no such effect was found for connections for which chimpanzees showed higher connectivity weights than macaques (i.e. chimpanzees > macaques, P = 0.17).
116-1	24742-24748	Second	_	
116-2	24748-24749	,	_	
116-3	24750-24759	examining	_	
116-4	24760-24763	the	_	
116-5	24764-24770	subset	_	
116-6	24771-24773	of	_	
116-7	24774-24788	species-shared	_	
116-8	24789-24800	connections	_	
116-9	24801-24803	of	_	
116-10	24804-24809	which	_	
116-11	24810-24816	humans	_	
116-12	24817-24823	showed	_	
116-13	24824-24830	higher	_	
116-14	24831-24841	fractional	_	
116-15	24842-24852	anisotropy	_	
116-16	24853-24861	compared	_	
116-17	24862-24864	to	_	
116-18	24865-24876	chimpanzees	_	
116-19	24877-24878	(	_	
116-20	24878-24881	i.e	_	
116-21	24881-24882	.	_	
116-22	24883-24888	human	_	
116-23	24889-24890	>	_	
116-24	24891-24901	chimpanzee	_	
116-25	24901-24902	,	_	
116-26	24903-24904	P	_	
116-27	24905-24906	<	_	
116-28	24907-24911	0.05	_	
116-29	24911-24912	)	_	
116-30	24913-24919	showed	_	
116-31	24920-24921	a	_	
116-32	24922-24935	significantly	_	
116-33	24936-24942	higher	_	
116-34	24943-24948	level	_	
116-35	24949-24951	of	_	
116-36	24952-24965	schizophrenia	_	
116-37	24966-24981	dysconnectivity	_	
116-38	24982-24983	(	_	
116-39	24983-24984	P	_	
116-40	24985-24986	=	_	
116-41	24987-24993	0.0014	_	
116-42	24993-24994	)	_	
116-43	24995-25003	compared	_	
116-44	25004-25006	to	_	
116-45	25007-25021	species-shared	_	
116-46	25022-25033	connections	_	
116-47	25033-25034	,	_	
116-48	25035-25038	but	_	
116-49	25039-25041	no	_	
116-50	25042-25046	such	_	
116-51	25047-25053	effect	_	
116-52	25054-25057	was	_	
116-53	25058-25063	found	_	
116-54	25064-25067	for	_	
116-55	25068-25079	connections	_	
116-56	25080-25083	for	_	
116-57	25084-25089	which	_	
116-58	25090-25101	chimpanzees	_	
116-59	25102-25108	showed	_	
116-60	25109-25115	higher	_	
116-61	25116-25128	connectivity	_	
116-62	25129-25136	weights	_	
116-63	25137-25141	than	_	
116-64	25142-25150	macaques	_	
116-65	25151-25152	(	_	
116-66	25152-25155	i.e	_	
116-67	25155-25156	.	_	
116-68	25157-25168	chimpanzees	_	
116-69	25169-25170	>	_	
116-70	25171-25179	macaques	_	
116-71	25179-25180	,	_	
116-72	25181-25182	P	_	
116-73	25183-25184	=	_	
116-74	25185-25189	0.17	_	
116-75	25189-25190	)	_	
116-76	25190-25191	.	_	

#Text=Furthermore, no specific relationship was found when we examined normalized fractional anisotropy in species-shared connections between chimpanzee and macaque (i.e. between-group differences in fractional anisotropy in connections shared between chimpanzees and macaques) and the pattern of schizophrenia dysconnectivity (r = 0.06, P = 0.29).
117-1	25192-25203	Furthermore	_	
117-2	25203-25204	,	_	
117-3	25205-25207	no	_	
117-4	25208-25216	specific	_	
117-5	25217-25229	relationship	_	
117-6	25230-25233	was	_	
117-7	25234-25239	found	_	
117-8	25240-25244	when	_	
117-9	25245-25247	we	_	
117-10	25248-25256	examined	_	
117-11	25257-25267	normalized	_	
117-12	25268-25278	fractional	_	
117-13	25279-25289	anisotropy	_	
117-14	25290-25292	in	_	
117-15	25293-25307	species-shared	_	
117-16	25308-25319	connections	_	
117-17	25320-25327	between	_	
117-18	25328-25338	chimpanzee	_	
117-19	25339-25342	and	_	
117-20	25343-25350	macaque	_	
117-21	25351-25352	(	_	
117-22	25352-25355	i.e	_	
117-23	25355-25356	.	_	
117-24	25357-25370	between-group	_	
117-25	25371-25382	differences	_	
117-26	25383-25385	in	_	
117-27	25386-25396	fractional	_	
117-28	25397-25407	anisotropy	_	
117-29	25408-25410	in	_	
117-30	25411-25422	connections	_	
117-31	25423-25429	shared	_	
117-32	25430-25437	between	_	
117-33	25438-25449	chimpanzees	_	
117-34	25450-25453	and	_	
117-35	25454-25462	macaques	_	
117-36	25462-25463	)	_	
117-37	25464-25467	and	_	
117-38	25468-25471	the	_	
117-39	25472-25479	pattern	_	
117-40	25480-25482	of	_	
117-41	25483-25496	schizophrenia	_	
117-42	25497-25512	dysconnectivity	_	
117-43	25513-25514	(	_	
117-44	25514-25515	r	_	
117-45	25516-25517	=	_	
117-46	25518-25522	0.06	_	
117-47	25522-25523	,	_	
117-48	25524-25525	P	_	
117-49	25526-25527	=	_	
117-50	25528-25532	0.29	_	
117-51	25532-25533	)	_	
117-52	25533-25534	.	_	

#Text=Human-chimpanzee-macaque comparison.
118-1	25537-25561	Human-chimpanzee-macaque	_	
118-2	25562-25572	comparison	_	
118-3	25572-25573	.	_	

#Text=Violin plot of schizophrenia dysconnectivity levels for human-specific connections (H), human-chimpanzee-specific connections (HC, connections observed in humans and chimpanzees, not in macaques) and human-chimpanzee-macaque shared connections (HCM).
119-1	25574-25580	Violin	_	
119-2	25581-25585	plot	_	
119-3	25586-25588	of	_	
119-4	25589-25602	schizophrenia	_	
119-5	25603-25618	dysconnectivity	_	
119-6	25619-25625	levels	_	
119-7	25626-25629	for	_	
119-8	25630-25644	human-specific	_	
119-9	25645-25656	connections	_	
119-10	25657-25658	(	_	
119-11	25658-25659	H	_	
119-12	25659-25660	)	_	
119-13	25660-25661	,	_	
119-14	25662-25687	human-chimpanzee-specific	_	
119-15	25688-25699	connections	_	
119-16	25700-25701	(	_	
119-17	25701-25703	HC	_	
119-18	25703-25704	,	_	
119-19	25705-25716	connections	_	
119-20	25717-25725	observed	_	
119-21	25726-25728	in	_	
119-22	25729-25735	humans	_	
119-23	25736-25739	and	_	
119-24	25740-25751	chimpanzees	_	
119-25	25751-25752	,	_	
119-26	25753-25756	not	_	
119-27	25757-25759	in	_	
119-28	25760-25768	macaques	_	
119-29	25768-25769	)	_	
119-30	25770-25773	and	_	
119-31	25774-25798	human-chimpanzee-macaque	_	
119-32	25799-25805	shared	_	
119-33	25806-25817	connections	_	
119-34	25818-25819	(	_	
119-35	25819-25822	HCM	_	
119-36	25822-25823	)	_	
119-37	25823-25824	.	_	

#Text=Boxes display the interval between 25th and 75th percentiles (q1 and q3); white lines indicate median values, white circles indicate mean values; whiskers indicate the interval between q1−1.5×(q3−q1) and q3+1.5×(q3−q1); violin plots show the distribution of values (smoothed for visualization with a 0.4 kernel).
120-1	25825-25830	Boxes	_	
120-2	25831-25838	display	_	
120-3	25839-25842	the	_	
120-4	25843-25851	interval	_	
120-5	25852-25859	between	_	
120-6	25860-25864	25th	_	
120-7	25865-25868	and	_	
120-8	25869-25873	75th	_	
120-9	25874-25885	percentiles	_	
120-10	25886-25887	(	_	
120-11	25887-25889	q1	_	
120-12	25890-25893	and	_	
120-13	25894-25896	q3	_	
120-14	25896-25897	)	_	
120-15	25897-25898	;	_	
120-16	25899-25904	white	_	
120-17	25905-25910	lines	_	
120-18	25911-25919	indicate	_	
120-19	25920-25926	median	_	
120-20	25927-25933	values	_	
120-21	25933-25934	,	_	
120-22	25935-25940	white	_	
120-23	25941-25948	circles	_	
120-24	25949-25957	indicate	_	
120-25	25958-25962	mean	_	
120-26	25963-25969	values	_	
120-27	25969-25970	;	_	
120-28	25971-25979	whiskers	_	
120-29	25980-25988	indicate	_	
120-30	25989-25992	the	_	
120-31	25993-26001	interval	_	
120-32	26002-26009	between	_	
120-33	26010-26012	q1	_	
120-34	26012-26013	−	_	
120-35	26013-26016	1.5	_	
120-36	26016-26017	×	_	
120-37	26017-26018	(	_	
120-38	26018-26020	q3	_	
120-39	26020-26021	−	_	
120-40	26021-26023	q1	_	
120-41	26023-26024	)	_	
120-42	26025-26028	and	_	
120-43	26029-26031	q3	_	
120-44	26031-26032	+	_	
120-45	26032-26035	1.5	_	
120-46	26035-26036	×	_	
120-47	26036-26037	(	_	
120-48	26037-26039	q3	_	
120-49	26039-26040	−	_	
120-50	26040-26042	q1	_	
120-51	26042-26043	)	_	
120-52	26043-26044	;	_	
120-53	26045-26051	violin	_	
120-54	26052-26057	plots	_	
120-55	26058-26062	show	_	
120-56	26063-26066	the	_	
120-57	26067-26079	distribution	_	
120-58	26080-26082	of	_	
120-59	26083-26089	values	_	
120-60	26090-26091	(	_	
120-61	26091-26099	smoothed	_	
120-62	26100-26103	for	_	
120-63	26104-26117	visualization	_	
120-64	26118-26122	with	_	
120-65	26123-26124	a	_	
120-66	26125-26128	0.4	_	
120-67	26129-26135	kernel	_	
120-68	26135-26136	)	_	
120-69	26136-26137	.	_	

#Text=BB38 atlas validation
#Text=Analysing the connectome data using the BB38 atlas revealed similar results (Supplementary Fig. 5).
121-1	26138-26142	BB38	_	
121-2	26143-26148	atlas	_	
121-3	26149-26159	validation	_	
121-4	26160-26169	Analysing	_	
121-5	26170-26173	the	_	
121-6	26174-26184	connectome	_	
121-7	26185-26189	data	_	
121-8	26190-26195	using	_	
121-9	26196-26199	the	_	
121-10	26200-26204	BB38	_	
121-11	26205-26210	atlas	_	
121-12	26211-26219	revealed	_	
121-13	26220-26227	similar	_	
121-14	26228-26235	results	_	
121-15	26236-26237	(	_	
121-16	26237-26250	Supplementary	_	
121-17	26251-26254	Fig	_	
121-18	26254-26255	.	_	
121-19	26256-26257	5	_	
121-20	26257-26258	)	_	
121-21	26258-26259	.	_	

#Text=First, comparing the BB38 human and BB38 chimpanzee group connectome showed 33 human-specific tracts (tracts observed in >60% of the humans, not in the chimpanzees).
122-1	26260-26265	First	_	
122-2	26265-26266	,	_	
122-3	26267-26276	comparing	_	
122-4	26277-26280	the	_	
122-5	26281-26285	BB38	_	
122-6	26286-26291	human	_	
122-7	26292-26295	and	_	
122-8	26296-26300	BB38	_	
122-9	26301-26311	chimpanzee	_	
122-10	26312-26317	group	_	
122-11	26318-26328	connectome	_	
122-12	26329-26335	showed	_	
122-13	26336-26338	33	_	
122-14	26339-26353	human-specific	_	
122-15	26354-26360	tracts	_	
122-16	26361-26362	(	_	
122-17	26362-26368	tracts	_	
122-18	26369-26377	observed	_	
122-19	26378-26380	in	_	
122-20	26381-26382	>	_	
122-21	26382-26385	60%	_	
122-22	26386-26388	of	_	
122-23	26389-26392	the	_	
122-24	26393-26399	humans	_	
122-25	26399-26400	,	_	
122-26	26401-26404	not	_	
122-27	26405-26407	in	_	
122-28	26408-26411	the	_	
122-29	26412-26423	chimpanzees	_	
122-30	26423-26424	)	_	
122-31	26424-26425	.	_	

#Text=In contrast, only seven chimpanzee-specific connections were observed.
123-1	26426-26428	In	_	
123-2	26429-26437	contrast	_	
123-3	26437-26438	,	_	
123-4	26439-26443	only	_	
123-5	26444-26449	seven	_	
123-6	26450-26469	chimpanzee-specific	_	
123-7	26470-26481	connections	_	
123-8	26482-26486	were	_	
123-9	26487-26495	observed	_	
123-10	26495-26496	.	_	

#Text=These tracts were found between frontal, temporal and parietal associative cortex (Supplementary Table 5).
124-1	26497-26502	These	_	
124-2	26503-26509	tracts	_	
124-3	26510-26514	were	_	
124-4	26515-26520	found	_	
124-5	26521-26528	between	_	
124-6	26529-26536	frontal	_	
124-7	26536-26537	,	_	
124-8	26538-26546	temporal	_	
124-9	26547-26550	and	_	
124-10	26551-26559	parietal	_	
124-11	26560-26571	associative	_	
124-12	26572-26578	cortex	_	
124-13	26579-26580	(	_	
124-14	26580-26593	Supplementary	_	
124-15	26594-26599	Table	_	
124-16	26600-26601	5	_	
124-17	26601-26602	)	_	
124-18	26602-26603	.	_	

#Text=Second, human-specific tracts showed significantly higher levels of schizophrenia dysconnectivity compared to human-chimpanzee shared connections (P = 0.0018).
125-1	26604-26610	Second	_	
125-2	26610-26611	,	_	
125-3	26612-26626	human-specific	_	
125-4	26627-26633	tracts	_	
125-5	26634-26640	showed	_	
125-6	26641-26654	significantly	_	
125-7	26655-26661	higher	_	
125-8	26662-26668	levels	_	
125-9	26669-26671	of	_	
125-10	26672-26685	schizophrenia	_	
125-11	26686-26701	dysconnectivity	_	
125-12	26702-26710	compared	_	
125-13	26711-26713	to	_	
125-14	26714-26730	human-chimpanzee	_	
125-15	26731-26737	shared	_	
125-16	26738-26749	connections	_	
125-17	26750-26751	(	_	
125-18	26751-26752	P	_	
125-19	26753-26754	=	_	
125-20	26755-26761	0.0018	_	
125-21	26761-26762	)	_	
125-22	26762-26763	.	_	

#Text=Similar effects were found for the two validation datasets analysed with the BB38 atlas (P = 0.0296, P = 0.0212).
126-1	26764-26771	Similar	_	
126-2	26772-26779	effects	_	
126-3	26780-26784	were	_	
126-4	26785-26790	found	_	
126-5	26791-26794	for	_	
126-6	26795-26798	the	_	
126-7	26799-26802	two	_	
126-8	26803-26813	validation	_	
126-9	26814-26822	datasets	_	
126-10	26823-26831	analysed	_	
126-11	26832-26836	with	_	
126-12	26837-26840	the	_	
126-13	26841-26845	BB38	_	
126-14	26846-26851	atlas	_	
126-15	26852-26853	(	_	
126-16	26853-26854	P	_	
126-17	26855-26856	=	_	
126-18	26857-26863	0.0296	_	
126-19	26863-26864	,	_	
126-20	26865-26866	P	_	
126-21	26867-26868	=	_	
126-22	26869-26875	0.0212	_	
126-23	26875-26876	)	_	
126-24	26876-26877	.	_	

#Text=Third, across the set of BB38 connections shared between humans and chimpanzees (i.e. connections found in at least 60% of both populations, 255 connections) the level of species difference in connectivity strength was again found to be positively associated with the level of schizophrenia dysconnectivity (r = 0.24; P = 0.0023; replication datasets: r = 0.18; P = 0.0116 and r = 0.17; P = 0.0197).
127-1	26878-26883	Third	_	
127-2	26883-26884	,	_	
127-3	26885-26891	across	_	
127-4	26892-26895	the	_	
127-5	26896-26899	set	_	
127-6	26900-26902	of	_	
127-7	26903-26907	BB38	_	
127-8	26908-26919	connections	_	
127-9	26920-26926	shared	_	
127-10	26927-26934	between	_	
127-11	26935-26941	humans	_	
127-12	26942-26945	and	_	
127-13	26946-26957	chimpanzees	_	
127-14	26958-26959	(	_	
127-15	26959-26962	i.e	_	
127-16	26962-26963	.	_	
127-17	26964-26975	connections	_	
127-18	26976-26981	found	_	
127-19	26982-26984	in	_	
127-20	26985-26987	at	_	
127-21	26988-26993	least	_	
127-22	26994-26997	60%	_	
127-23	26998-27000	of	_	
127-24	27001-27005	both	_	
127-25	27006-27017	populations	_	
127-26	27017-27018	,	_	
127-27	27019-27022	255	_	
127-28	27023-27034	connections	_	
127-29	27034-27035	)	_	
127-30	27036-27039	the	_	
127-31	27040-27045	level	_	
127-32	27046-27048	of	_	
127-33	27049-27056	species	_	
127-34	27057-27067	difference	_	
127-35	27068-27070	in	_	
127-36	27071-27083	connectivity	_	
127-37	27084-27092	strength	_	
127-38	27093-27096	was	_	
127-39	27097-27102	again	_	
127-40	27103-27108	found	_	
127-41	27109-27111	to	_	
127-42	27112-27114	be	_	
127-43	27115-27125	positively	_	
127-44	27126-27136	associated	_	
127-45	27137-27141	with	_	
127-46	27142-27145	the	_	
127-47	27146-27151	level	_	
127-48	27152-27154	of	_	
127-49	27155-27168	schizophrenia	_	
127-50	27169-27184	dysconnectivity	_	
127-51	27185-27186	(	_	
127-52	27186-27187	r	_	
127-53	27188-27189	=	_	
127-54	27190-27194	0.24	_	
127-55	27194-27195	;	_	
127-56	27196-27197	P	_	
127-57	27198-27199	=	_	
127-58	27200-27206	0.0023	_	
127-59	27206-27207	;	_	
127-60	27208-27219	replication	_	
127-61	27220-27228	datasets	_	
127-62	27228-27229	:	_	
127-63	27230-27231	r	_	
127-64	27232-27233	=	_	
127-65	27234-27238	0.18	_	
127-66	27238-27239	;	_	
127-67	27240-27241	P	_	
127-68	27242-27243	=	_	
127-69	27244-27250	0.0116	_	
127-70	27251-27254	and	_	
127-71	27255-27256	r	_	
127-72	27257-27258	=	_	
127-73	27259-27263	0.17	_	
127-74	27263-27264	;	_	
127-75	27265-27266	P	_	
127-76	27267-27268	=	_	
127-77	27269-27275	0.0197	_	
127-78	27275-27276	)	_	
127-79	27276-27277	.	_	

#Text=Discussion
#Text=Our findings suggest that evolutionary modifications to connections of the human cerebrum are associated with the pattern of cortical dysconnectivity in schizophrenia.
128-1	27278-27288	Discussion	_	
128-2	27289-27292	Our	_	
128-3	27293-27301	findings	_	
128-4	27302-27309	suggest	_	
128-5	27310-27314	that	_	
128-6	27315-27327	evolutionary	_	
128-7	27328-27341	modifications	_	
128-8	27342-27344	to	_	
128-9	27345-27356	connections	_	
128-10	27357-27359	of	_	
128-11	27360-27363	the	_	
128-12	27364-27369	human	_	
128-13	27370-27378	cerebrum	_	
128-14	27379-27382	are	_	
128-15	27383-27393	associated	_	
128-16	27394-27398	with	_	
128-17	27399-27402	the	_	
128-18	27403-27410	pattern	_	
128-19	27411-27413	of	_	
128-20	27414-27422	cortical	_	
128-21	27423-27438	dysconnectivity	_	
128-22	27439-27441	in	_	
128-23	27442-27455	schizophrenia	_	
128-24	27455-27456	.	_	

#Text=Compared to our closest living relative the chimpanzee, connections present only in humans showed on average a higher involvement in schizophrenia pathology than the majority class of connections that are shared between the two species.
129-1	27457-27465	Compared	_	
129-2	27466-27468	to	_	
129-3	27469-27472	our	_	
129-4	27473-27480	closest	_	
129-5	27481-27487	living	_	
129-6	27488-27496	relative	_	
129-7	27497-27500	the	_	
129-8	27501-27511	chimpanzee	_	
129-9	27511-27512	,	_	
129-10	27513-27524	connections	_	
129-11	27525-27532	present	_	
129-12	27533-27537	only	_	
129-13	27538-27540	in	_	
129-14	27541-27547	humans	_	
129-15	27548-27554	showed	_	
129-16	27555-27557	on	_	
129-17	27558-27565	average	_	
129-18	27566-27567	a	_	
129-19	27568-27574	higher	_	
129-20	27575-27586	involvement	_	
129-21	27587-27589	in	_	
129-22	27590-27603	schizophrenia	_	
129-23	27604-27613	pathology	_	
129-24	27614-27618	than	_	
129-25	27619-27622	the	_	
129-26	27623-27631	majority	_	
129-27	27632-27637	class	_	
129-28	27638-27640	of	_	
129-29	27641-27652	connections	_	
129-30	27653-27657	that	_	
129-31	27658-27661	are	_	
129-32	27662-27668	shared	_	
129-33	27669-27676	between	_	
129-34	27677-27680	the	_	
129-35	27681-27684	two	_	
129-36	27685-27692	species	_	
129-37	27692-27693	.	_	

#Text=Comparing cerebral connectome organization across macaques, chimpanzees, and humans further suggests that aspects of schizophrenia dysconnectivity are likely related to features of connectivity that evolved in the human lineage after it separated from the lineage leading to chimpanzees, that is, to human evolutionary specializations.
130-1	27694-27703	Comparing	_	
130-2	27704-27712	cerebral	_	
130-3	27713-27723	connectome	_	
130-4	27724-27736	organization	_	
130-5	27737-27743	across	_	
130-6	27744-27752	macaques	_	
130-7	27752-27753	,	_	
130-8	27754-27765	chimpanzees	_	
130-9	27765-27766	,	_	
130-10	27767-27770	and	_	
130-11	27771-27777	humans	_	
130-12	27778-27785	further	_	
130-13	27786-27794	suggests	_	
130-14	27795-27799	that	_	
130-15	27800-27807	aspects	_	
130-16	27808-27810	of	_	
130-17	27811-27824	schizophrenia	_	
130-18	27825-27840	dysconnectivity	_	
130-19	27841-27844	are	_	
130-20	27845-27851	likely	_	
130-21	27852-27859	related	_	
130-22	27860-27862	to	_	
130-23	27863-27871	features	_	
130-24	27872-27874	of	_	
130-25	27875-27887	connectivity	_	
130-26	27888-27892	that	_	
130-27	27893-27900	evolved	_	
130-28	27901-27903	in	_	
130-29	27904-27907	the	_	
130-30	27908-27913	human	_	
130-31	27914-27921	lineage	_	
130-32	27922-27927	after	_	
130-33	27928-27930	it	_	
130-34	27931-27940	separated	_	
130-35	27941-27945	from	_	
130-36	27946-27949	the	_	
130-37	27950-27957	lineage	_	
130-38	27958-27965	leading	_	
130-39	27966-27968	to	_	
130-40	27969-27980	chimpanzees	_	
130-41	27980-27981	,	_	
130-42	27982-27986	that	_	
130-43	27987-27989	is	_	
130-44	27989-27990	,	_	
130-45	27991-27993	to	_	
130-46	27994-27999	human	_	
130-47	28000-28012	evolutionary	_	
130-48	28013-28028	specializations	_	
130-49	28028-28029	.	_	

#Text=Our findings suggest that modifications in brain circuitry in service of developing more complex brain functionality in humans may have potentially also shaped aspects of human-specific brain dysfunction.
131-1	28030-28033	Our	_	
131-2	28034-28042	findings	_	
131-3	28043-28050	suggest	_	
131-4	28051-28055	that	_	
131-5	28056-28069	modifications	_	
131-6	28070-28072	in	_	
131-7	28073-28078	brain	_	
131-8	28079-28088	circuitry	_	
131-9	28089-28091	in	_	
131-10	28092-28099	service	_	
131-11	28100-28102	of	_	
131-12	28103-28113	developing	_	
131-13	28114-28118	more	_	
131-14	28119-28126	complex	_	
131-15	28127-28132	brain	_	
131-16	28133-28146	functionality	_	
131-17	28147-28149	in	_	
131-18	28150-28156	humans	_	
131-19	28157-28160	may	_	
131-20	28161-28165	have	_	
131-21	28166-28177	potentially	_	
131-22	28178-28182	also	_	
131-23	28183-28189	shaped	_	
131-24	28190-28197	aspects	_	
131-25	28198-28200	of	_	
131-26	28201-28215	human-specific	_	
131-27	28216-28221	brain	_	
131-28	28222-28233	dysfunction	_	
131-29	28233-28234	.	_	

#Text=Cross-species comparisons of connectome layout over a wide range of taxa ranging from nematode to avian to mammalian species have revealed strong common principles of connectome organization.
132-1	28235-28248	Cross-species	_	
132-2	28249-28260	comparisons	_	
132-3	28261-28263	of	_	
132-4	28264-28274	connectome	_	
132-5	28275-28281	layout	_	
132-6	28282-28286	over	_	
132-7	28287-28288	a	_	
132-8	28289-28293	wide	_	
132-9	28294-28299	range	_	
132-10	28300-28302	of	_	
132-11	28303-28307	taxa	_	
132-12	28308-28315	ranging	_	
132-13	28316-28320	from	_	
132-14	28321-28329	nematode	_	
132-15	28330-28332	to	_	
132-16	28333-28338	avian	_	
132-17	28339-28341	to	_	
132-18	28342-28351	mammalian	_	
132-19	28352-28359	species	_	
132-20	28360-28364	have	_	
132-21	28365-28373	revealed	_	
132-22	28374-28380	strong	_	
132-23	28381-28387	common	_	
132-24	28388-28398	principles	_	
132-25	28399-28401	of	_	
132-26	28402-28412	connectome	_	
132-27	28413-28425	organization	_	
132-28	28425-28426	.	_	

#Text=These putative ‘architectural principles of wiring’ tend to involve a general trade-off between a drive to minimize the expenditure of neural wiring favouring the formation of short-range local circuitry and, on the other hand, forces that favour the development of long-range connections and topological network attributes that are beneficial for global communication and integration, a network property arguably important for integrated brain function.
133-1	28427-28432	These	_	
133-2	28433-28441	putative	_	
133-3	28442-28443	‘	_	
133-4	28443-28456	architectural	_	
133-5	28457-28467	principles	_	
133-6	28468-28470	of	_	
133-7	28471-28477	wiring	_	
133-8	28477-28478	’	_	
133-9	28479-28483	tend	_	
133-10	28484-28486	to	_	
133-11	28487-28494	involve	_	
133-12	28495-28496	a	_	
133-13	28497-28504	general	_	
133-14	28505-28514	trade-off	_	
133-15	28515-28522	between	_	
133-16	28523-28524	a	_	
133-17	28525-28530	drive	_	
133-18	28531-28533	to	_	
133-19	28534-28542	minimize	_	
133-20	28543-28546	the	_	
133-21	28547-28558	expenditure	_	
133-22	28559-28561	of	_	
133-23	28562-28568	neural	_	
133-24	28569-28575	wiring	_	
133-25	28576-28585	favouring	_	
133-26	28586-28589	the	_	
133-27	28590-28599	formation	_	
133-28	28600-28602	of	_	
133-29	28603-28614	short-range	_	
133-30	28615-28620	local	_	
133-31	28621-28630	circuitry	_	
133-32	28631-28634	and	_	
133-33	28634-28635	,	_	
133-34	28636-28638	on	_	
133-35	28639-28642	the	_	
133-36	28643-28648	other	_	
133-37	28649-28653	hand	_	
133-38	28653-28654	,	_	
133-39	28655-28661	forces	_	
133-40	28662-28666	that	_	
133-41	28667-28673	favour	_	
133-42	28674-28677	the	_	
133-43	28678-28689	development	_	
133-44	28690-28692	of	_	
133-45	28693-28703	long-range	_	
133-46	28704-28715	connections	_	
133-47	28716-28719	and	_	
133-48	28720-28731	topological	_	
133-49	28732-28739	network	_	
133-50	28740-28750	attributes	_	
133-51	28751-28755	that	_	
133-52	28756-28759	are	_	
133-53	28760-28770	beneficial	_	
133-54	28771-28774	for	_	
133-55	28775-28781	global	_	
133-56	28782-28795	communication	_	
133-57	28796-28799	and	_	
133-58	28800-28811	integration	_	
133-59	28811-28812	,	_	
133-60	28813-28814	a	_	
133-61	28815-28822	network	_	
133-62	28823-28831	property	_	
133-63	28832-28840	arguably	_	
133-64	28841-28850	important	_	
133-65	28851-28854	for	_	
133-66	28855-28865	integrated	_	
133-67	28866-28871	brain	_	
133-68	28872-28880	function	_	
133-69	28880-28881	.	_	

#Text=Such a trade-off may involve increased selection pressure for long-range associative connections to maintain the integrity of the network in expanding brains, and could potentially have resulted in an increased vulnerability of relatively sparse long-range connections that manifests as pathology and associated disrupted cognitive functioning in humans.
134-1	28882-28886	Such	_	
134-2	28887-28888	a	_	
134-3	28889-28898	trade-off	_	
134-4	28899-28902	may	_	
134-5	28903-28910	involve	_	
134-6	28911-28920	increased	_	
134-7	28921-28930	selection	_	
134-8	28931-28939	pressure	_	
134-9	28940-28943	for	_	
134-10	28944-28954	long-range	_	
134-11	28955-28966	associative	_	
134-12	28967-28978	connections	_	
134-13	28979-28981	to	_	
134-14	28982-28990	maintain	_	
134-15	28991-28994	the	_	
134-16	28995-29004	integrity	_	
134-17	29005-29007	of	_	
134-18	29008-29011	the	_	
134-19	29012-29019	network	_	
134-20	29020-29022	in	_	
134-21	29023-29032	expanding	_	
134-22	29033-29039	brains	_	
134-23	29039-29040	,	_	
134-24	29041-29044	and	_	
134-25	29045-29050	could	_	
134-26	29051-29062	potentially	_	
134-27	29063-29067	have	_	
134-28	29068-29076	resulted	_	
134-29	29077-29079	in	_	
134-30	29080-29082	an	_	
134-31	29083-29092	increased	_	
134-32	29093-29106	vulnerability	_	
134-33	29107-29109	of	_	
134-34	29110-29120	relatively	_	
134-35	29121-29127	sparse	_	
134-36	29128-29138	long-range	_	
134-37	29139-29150	connections	_	
134-38	29151-29155	that	_	
134-39	29156-29165	manifests	_	
134-40	29166-29168	as	_	
134-41	29169-29178	pathology	_	
134-42	29179-29182	and	_	
134-43	29183-29193	associated	_	
134-44	29194-29203	disrupted	_	
134-45	29204-29213	cognitive	_	
134-46	29214-29225	functioning	_	
134-47	29226-29228	in	_	
134-48	29229-29235	humans	_	
134-49	29235-29236	.	_	

#Text=Neuroimaging studies have indeed suggested that topologically important association pathways may be particularly involved in schizophrenia.
135-1	29237-29249	Neuroimaging	_	
135-2	29250-29257	studies	_	
135-3	29258-29262	have	_	
135-4	29263-29269	indeed	_	
135-5	29270-29279	suggested	_	
135-6	29280-29284	that	_	
135-7	29285-29298	topologically	_	
135-8	29299-29308	important	_	
135-9	29309-29320	association	_	
135-10	29321-29329	pathways	_	
135-11	29330-29333	may	_	
135-12	29334-29336	be	_	
135-13	29337-29349	particularly	_	
135-14	29350-29358	involved	_	
135-15	29359-29361	in	_	
135-16	29362-29375	schizophrenia	_	
135-17	29375-29376	.	_	

#Text=The evolutionary development of such white matter pathways in the human brain satisfy the increased pressure for cortico-cortical integration resulting from brain enlargement but may also contribute to pathological vulnerability for schizophrenia.
136-1	29377-29380	The	_	
136-2	29381-29393	evolutionary	_	
136-3	29394-29405	development	_	
136-4	29406-29408	of	_	
136-5	29409-29413	such	_	
136-6	29414-29419	white	_	
136-7	29420-29426	matter	_	
136-8	29427-29435	pathways	_	
136-9	29436-29438	in	_	
136-10	29439-29442	the	_	
136-11	29443-29448	human	_	
136-12	29449-29454	brain	_	
136-13	29455-29462	satisfy	_	
136-14	29463-29466	the	_	
136-15	29467-29476	increased	_	
136-16	29477-29485	pressure	_	
136-17	29486-29489	for	_	
136-18	29490-29506	cortico-cortical	_	
136-19	29507-29518	integration	_	
136-20	29519-29528	resulting	_	
136-21	29529-29533	from	_	
136-22	29534-29539	brain	_	
136-23	29540-29551	enlargement	_	
136-24	29552-29555	but	_	
136-25	29556-29559	may	_	
136-26	29560-29564	also	_	
136-27	29565-29575	contribute	_	
136-28	29576-29578	to	_	
136-29	29579-29591	pathological	_	
136-30	29592-29605	vulnerability	_	
136-31	29606-29609	for	_	
136-32	29610-29623	schizophrenia	_	
136-33	29623-29624	.	_	

#Text=The examined set of human-specific connections involved cortico-cortical connections around the language network, including the posterior part of the left superior temporal sulcus, left middle temporal gyrus, left pars opercularis, left inferior parietal cortex, and posterior parts of the left middle temporal gyrus.
137-1	29625-29628	The	_	
137-2	29629-29637	examined	_	
137-3	29638-29641	set	_	
137-4	29642-29644	of	_	
137-5	29645-29659	human-specific	_	
137-6	29660-29671	connections	_	
137-7	29672-29680	involved	_	
137-8	29681-29697	cortico-cortical	_	
137-9	29698-29709	connections	_	
137-10	29710-29716	around	_	
137-11	29717-29720	the	_	
137-12	29721-29729	language	_	
137-13	29730-29737	network	_	
137-14	29737-29738	,	_	
137-15	29739-29748	including	_	
137-16	29749-29752	the	_	
137-17	29753-29762	posterior	_	
137-18	29763-29767	part	_	
137-19	29768-29770	of	_	
137-20	29771-29774	the	_	
137-21	29775-29779	left	_	
137-22	29780-29788	superior	_	
137-23	29789-29797	temporal	_	
137-24	29798-29804	sulcus	_	
137-25	29804-29805	,	_	
137-26	29806-29810	left	_	
137-27	29811-29817	middle	_	
137-28	29818-29826	temporal	_	
137-29	29827-29832	gyrus	_	
137-30	29832-29833	,	_	
137-31	29834-29838	left	_	
137-32	29839-29843	pars	_	
137-33	29844-29855	opercularis	_	
137-34	29855-29856	,	_	
137-35	29857-29861	left	_	
137-36	29862-29870	inferior	_	
137-37	29871-29879	parietal	_	
137-38	29880-29886	cortex	_	
137-39	29886-29887	,	_	
137-40	29888-29891	and	_	
137-41	29892-29901	posterior	_	
137-42	29902-29907	parts	_	
137-43	29908-29910	of	_	
137-44	29911-29914	the	_	
137-45	29915-29919	left	_	
137-46	29920-29926	middle	_	
137-47	29927-29935	temporal	_	
137-48	29936-29941	gyrus	_	
137-49	29941-29942	.	_	

#Text=These regions have an integral role in semantic comprehension and language processing.
138-1	29943-29948	These	_	
138-2	29949-29956	regions	_	
138-3	29957-29961	have	_	
138-4	29962-29964	an	_	
138-5	29965-29973	integral	_	
138-6	29974-29978	role	_	
138-7	29979-29981	in	_	
138-8	29982-29990	semantic	_	
138-9	29991-30004	comprehension	_	
138-10	30005-30008	and	_	
138-11	30009-30017	language	_	
138-12	30018-30028	processing	_	
138-13	30028-30029	.	_	

#Text=Furthermore, observed human-specific connections included connections of the orbitofrontal cortex, parietal and temporal associative cortex, cortical areas and connections involved in cognitive control, social cognition, emotional processing, and affiliative behaviour.
139-1	30030-30041	Furthermore	_	
139-2	30041-30042	,	_	
139-3	30043-30051	observed	_	
139-4	30052-30066	human-specific	_	
139-5	30067-30078	connections	_	
139-6	30079-30087	included	_	
139-7	30088-30099	connections	_	
139-8	30100-30102	of	_	
139-9	30103-30106	the	_	
139-10	30107-30120	orbitofrontal	_	
139-11	30121-30127	cortex	_	
139-12	30127-30128	,	_	
139-13	30129-30137	parietal	_	
139-14	30138-30141	and	_	
139-15	30142-30150	temporal	_	
139-16	30151-30162	associative	_	
139-17	30163-30169	cortex	_	
139-18	30169-30170	,	_	
139-19	30171-30179	cortical	_	
139-20	30180-30185	areas	_	
139-21	30186-30189	and	_	
139-22	30190-30201	connections	_	
139-23	30202-30210	involved	_	
139-24	30211-30213	in	_	
139-25	30214-30223	cognitive	_	
139-26	30224-30231	control	_	
139-27	30231-30232	,	_	
139-28	30233-30239	social	_	
139-29	30240-30249	cognition	_	
139-30	30249-30250	,	_	
139-31	30251-30260	emotional	_	
139-32	30261-30271	processing	_	
139-33	30271-30272	,	_	
139-34	30273-30276	and	_	
139-35	30277-30288	affiliative	_	
139-36	30289-30298	behaviour	_	
139-37	30298-30299	.	_	

#Text=These brain functions are commonly suggested to be compromised in schizophrenia.
140-1	30300-30305	These	_	
140-2	30306-30311	brain	_	
140-3	30312-30321	functions	_	
140-4	30322-30325	are	_	
140-5	30326-30334	commonly	_	
140-6	30335-30344	suggested	_	
140-7	30345-30347	to	_	
140-8	30348-30350	be	_	
140-9	30351-30362	compromised	_	
140-10	30363-30365	in	_	
140-11	30366-30379	schizophrenia	_	
140-12	30379-30380	.	_	

#Text=In a post hoc analysis we cross-correlated the cortical map of human-specific connections with cortical mappings of human brain functions derived from the Neurosynth dataset (a large standardized collation of meta-analytic data of 10 000+ functional MRI studies on various cognitive tasks) (Supplementary material), which indicated potential involvement of the set of human-specific connections in ‘numerical cognition’, ‘verbal semantics’, ‘cognitive control’ and ‘inhibition’ (all P < 0.05, FDR corrected) (Supplementary Table 8).
141-1	30381-30383	In	_	
141-2	30384-30385	a	_	
141-3	30386-30390	post	_	
141-4	30391-30394	hoc	_	
141-5	30395-30403	analysis	_	
141-6	30404-30406	we	_	
141-7	30407-30423	cross-correlated	_	
141-8	30424-30427	the	_	
141-9	30428-30436	cortical	_	
141-10	30437-30440	map	_	
141-11	30441-30443	of	_	
141-12	30444-30458	human-specific	_	
141-13	30459-30470	connections	_	
141-14	30471-30475	with	_	
141-15	30476-30484	cortical	_	
141-16	30485-30493	mappings	_	
141-17	30494-30496	of	_	
141-18	30497-30502	human	_	
141-19	30503-30508	brain	_	
141-20	30509-30518	functions	_	
141-21	30519-30526	derived	_	
141-22	30527-30531	from	_	
141-23	30532-30535	the	_	
141-24	30536-30546	Neurosynth	_	
141-25	30547-30554	dataset	_	
141-26	30555-30556	(	_	
141-27	30556-30557	a	_	
141-28	30558-30563	large	_	
141-29	30564-30576	standardized	_	
141-30	30577-30586	collation	_	
141-31	30587-30589	of	_	
141-32	30590-30603	meta-analytic	_	
141-33	30604-30608	data	_	
141-34	30609-30611	of	_	
141-35	30612-30614	10	_	
141-36	30615-30618	000	_	
141-37	30618-30619	+	_	
141-38	30620-30630	functional	_	
141-39	30631-30634	MRI	_	
141-40	30635-30642	studies	_	
141-41	30643-30645	on	_	
141-42	30646-30653	various	_	
141-43	30654-30663	cognitive	_	
141-44	30664-30669	tasks	_	
141-45	30669-30670	)	_	
141-46	30671-30672	(	_	
141-47	30672-30685	Supplementary	_	
141-48	30686-30694	material	_	
141-49	30694-30695	)	_	
141-50	30695-30696	,	_	
141-51	30697-30702	which	_	
141-52	30703-30712	indicated	_	
141-53	30713-30722	potential	_	
141-54	30723-30734	involvement	_	
141-55	30735-30737	of	_	
141-56	30738-30741	the	_	
141-57	30742-30745	set	_	
141-58	30746-30748	of	_	
141-59	30749-30763	human-specific	_	
141-60	30764-30775	connections	_	
141-61	30776-30778	in	_	
141-62	30779-30780	‘	_	
141-63	30780-30789	numerical	_	
141-64	30790-30799	cognition	_	
141-65	30799-30800	’	_	
141-66	30800-30801	,	_	
141-67	30802-30803	‘	_	
141-68	30803-30809	verbal	_	
141-69	30810-30819	semantics	_	
141-70	30819-30820	’	_	
141-71	30820-30821	,	_	
141-72	30822-30823	‘	_	
141-73	30823-30832	cognitive	_	
141-74	30833-30840	control	_	
141-75	30840-30841	’	_	
141-76	30842-30845	and	_	
141-77	30846-30847	‘	_	
141-78	30847-30857	inhibition	_	
141-79	30857-30858	’	_	
141-80	30859-30860	(	_	
141-81	30860-30863	all	_	
141-82	30864-30865	P	_	
141-83	30866-30867	<	_	
141-84	30868-30872	0.05	_	
141-85	30872-30873	,	_	
141-86	30874-30877	FDR	_	
141-87	30878-30887	corrected	_	
141-88	30887-30888	)	_	
141-89	30889-30890	(	_	
141-90	30890-30903	Supplementary	_	
141-91	30904-30909	Table	_	
141-92	30910-30911	8	_	
141-93	30911-30912	)	_	
141-94	30912-30913	.	_	

#Text=Several of these functions have been suggested to be altered in schizophrenia, which supports the notion of evolutionary development of certain human cognitive functions—and accompanied modifications in brain circuitry—to relate to aspects of the disorder.
142-1	30914-30921	Several	_	
142-2	30922-30924	of	_	
142-3	30925-30930	these	_	
142-4	30931-30940	functions	_	
142-5	30941-30945	have	_	
142-6	30946-30950	been	_	
142-7	30951-30960	suggested	_	
142-8	30961-30963	to	_	
142-9	30964-30966	be	_	
142-10	30967-30974	altered	_	
142-11	30975-30977	in	_	
142-12	30978-30991	schizophrenia	_	
142-13	30991-30992	,	_	
142-14	30993-30998	which	_	
142-15	30999-31007	supports	_	
142-16	31008-31011	the	_	
142-17	31012-31018	notion	_	
142-18	31019-31021	of	_	
142-19	31022-31034	evolutionary	_	
142-20	31035-31046	development	_	
142-21	31047-31049	of	_	
142-22	31050-31057	certain	_	
142-23	31058-31063	human	_	
142-24	31064-31073	cognitive	_	
142-25	31074-31087	functions—and	_	
142-26	31088-31099	accompanied	_	
142-27	31100-31113	modifications	_	
142-28	31114-31116	in	_	
142-29	31117-31122	brain	_	
142-30	31123-31135	circuitry—to	_	
142-31	31136-31142	relate	_	
142-32	31143-31145	to	_	
142-33	31146-31153	aspects	_	
142-34	31154-31156	of	_	
142-35	31157-31160	the	_	
142-36	31161-31169	disorder	_	
142-37	31169-31170	.	_	

#Text=We note in this context that human-specific connections do not necessarily imply the evolution of completely new white matter tracts in and around these areas.
143-1	31171-31173	We	_	
143-2	31174-31178	note	_	
143-3	31179-31181	in	_	
143-4	31182-31186	this	_	
143-5	31187-31194	context	_	
143-6	31195-31199	that	_	
143-7	31200-31214	human-specific	_	
143-8	31215-31226	connections	_	
143-9	31227-31229	do	_	
143-10	31230-31233	not	_	
143-11	31234-31245	necessarily	_	
143-12	31246-31251	imply	_	
143-13	31252-31255	the	_	
143-14	31256-31265	evolution	_	
143-15	31266-31268	of	_	
143-16	31269-31279	completely	_	
143-17	31280-31283	new	_	
143-18	31284-31289	white	_	
143-19	31290-31296	matter	_	
143-20	31297-31303	tracts	_	
143-21	31304-31306	in	_	
143-22	31307-31310	and	_	
143-23	31311-31317	around	_	
143-24	31318-31323	these	_	
143-25	31324-31329	areas	_	
143-26	31329-31330	.	_	

#Text=Instead, these connections could involve enhancement of evolutionarily conserved tracts between cortical areas, but with more elaborate and widespread projections resulting in new region-to-region connections in the service of enhanced brain functionality.
144-1	31331-31338	Instead	_	
144-2	31338-31339	,	_	
144-3	31340-31345	these	_	
144-4	31346-31357	connections	_	
144-5	31358-31363	could	_	
144-6	31364-31371	involve	_	
144-7	31372-31383	enhancement	_	
144-8	31384-31386	of	_	
144-9	31387-31401	evolutionarily	_	
144-10	31402-31411	conserved	_	
144-11	31412-31418	tracts	_	
144-12	31419-31426	between	_	
144-13	31427-31435	cortical	_	
144-14	31436-31441	areas	_	
144-15	31441-31442	,	_	
144-16	31443-31446	but	_	
144-17	31447-31451	with	_	
144-18	31452-31456	more	_	
144-19	31457-31466	elaborate	_	
144-20	31467-31470	and	_	
144-21	31471-31481	widespread	_	
144-22	31482-31493	projections	_	
144-23	31494-31503	resulting	_	
144-24	31504-31506	in	_	
144-25	31507-31510	new	_	
144-26	31511-31527	region-to-region	_	
144-27	31528-31539	connections	_	
144-28	31540-31542	in	_	
144-29	31543-31546	the	_	
144-30	31547-31554	service	_	
144-31	31555-31557	of	_	
144-32	31558-31566	enhanced	_	
144-33	31567-31572	brain	_	
144-34	31573-31586	functionality	_	
144-35	31586-31587	.	_	

#Text=Indeed, homologues of frontal-temporal language areas (i.e.
145-1	31588-31594	Indeed	_	
145-2	31594-31595	,	_	
145-3	31596-31606	homologues	_	
145-4	31607-31609	of	_	
145-5	31610-31626	frontal-temporal	_	
145-6	31627-31635	language	_	
145-7	31636-31641	areas	_	
145-8	31642-31643	(	_	
145-9	31643-31646	i.e	_	
145-10	31646-31647	.	_	

#Text=Wernicke’s and Broca’s areas) for example have been reported across several primate species, but with humans exhibiting modified microstructural organization and more specialized connectivity, presumably related to development of specialized language processing skills in humans.
146-1	31648-31656	Wernicke	_	
146-2	31656-31657	’	_	
146-3	31657-31658	s	_	
146-4	31659-31662	and	_	
146-5	31663-31668	Broca	_	
146-6	31668-31669	’	_	
146-7	31669-31670	s	_	
146-8	31671-31676	areas	_	
146-9	31676-31677	)	_	
146-10	31678-31681	for	_	
146-11	31682-31689	example	_	
146-12	31690-31694	have	_	
146-13	31695-31699	been	_	
146-14	31700-31708	reported	_	
146-15	31709-31715	across	_	
146-16	31716-31723	several	_	
146-17	31724-31731	primate	_	
146-18	31732-31739	species	_	
146-19	31739-31740	,	_	
146-20	31741-31744	but	_	
146-21	31745-31749	with	_	
146-22	31750-31756	humans	_	
146-23	31757-31767	exhibiting	_	
146-24	31768-31776	modified	_	
146-25	31777-31792	microstructural	_	
146-26	31793-31805	organization	_	
146-27	31806-31809	and	_	
146-28	31810-31814	more	_	
146-29	31815-31826	specialized	_	
146-30	31827-31839	connectivity	_	
146-31	31839-31840	,	_	
146-32	31841-31851	presumably	_	
146-33	31852-31859	related	_	
146-34	31860-31862	to	_	
146-35	31863-31874	development	_	
146-36	31875-31877	of	_	
146-37	31878-31889	specialized	_	
146-38	31890-31898	language	_	
146-39	31899-31909	processing	_	
146-40	31910-31916	skills	_	
146-41	31917-31919	in	_	
146-42	31920-31926	humans	_	
146-43	31926-31927	.	_	

#Text=Our findings suggest that evolutionary modifications in brain connectivity in humans may have played a role in the development of aspects of schizophrenia.
147-1	31928-31931	Our	_	
147-2	31932-31940	findings	_	
147-3	31941-31948	suggest	_	
147-4	31949-31953	that	_	
147-5	31954-31966	evolutionary	_	
147-6	31967-31980	modifications	_	
147-7	31981-31983	in	_	
147-8	31984-31989	brain	_	
147-9	31990-32002	connectivity	_	
147-10	32003-32005	in	_	
147-11	32006-32012	humans	_	
147-12	32013-32016	may	_	
147-13	32017-32021	have	_	
147-14	32022-32028	played	_	
147-15	32029-32030	a	_	
147-16	32031-32035	role	_	
147-17	32036-32038	in	_	
147-18	32039-32042	the	_	
147-19	32043-32054	development	_	
147-20	32055-32057	of	_	
147-21	32058-32065	aspects	_	
147-22	32066-32068	of	_	
147-23	32069-32082	schizophrenia	_	
147-24	32082-32083	.	_	

#Text=We find it important to note that our comparative neurobiological findings do not in any way imply that connectome maps of patients display a less complex state.
148-1	32084-32086	We	_	
148-2	32087-32091	find	_	
148-3	32092-32094	it	_	
148-4	32095-32104	important	_	
148-5	32105-32107	to	_	
148-6	32108-32112	note	_	
148-7	32113-32117	that	_	
148-8	32118-32121	our	_	
148-9	32122-32133	comparative	_	
148-10	32134-32149	neurobiological	_	
148-11	32150-32158	findings	_	
148-12	32159-32161	do	_	
148-13	32162-32165	not	_	
148-14	32166-32168	in	_	
148-15	32169-32172	any	_	
148-16	32173-32176	way	_	
148-17	32177-32182	imply	_	
148-18	32183-32187	that	_	
148-19	32188-32198	connectome	_	
148-20	32199-32203	maps	_	
148-21	32204-32206	of	_	
148-22	32207-32215	patients	_	
148-23	32216-32223	display	_	
148-24	32224-32225	a	_	
148-25	32226-32230	less	_	
148-26	32231-32238	complex	_	
148-27	32239-32244	state	_	
148-28	32244-32245	.	_	

#Text=Our findings also do not imply that all brain changes in schizophrenia can be traced back to evolutionary modifications, nor that all aspects of schizophrenia can be explained from an evolutionary viewpoint.
149-1	32246-32249	Our	_	
149-2	32250-32258	findings	_	
149-3	32259-32263	also	_	
149-4	32264-32266	do	_	
149-5	32267-32270	not	_	
149-6	32271-32276	imply	_	
149-7	32277-32281	that	_	
149-8	32282-32285	all	_	
149-9	32286-32291	brain	_	
149-10	32292-32299	changes	_	
149-11	32300-32302	in	_	
149-12	32303-32316	schizophrenia	_	
149-13	32317-32320	can	_	
149-14	32321-32323	be	_	
149-15	32324-32330	traced	_	
149-16	32331-32335	back	_	
149-17	32336-32338	to	_	
149-18	32339-32351	evolutionary	_	
149-19	32352-32365	modifications	_	
149-20	32365-32366	,	_	
149-21	32367-32370	nor	_	
149-22	32371-32375	that	_	
149-23	32376-32379	all	_	
149-24	32380-32387	aspects	_	
149-25	32388-32390	of	_	
149-26	32391-32404	schizophrenia	_	
149-27	32405-32408	can	_	
149-28	32409-32411	be	_	
149-29	32412-32421	explained	_	
149-30	32422-32426	from	_	
149-31	32427-32429	an	_	
149-32	32430-32442	evolutionary	_	
149-33	32443-32452	viewpoint	_	
149-34	32452-32453	.	_	

#Text=In contrast, schizophrenia is a multifactorial condition, with many genetic, brain, lifestyle and environmental factors all playing a role in the development of the disorder.
150-1	32454-32456	In	_	
150-2	32457-32465	contrast	_	
150-3	32465-32466	,	_	
150-4	32467-32480	schizophrenia	_	
150-5	32481-32483	is	_	
150-6	32484-32485	a	_	
150-7	32486-32500	multifactorial	_	
150-8	32501-32510	condition	_	
150-9	32510-32511	,	_	
150-10	32512-32516	with	_	
150-11	32517-32521	many	_	
150-12	32522-32529	genetic	_	
150-13	32529-32530	,	_	
150-14	32531-32536	brain	_	
150-15	32536-32537	,	_	
150-16	32538-32547	lifestyle	_	
150-17	32548-32551	and	_	
150-18	32552-32565	environmental	_	
150-19	32566-32573	factors	_	
150-20	32574-32577	all	_	
150-21	32578-32585	playing	_	
150-22	32586-32587	a	_	
150-23	32588-32592	role	_	
150-24	32593-32595	in	_	
150-25	32596-32599	the	_	
150-26	32600-32611	development	_	
150-27	32612-32614	of	_	
150-28	32615-32618	the	_	
150-29	32619-32627	disorder	_	
150-30	32627-32628	.	_	

#Text=Our findings merely suggest that recent evolutionary modifications in brain circuitry in humans may have been one of the factors that have played a role in the development of the disorder in humans.
151-1	32629-32632	Our	_	
151-2	32633-32641	findings	_	
151-3	32642-32648	merely	_	
151-4	32649-32656	suggest	_	
151-5	32657-32661	that	_	
151-6	32662-32668	recent	_	
151-7	32669-32681	evolutionary	_	
151-8	32682-32695	modifications	_	
151-9	32696-32698	in	_	
151-10	32699-32704	brain	_	
151-11	32705-32714	circuitry	_	
151-12	32715-32717	in	_	
151-13	32718-32724	humans	_	
151-14	32725-32728	may	_	
151-15	32729-32733	have	_	
151-16	32734-32738	been	_	
151-17	32739-32742	one	_	
151-18	32743-32745	of	_	
151-19	32746-32749	the	_	
151-20	32750-32757	factors	_	
151-21	32758-32762	that	_	
151-22	32763-32767	have	_	
151-23	32768-32774	played	_	
151-24	32775-32776	a	_	
151-25	32777-32781	role	_	
151-26	32782-32784	in	_	
151-27	32785-32788	the	_	
151-28	32789-32800	development	_	
151-29	32801-32803	of	_	
151-30	32804-32807	the	_	
151-31	32808-32816	disorder	_	
151-32	32817-32819	in	_	
151-33	32820-32826	humans	_	
151-34	32826-32827	.	_	

#Text=In contrast to our findings in schizophrenia, we did not observe similar involvement of human-specific connections in brain dysconnectivity in ASD, OCD, major depression, bvFTD, and/or Alzheimer’s disease and MCI.
152-1	32828-32830	In	_	
152-2	32831-32839	contrast	_	
152-3	32840-32842	to	_	
152-4	32843-32846	our	_	
152-5	32847-32855	findings	_	
152-6	32856-32858	in	_	
152-7	32859-32872	schizophrenia	_	
152-8	32872-32873	,	_	
152-9	32874-32876	we	_	
152-10	32877-32880	did	_	
152-11	32881-32884	not	_	
152-12	32885-32892	observe	_	
152-13	32893-32900	similar	_	
152-14	32901-32912	involvement	_	
152-15	32913-32915	of	_	
152-16	32916-32930	human-specific	_	
152-17	32931-32942	connections	_	
152-18	32943-32945	in	_	
152-19	32946-32951	brain	_	
152-20	32952-32967	dysconnectivity	_	
152-21	32968-32970	in	_	
152-22	32971-32974	ASD	_	
152-23	32974-32975	,	_	
152-24	32976-32979	OCD	_	
152-25	32979-32980	,	_	
152-26	32981-32986	major	_	
152-27	32987-32997	depression	_	
152-28	32997-32998	,	_	
152-29	32999-33004	bvFTD	_	
152-30	33004-33005	,	_	
152-31	33006-33009	and	_	
152-32	33009-33010	/	_	
152-33	33010-33012	or	_	
152-34	33013-33022	Alzheimer	_	
152-35	33022-33023	’	_	
152-36	33023-33024	s	_	
152-37	33025-33032	disease	_	
152-38	33033-33036	and	_	
152-39	33037-33040	MCI	_	
152-40	33040-33041	.	_	

#Text=A moderate (non-significant) trend effect was only found for bipolar disorder, a disorder that shows genetic overlap with schizophrenia and is also characterized by high levels of psychosis.
153-1	33042-33043	A	_	
153-2	33044-33052	moderate	_	
153-3	33053-33054	(	_	
153-4	33054-33069	non-significant	_	
153-5	33069-33070	)	_	
153-6	33071-33076	trend	_	
153-7	33077-33083	effect	_	
153-8	33084-33087	was	_	
153-9	33088-33092	only	_	
153-10	33093-33098	found	_	
153-11	33099-33102	for	_	
153-12	33103-33110	bipolar	_	
153-13	33111-33119	disorder	_	
153-14	33119-33120	,	_	
153-15	33121-33122	a	_	
153-16	33123-33131	disorder	_	
153-17	33132-33136	that	_	
153-18	33137-33142	shows	_	
153-19	33143-33150	genetic	_	
153-20	33151-33158	overlap	_	
153-21	33159-33163	with	_	
153-22	33164-33177	schizophrenia	_	
153-23	33178-33181	and	_	
153-24	33182-33184	is	_	
153-25	33185-33189	also	_	
153-26	33190-33203	characterized	_	
153-27	33204-33206	by	_	
153-28	33207-33211	high	_	
153-29	33212-33218	levels	_	
153-30	33219-33221	of	_	
153-31	33222-33231	psychosis	_	
153-32	33231-33232	.	_	

#Text=From these null findings we tentatively conclude that human modifications of brain connectivity may be particularly related to the pattern of dysconnectivity related to psychosis.
154-1	33233-33237	From	_	
154-2	33238-33243	these	_	
154-3	33244-33248	null	_	
154-4	33249-33257	findings	_	
154-5	33258-33260	we	_	
154-6	33261-33272	tentatively	_	
154-7	33273-33281	conclude	_	
154-8	33282-33286	that	_	
154-9	33287-33292	human	_	
154-10	33293-33306	modifications	_	
154-11	33307-33309	of	_	
154-12	33310-33315	brain	_	
154-13	33316-33328	connectivity	_	
154-14	33329-33332	may	_	
154-15	33333-33335	be	_	
154-16	33336-33348	particularly	_	
154-17	33349-33356	related	_	
154-18	33357-33359	to	_	
154-19	33360-33363	the	_	
154-20	33364-33371	pattern	_	
154-21	33372-33374	of	_	
154-22	33375-33390	dysconnectivity	_	
154-23	33391-33398	related	_	
154-24	33399-33401	to	_	
154-25	33402-33411	psychosis	_	
154-26	33411-33412	.	_	

#Text=This interpretation is supported by the suggestion that certain other psychiatric traits, such as low mood, depression, and anxiety can also manifest in non-human animals and may thus potentially be more related to changes in other brain circuitry.
155-1	33413-33417	This	_	
155-2	33418-33432	interpretation	_	
155-3	33433-33435	is	_	
155-4	33436-33445	supported	_	
155-5	33446-33448	by	_	
155-6	33449-33452	the	_	
155-7	33453-33463	suggestion	_	
155-8	33464-33468	that	_	
155-9	33469-33476	certain	_	
155-10	33477-33482	other	_	
155-11	33483-33494	psychiatric	_	
155-12	33495-33501	traits	_	
155-13	33501-33502	,	_	
155-14	33503-33507	such	_	
155-15	33508-33510	as	_	
155-16	33511-33514	low	_	
155-17	33515-33519	mood	_	
155-18	33519-33520	,	_	
155-19	33521-33531	depression	_	
155-20	33531-33532	,	_	
155-21	33533-33536	and	_	
155-22	33537-33544	anxiety	_	
155-23	33545-33548	can	_	
155-24	33549-33553	also	_	
155-25	33554-33562	manifest	_	
155-26	33563-33565	in	_	
155-27	33566-33575	non-human	_	
155-28	33576-33583	animals	_	
155-29	33584-33587	and	_	
155-30	33588-33591	may	_	
155-31	33592-33596	thus	_	
155-32	33597-33608	potentially	_	
155-33	33609-33611	be	_	
155-34	33612-33616	more	_	
155-35	33617-33624	related	_	
155-36	33625-33627	to	_	
155-37	33628-33635	changes	_	
155-38	33636-33638	in	_	
155-39	33639-33644	other	_	
155-40	33645-33650	brain	_	
155-41	33651-33660	circuitry	_	
155-42	33660-33661	.	_	

#Text=OCD-like traits such as abnormal repetitive behaviour are, for example, suggested to exist in non-human animals and believed to relate to aspects of comparable frontostriatal circuitry between animals and human patients.
156-1	33662-33670	OCD-like	_	
156-2	33671-33677	traits	_	
156-3	33678-33682	such	_	
156-4	33683-33685	as	_	
156-5	33686-33694	abnormal	_	
156-6	33695-33705	repetitive	_	
156-7	33706-33715	behaviour	_	
156-8	33716-33719	are	_	
156-9	33719-33720	,	_	
156-10	33721-33724	for	_	
156-11	33725-33732	example	_	
156-12	33732-33733	,	_	
156-13	33734-33743	suggested	_	
156-14	33744-33746	to	_	
156-15	33747-33752	exist	_	
156-16	33753-33755	in	_	
156-17	33756-33765	non-human	_	
156-18	33766-33773	animals	_	
156-19	33774-33777	and	_	
156-20	33778-33786	believed	_	
156-21	33787-33789	to	_	
156-22	33790-33796	relate	_	
156-23	33797-33799	to	_	
156-24	33800-33807	aspects	_	
156-25	33808-33810	of	_	
156-26	33811-33821	comparable	_	
156-27	33822-33836	frontostriatal	_	
156-28	33837-33846	circuitry	_	
156-29	33847-33854	between	_	
156-30	33855-33862	animals	_	
156-31	33863-33866	and	_	
156-32	33867-33872	human	_	
156-33	33873-33881	patients	_	
156-34	33881-33882	.	_	

#Text=Similarly, case studies have reported spontaneous autistic traits in developing non-human primates, with underlying genetic variations overlapping with those in humans, suggesting that these traits may potentially be more associated with alterations in brain circuitry shared between humans and other primates.
157-1	33883-33892	Similarly	_	
157-2	33892-33893	,	_	
157-3	33894-33898	case	_	
157-4	33899-33906	studies	_	
157-5	33907-33911	have	_	
157-6	33912-33920	reported	_	
157-7	33921-33932	spontaneous	_	
157-8	33933-33941	autistic	_	
157-9	33942-33948	traits	_	
157-10	33949-33951	in	_	
157-11	33952-33962	developing	_	
157-12	33963-33972	non-human	_	
157-13	33973-33981	primates	_	
157-14	33981-33982	,	_	
157-15	33983-33987	with	_	
157-16	33988-33998	underlying	_	
157-17	33999-34006	genetic	_	
157-18	34007-34017	variations	_	
157-19	34018-34029	overlapping	_	
157-20	34030-34034	with	_	
157-21	34035-34040	those	_	
157-22	34041-34043	in	_	
157-23	34044-34050	humans	_	
157-24	34050-34051	,	_	
157-25	34052-34062	suggesting	_	
157-26	34063-34067	that	_	
157-27	34068-34073	these	_	
157-28	34074-34080	traits	_	
157-29	34081-34084	may	_	
157-30	34085-34096	potentially	_	
157-31	34097-34099	be	_	
157-32	34100-34104	more	_	
157-33	34105-34115	associated	_	
157-34	34116-34120	with	_	
157-35	34121-34132	alterations	_	
157-36	34133-34135	in	_	
157-37	34136-34141	brain	_	
157-38	34142-34151	circuitry	_	
157-39	34152-34158	shared	_	
157-40	34159-34166	between	_	
157-41	34167-34173	humans	_	
157-42	34174-34177	and	_	
157-43	34178-34183	other	_	
157-44	34184-34192	primates	_	
157-45	34192-34193	.	_	

#Text=However, it is important to consider differences in examined group sample sizes (Supplementary Tables 6 and 7), which results in different levels of statistical power across the examined disorder datasets, limiting direct comparison of effects across disorders.
158-1	34194-34201	However	_	
158-2	34201-34202	,	_	
158-3	34203-34205	it	_	
158-4	34206-34208	is	_	
158-5	34209-34218	important	_	
158-6	34219-34221	to	_	
158-7	34222-34230	consider	_	
158-8	34231-34242	differences	_	
158-9	34243-34245	in	_	
158-10	34246-34254	examined	_	
158-11	34255-34260	group	_	
158-12	34261-34267	sample	_	
158-13	34268-34273	sizes	_	
158-14	34274-34275	(	_	
158-15	34275-34288	Supplementary	_	
158-16	34289-34295	Tables	_	
158-17	34296-34297	6	_	
158-18	34298-34301	and	_	
158-19	34302-34303	7	_	
158-20	34303-34304	)	_	
158-21	34304-34305	,	_	
158-22	34306-34311	which	_	
158-23	34312-34319	results	_	
158-24	34320-34322	in	_	
158-25	34323-34332	different	_	
158-26	34333-34339	levels	_	
158-27	34340-34342	of	_	
158-28	34343-34354	statistical	_	
158-29	34355-34360	power	_	
158-30	34361-34367	across	_	
158-31	34368-34371	the	_	
158-32	34372-34380	examined	_	
158-33	34381-34389	disorder	_	
158-34	34390-34398	datasets	_	
158-35	34398-34399	,	_	
158-36	34400-34408	limiting	_	
158-37	34409-34415	direct	_	
158-38	34416-34426	comparison	_	
158-39	34427-34429	of	_	
158-40	34430-34437	effects	_	
158-41	34438-34444	across	_	
158-42	34445-34454	disorders	_	
158-43	34454-34455	.	_	

#Text=Furthermore, it is important to note that like schizophrenia, the other disorders also involve widespread changes in brain structure and function (; for review see) and evolutionary pressure on brain organization may have similarly played a role in other aspects of the biological background of these conditions.
159-1	34456-34467	Furthermore	_	
159-2	34467-34468	,	_	
159-3	34469-34471	it	_	
159-4	34472-34474	is	_	
159-5	34475-34484	important	_	
159-6	34485-34487	to	_	
159-7	34488-34492	note	_	
159-8	34493-34497	that	_	
159-9	34498-34502	like	_	
159-10	34503-34516	schizophrenia	_	
159-11	34516-34517	,	_	
159-12	34518-34521	the	_	
159-13	34522-34527	other	_	
159-14	34528-34537	disorders	_	
159-15	34538-34542	also	_	
159-16	34543-34550	involve	_	
159-17	34551-34561	widespread	_	
159-18	34562-34569	changes	_	
159-19	34570-34572	in	_	
159-20	34573-34578	brain	_	
159-21	34579-34588	structure	_	
159-22	34589-34592	and	_	
159-23	34593-34601	function	_	
159-24	34602-34603	(	_	
159-25	34603-34604	;	_	
159-26	34605-34608	for	_	
159-27	34609-34615	review	_	
159-28	34616-34619	see	_	
159-29	34619-34620	)	_	
159-30	34621-34624	and	_	
159-31	34625-34637	evolutionary	_	
159-32	34638-34646	pressure	_	
159-33	34647-34649	on	_	
159-34	34650-34655	brain	_	
159-35	34656-34668	organization	_	
159-36	34669-34672	may	_	
159-37	34673-34677	have	_	
159-38	34678-34687	similarly	_	
159-39	34688-34694	played	_	
159-40	34695-34696	a	_	
159-41	34697-34701	role	_	
159-42	34702-34704	in	_	
159-43	34705-34710	other	_	
159-44	34711-34718	aspects	_	
159-45	34719-34721	of	_	
159-46	34722-34725	the	_	
159-47	34726-34736	biological	_	
159-48	34737-34747	background	_	
159-49	34748-34750	of	_	
159-50	34751-34756	these	_	
159-51	34757-34767	conditions	_	
159-52	34767-34768	.	_	

#Text=We do not rule out that other aspects of brain connectivity (e.g. function, developmental topological layout etc.) may still be related to evolutionary processes in these conditions.
160-1	34769-34771	We	_	
160-2	34772-34774	do	_	
160-3	34775-34778	not	_	
160-4	34779-34783	rule	_	
160-5	34784-34787	out	_	
160-6	34788-34792	that	_	
160-7	34793-34798	other	_	
160-8	34799-34806	aspects	_	
160-9	34807-34809	of	_	
160-10	34810-34815	brain	_	
160-11	34816-34828	connectivity	_	
160-12	34829-34830	(	_	
160-13	34830-34833	e.g	_	
160-14	34833-34834	.	_	
160-15	34835-34843	function	_	
160-16	34843-34844	,	_	
160-17	34845-34858	developmental	_	
160-18	34859-34870	topological	_	
160-19	34871-34877	layout	_	
160-20	34878-34881	etc	_	
160-21	34881-34882	.	_	
160-22	34882-34883	)	_	
160-23	34884-34887	may	_	
160-24	34888-34893	still	_	
160-25	34894-34896	be	_	
160-26	34897-34904	related	_	
160-27	34905-34907	to	_	
160-28	34908-34920	evolutionary	_	
160-29	34921-34930	processes	_	
160-30	34931-34933	in	_	
160-31	34934-34939	these	_	
160-32	34940-34950	conditions	_	
160-33	34950-34951	.	_	

#Text=Future studies further examining the potential contribution of evolutionary changes in brain organization to schizophrenia and other mental disorders are of interest.
161-1	34952-34958	Future	_	
161-2	34959-34966	studies	_	
161-3	34967-34974	further	_	
161-4	34975-34984	examining	_	
161-5	34985-34988	the	_	
161-6	34989-34998	potential	_	
161-7	34999-35011	contribution	_	
161-8	35012-35014	of	_	
161-9	35015-35027	evolutionary	_	
161-10	35028-35035	changes	_	
161-11	35036-35038	in	_	
161-12	35039-35044	brain	_	
161-13	35045-35057	organization	_	
161-14	35058-35060	to	_	
161-15	35061-35074	schizophrenia	_	
161-16	35075-35078	and	_	
161-17	35079-35084	other	_	
161-18	35085-35091	mental	_	
161-19	35092-35101	disorders	_	
161-20	35102-35105	are	_	
161-21	35106-35108	of	_	
161-22	35109-35117	interest	_	
161-23	35117-35118	.	_	

#Text=This is underscored by GWAS studies showing evolutionary changes in the human genome related to several psychiatric disorders and the notion of genetic overlap between schizophrenia and other mental disorders.
162-1	35119-35123	This	_	
162-2	35124-35126	is	_	
162-3	35127-35138	underscored	_	
162-4	35139-35141	by	_	
162-5	35142-35146	GWAS	_	
162-6	35147-35154	studies	_	
162-7	35155-35162	showing	_	
162-8	35163-35175	evolutionary	_	
162-9	35176-35183	changes	_	
162-10	35184-35186	in	_	
162-11	35187-35190	the	_	
162-12	35191-35196	human	_	
162-13	35197-35203	genome	_	
162-14	35204-35211	related	_	
162-15	35212-35214	to	_	
162-16	35215-35222	several	_	
162-17	35223-35234	psychiatric	_	
162-18	35235-35244	disorders	_	
162-19	35245-35248	and	_	
162-20	35249-35252	the	_	
162-21	35253-35259	notion	_	
162-22	35260-35262	of	_	
162-23	35263-35270	genetic	_	
162-24	35271-35278	overlap	_	
162-25	35279-35286	between	_	
162-26	35287-35300	schizophrenia	_	
162-27	35301-35304	and	_	
162-28	35305-35310	other	_	
162-29	35311-35317	mental	_	
162-30	35318-35327	disorders	_	
162-31	35327-35328	.	_	

#Text=Our post hoc comparative analysis across macaques, chimpanzees, and humans suggest that the ‘origin’ of schizophrenia brain dysconnectivity may particularly relate to the time period after the divergence of humans from our common ancestor with chimpanzees.
163-1	35329-35332	Our	_	
163-2	35333-35337	post	_	
163-3	35338-35341	hoc	_	
163-4	35342-35353	comparative	_	
163-5	35354-35362	analysis	_	
163-6	35363-35369	across	_	
163-7	35370-35378	macaques	_	
163-8	35378-35379	,	_	
163-9	35380-35391	chimpanzees	_	
163-10	35391-35392	,	_	
163-11	35393-35396	and	_	
163-12	35397-35403	humans	_	
163-13	35404-35411	suggest	_	
163-14	35412-35416	that	_	
163-15	35417-35420	the	_	
163-16	35421-35422	‘	_	
163-17	35422-35428	origin	_	
163-18	35428-35429	’	_	
163-19	35430-35432	of	_	
163-20	35433-35446	schizophrenia	_	
163-21	35447-35452	brain	_	
163-22	35453-35468	dysconnectivity	_	
163-23	35469-35472	may	_	
163-24	35473-35485	particularly	_	
163-25	35486-35492	relate	_	
163-26	35493-35495	to	_	
163-27	35496-35499	the	_	
163-28	35500-35504	time	_	
163-29	35505-35511	period	_	
163-30	35512-35517	after	_	
163-31	35518-35521	the	_	
163-32	35522-35532	divergence	_	
163-33	35533-35535	of	_	
163-34	35536-35542	humans	_	
163-35	35543-35547	from	_	
163-36	35548-35551	our	_	
163-37	35552-35558	common	_	
163-38	35559-35567	ancestor	_	
163-39	35568-35572	with	_	
163-40	35573-35584	chimpanzees	_	
163-41	35584-35585	.	_	

#Text=Other primate species seem to have not evolved a connectome layout vulnerable to brain dysconnectivity associated with schizophrenia traits.
164-1	35586-35591	Other	_	
164-2	35592-35599	primate	_	
164-3	35600-35607	species	_	
164-4	35608-35612	seem	_	
164-5	35613-35615	to	_	
164-6	35616-35620	have	_	
164-7	35621-35624	not	_	
164-8	35625-35632	evolved	_	
164-9	35633-35634	a	_	
164-10	35635-35645	connectome	_	
164-11	35646-35652	layout	_	
164-12	35653-35663	vulnerable	_	
164-13	35664-35666	to	_	
164-14	35667-35672	brain	_	
164-15	35673-35688	dysconnectivity	_	
164-16	35689-35699	associated	_	
164-17	35700-35704	with	_	
164-18	35705-35718	schizophrenia	_	
164-19	35719-35725	traits	_	
164-20	35725-35726	.	_	

#Text=This is supported by comparative genomic studies.
165-1	35727-35731	This	_	
165-2	35732-35734	is	_	
165-3	35735-35744	supported	_	
165-4	35745-35747	by	_	
165-5	35748-35759	comparative	_	
165-6	35760-35767	genomic	_	
165-7	35768-35775	studies	_	
165-8	35775-35776	.	_	

#Text=Genetic loci associated with schizophrenia tend to be more prevalent in areas of the genome subject to recent positive selection in humans, consistent with the hypothesis that risk for schizophrenia has developed in recent human evolution.
166-1	35777-35784	Genetic	_	
166-2	35785-35789	loci	_	
166-3	35790-35800	associated	_	
166-4	35801-35805	with	_	
166-5	35806-35819	schizophrenia	_	
166-6	35820-35824	tend	_	
166-7	35825-35827	to	_	
166-8	35828-35830	be	_	
166-9	35831-35835	more	_	
166-10	35836-35845	prevalent	_	
166-11	35846-35848	in	_	
166-12	35849-35854	areas	_	
166-13	35855-35857	of	_	
166-14	35858-35861	the	_	
166-15	35862-35868	genome	_	
166-16	35869-35876	subject	_	
166-17	35877-35879	to	_	
166-18	35880-35886	recent	_	
166-19	35887-35895	positive	_	
166-20	35896-35905	selection	_	
166-21	35906-35908	in	_	
166-22	35909-35915	humans	_	
166-23	35915-35916	,	_	
166-24	35917-35927	consistent	_	
166-25	35928-35932	with	_	
166-26	35933-35936	the	_	
166-27	35937-35947	hypothesis	_	
166-28	35948-35952	that	_	
166-29	35953-35957	risk	_	
166-30	35958-35961	for	_	
166-31	35962-35975	schizophrenia	_	
166-32	35976-35979	has	_	
166-33	35980-35989	developed	_	
166-34	35990-35992	in	_	
166-35	35993-35999	recent	_	
166-36	36000-36005	human	_	
166-37	36006-36015	evolution	_	
166-38	36015-36016	.	_	

#Text=Human accelerated regions of the genome (HAR) for example have been noted to be enriched for schizophrenia risk genes, with mutations in these genes related to disruptions in cognition and social behaviour.
167-1	36017-36022	Human	_	
167-2	36023-36034	accelerated	_	
167-3	36035-36042	regions	_	
167-4	36043-36045	of	_	
167-5	36046-36049	the	_	
167-6	36050-36056	genome	_	
167-7	36057-36058	(	_	
167-8	36058-36061	HAR	_	
167-9	36061-36062	)	_	
167-10	36063-36066	for	_	
167-11	36067-36074	example	_	
167-12	36075-36079	have	_	
167-13	36080-36084	been	_	
167-14	36085-36090	noted	_	
167-15	36091-36093	to	_	
167-16	36094-36096	be	_	
167-17	36097-36105	enriched	_	
167-18	36106-36109	for	_	
167-19	36110-36123	schizophrenia	_	
167-20	36124-36128	risk	_	
167-21	36129-36134	genes	_	
167-22	36134-36135	,	_	
167-23	36136-36140	with	_	
167-24	36141-36150	mutations	_	
167-25	36151-36153	in	_	
167-26	36154-36159	these	_	
167-27	36160-36165	genes	_	
167-28	36166-36173	related	_	
167-29	36174-36176	to	_	
167-30	36177-36188	disruptions	_	
167-31	36189-36191	in	_	
167-32	36192-36201	cognition	_	
167-33	36202-36205	and	_	
167-34	36206-36212	social	_	
167-35	36213-36222	behaviour	_	
167-36	36222-36223	.	_	

#Text=In a post hoc analysis, we used gene expression data from the Allen Human Brain Atlas to examine the transcriptomic profile of HAR genes across cortical regions, and we indeed observed indications of higher expression of HAR genes in cortical areas that display human-specific connections compared to regions mostly connected by shared connections (P = 0.0048, permutation testing) (Supplementary material).
168-1	36224-36226	In	_	
168-2	36227-36228	a	_	
168-3	36229-36233	post	_	
168-4	36234-36237	hoc	_	
168-5	36238-36246	analysis	_	
168-6	36246-36247	,	_	
168-7	36248-36250	we	_	
168-8	36251-36255	used	_	
168-9	36256-36260	gene	_	
168-10	36261-36271	expression	_	
168-11	36272-36276	data	_	
168-12	36277-36281	from	_	
168-13	36282-36285	the	_	
168-14	36286-36291	Allen	_	
168-15	36292-36297	Human	_	
168-16	36298-36303	Brain	_	
168-17	36304-36309	Atlas	_	
168-18	36310-36312	to	_	
168-19	36313-36320	examine	_	
168-20	36321-36324	the	_	
168-21	36325-36339	transcriptomic	_	
168-22	36340-36347	profile	_	
168-23	36348-36350	of	_	
168-24	36351-36354	HAR	_	
168-25	36355-36360	genes	_	
168-26	36361-36367	across	_	
168-27	36368-36376	cortical	_	
168-28	36377-36384	regions	_	
168-29	36384-36385	,	_	
168-30	36386-36389	and	_	
168-31	36390-36392	we	_	
168-32	36393-36399	indeed	_	
168-33	36400-36408	observed	_	
168-34	36409-36420	indications	_	
168-35	36421-36423	of	_	
168-36	36424-36430	higher	_	
168-37	36431-36441	expression	_	
168-38	36442-36444	of	_	
168-39	36445-36448	HAR	_	
168-40	36449-36454	genes	_	
168-41	36455-36457	in	_	
168-42	36458-36466	cortical	_	
168-43	36467-36472	areas	_	
168-44	36473-36477	that	_	
168-45	36478-36485	display	_	
168-46	36486-36500	human-specific	_	
168-47	36501-36512	connections	_	
168-48	36513-36521	compared	_	
168-49	36522-36524	to	_	
168-50	36525-36532	regions	_	
168-51	36533-36539	mostly	_	
168-52	36540-36549	connected	_	
168-53	36550-36552	by	_	
168-54	36553-36559	shared	_	
168-55	36560-36571	connections	_	
168-56	36572-36573	(	_	
168-57	36573-36574	P	_	
168-58	36575-36576	=	_	
168-59	36577-36583	0.0048	_	
168-60	36583-36584	,	_	
168-61	36585-36596	permutation	_	
168-62	36597-36604	testing	_	
168-63	36604-36605	)	_	
168-64	36606-36607	(	_	
168-65	36607-36620	Supplementary	_	
168-66	36621-36629	material	_	
168-67	36629-36630	)	_	
168-68	36630-36631	.	_	

#Text=This corroborates recent observations that HAR genes may have played a key role in shaping higher-order cognitive functional networks during recent human brain evolution.
169-1	36632-36636	This	_	
169-2	36637-36649	corroborates	_	
169-3	36650-36656	recent	_	
169-4	36657-36669	observations	_	
169-5	36670-36674	that	_	
169-6	36675-36678	HAR	_	
169-7	36679-36684	genes	_	
169-8	36685-36688	may	_	
169-9	36689-36693	have	_	
169-10	36694-36700	played	_	
169-11	36701-36702	a	_	
169-12	36703-36706	key	_	
169-13	36707-36711	role	_	
169-14	36712-36714	in	_	
169-15	36715-36722	shaping	_	
169-16	36723-36735	higher-order	_	
169-17	36736-36745	cognitive	_	
169-18	36746-36756	functional	_	
169-19	36757-36765	networks	_	
169-20	36766-36772	during	_	
169-21	36773-36779	recent	_	
169-22	36780-36785	human	_	
169-23	36786-36791	brain	_	
169-24	36792-36801	evolution	_	
169-25	36801-36802	.	_	

#Text=Together, these observations underscore that multi-scale studies into the relationship between expression patterns of schizophrenia risk genes, human genomic changes and patterns of brain connectivity provide means to further elucidate the biological underpinnings of psychiatric and neurological disorders.
170-1	36803-36811	Together	_	
170-2	36811-36812	,	_	
170-3	36813-36818	these	_	
170-4	36819-36831	observations	_	
170-5	36832-36842	underscore	_	
170-6	36843-36847	that	_	
170-7	36848-36859	multi-scale	_	
170-8	36860-36867	studies	_	
170-9	36868-36872	into	_	
170-10	36873-36876	the	_	
170-11	36877-36889	relationship	_	
170-12	36890-36897	between	_	
170-13	36898-36908	expression	_	
170-14	36909-36917	patterns	_	
170-15	36918-36920	of	_	
170-16	36921-36934	schizophrenia	_	
170-17	36935-36939	risk	_	
170-18	36940-36945	genes	_	
170-19	36945-36946	,	_	
170-20	36947-36952	human	_	
170-21	36953-36960	genomic	_	
170-22	36961-36968	changes	_	
170-23	36969-36972	and	_	
170-24	36973-36981	patterns	_	
170-25	36982-36984	of	_	
170-26	36985-36990	brain	_	
170-27	36991-37003	connectivity	_	
170-28	37004-37011	provide	_	
170-29	37012-37017	means	_	
170-30	37018-37020	to	_	
170-31	37021-37028	further	_	
170-32	37029-37038	elucidate	_	
170-33	37039-37042	the	_	
170-34	37043-37053	biological	_	
170-35	37054-37067	underpinnings	_	
170-36	37068-37070	of	_	
170-37	37071-37082	psychiatric	_	
170-38	37083-37086	and	_	
170-39	37087-37099	neurological	_	
170-40	37100-37109	disorders	_	
170-41	37109-37110	.	_	

#Text=The field of comparative connectomics is currently limited by the relatively sparse availability of connectome data from different primate species and by the variety of employed methodologies and experimental conditions used to derive connectomes.
171-1	37111-37114	The	_	
171-2	37115-37120	field	_	
171-3	37121-37123	of	_	
171-4	37124-37135	comparative	_	
171-5	37136-37148	connectomics	_	
171-6	37149-37151	is	_	
171-7	37152-37161	currently	_	
171-8	37162-37169	limited	_	
171-9	37170-37172	by	_	
171-10	37173-37176	the	_	
171-11	37177-37187	relatively	_	
171-12	37188-37194	sparse	_	
171-13	37195-37207	availability	_	
171-14	37208-37210	of	_	
171-15	37211-37221	connectome	_	
171-16	37222-37226	data	_	
171-17	37227-37231	from	_	
171-18	37232-37241	different	_	
171-19	37242-37249	primate	_	
171-20	37250-37257	species	_	
171-21	37258-37261	and	_	
171-22	37262-37264	by	_	
171-23	37265-37268	the	_	
171-24	37269-37276	variety	_	
171-25	37277-37279	of	_	
171-26	37280-37288	employed	_	
171-27	37289-37302	methodologies	_	
171-28	37303-37306	and	_	
171-29	37307-37319	experimental	_	
171-30	37320-37330	conditions	_	
171-31	37331-37335	used	_	
171-32	37336-37338	to	_	
171-33	37339-37345	derive	_	
171-34	37346-37357	connectomes	_	
171-35	37357-37358	.	_	

#Text=To overcome these issues as much as possible, we included DWI data from a unique and rather large sample of chimpanzees (n = 22), data that were carefully acquired under very similar conditions (e.g. all in vivo acquired MRI data, avoiding a less optimal comparison between post-mortem acquired animal and in vivo acquired human data, matching levels of signal-to-noise ratio (SNR) across human and animal datasets, preserved cross-species voxel resolution).
172-1	37359-37361	To	_	
172-2	37362-37370	overcome	_	
172-3	37371-37376	these	_	
172-4	37377-37383	issues	_	
172-5	37384-37386	as	_	
172-6	37387-37391	much	_	
172-7	37392-37394	as	_	
172-8	37395-37403	possible	_	
172-9	37403-37404	,	_	
172-10	37405-37407	we	_	
172-11	37408-37416	included	_	
172-12	37417-37420	DWI	_	
172-13	37421-37425	data	_	
172-14	37426-37430	from	_	
172-15	37431-37432	a	_	
172-16	37433-37439	unique	_	
172-17	37440-37443	and	_	
172-18	37444-37450	rather	_	
172-19	37451-37456	large	_	
172-20	37457-37463	sample	_	
172-21	37464-37466	of	_	
172-22	37467-37478	chimpanzees	_	
172-23	37479-37480	(	_	
172-24	37480-37481	n	_	
172-25	37482-37483	=	_	
172-26	37484-37486	22	_	
172-27	37486-37487	)	_	
172-28	37487-37488	,	_	
172-29	37489-37493	data	_	
172-30	37494-37498	that	_	
172-31	37499-37503	were	_	
172-32	37504-37513	carefully	_	
172-33	37514-37522	acquired	_	
172-34	37523-37528	under	_	
172-35	37529-37533	very	_	
172-36	37534-37541	similar	_	
172-37	37542-37552	conditions	_	
172-38	37553-37554	(	_	
172-39	37554-37557	e.g	_	
172-40	37557-37558	.	_	
172-41	37559-37562	all	_	
172-42	37563-37565	in	_	
172-43	37566-37570	vivo	_	
172-44	37571-37579	acquired	_	
172-45	37580-37583	MRI	_	
172-46	37584-37588	data	_	
172-47	37588-37589	,	_	
172-48	37590-37598	avoiding	_	
172-49	37599-37600	a	_	
172-50	37601-37605	less	_	
172-51	37606-37613	optimal	_	
172-52	37614-37624	comparison	_	
172-53	37625-37632	between	_	
172-54	37633-37644	post-mortem	_	
172-55	37645-37653	acquired	_	
172-56	37654-37660	animal	_	
172-57	37661-37664	and	_	
172-58	37665-37667	in	_	
172-59	37668-37672	vivo	_	
172-60	37673-37681	acquired	_	
172-61	37682-37687	human	_	
172-62	37688-37692	data	_	
172-63	37692-37693	,	_	
172-64	37694-37702	matching	_	
172-65	37703-37709	levels	_	
172-66	37710-37712	of	_	
172-67	37713-37728	signal-to-noise	_	
172-68	37729-37734	ratio	_	
172-69	37735-37736	(	_	
172-70	37736-37739	SNR	_	
172-71	37739-37740	)	_	
172-72	37741-37747	across	_	
172-73	37748-37753	human	_	
172-74	37754-37757	and	_	
172-75	37758-37764	animal	_	
172-76	37765-37773	datasets	_	
172-77	37773-37774	,	_	
172-78	37775-37784	preserved	_	
172-79	37785-37798	cross-species	_	
172-80	37799-37804	voxel	_	
172-81	37805-37815	resolution	_	
172-82	37815-37816	)	_	
172-83	37816-37817	.	_	

#Text=However, it remains difficult to rule out all effects of brain volume or global data differences.
173-1	37818-37825	However	_	
173-2	37825-37826	,	_	
173-3	37827-37829	it	_	
173-4	37830-37837	remains	_	
173-5	37838-37847	difficult	_	
173-6	37848-37850	to	_	
173-7	37851-37855	rule	_	
173-8	37856-37859	out	_	
173-9	37860-37863	all	_	
173-10	37864-37871	effects	_	
173-11	37872-37874	of	_	
173-12	37875-37880	brain	_	
173-13	37881-37887	volume	_	
173-14	37888-37890	or	_	
173-15	37891-37897	global	_	
173-16	37898-37902	data	_	
173-17	37903-37914	differences	_	
173-18	37914-37915	.	_	

#Text=Furthermore, despite validation of our findings with the homologous BB-38 atlas, the potential impact of areas being more or less variable within and across species remains unknown.
174-1	37916-37927	Furthermore	_	
174-2	37927-37928	,	_	
174-3	37929-37936	despite	_	
174-4	37937-37947	validation	_	
174-5	37948-37950	of	_	
174-6	37951-37954	our	_	
174-7	37955-37963	findings	_	
174-8	37964-37968	with	_	
174-9	37969-37972	the	_	
174-10	37973-37983	homologous	_	
174-11	37984-37986	BB	_	
174-12	37986-37987	-	_	
174-13	37987-37989	38	_	
174-14	37990-37995	atlas	_	
174-15	37995-37996	,	_	
174-16	37997-38000	the	_	
174-17	38001-38010	potential	_	
174-18	38011-38017	impact	_	
174-19	38018-38020	of	_	
174-20	38021-38026	areas	_	
174-21	38027-38032	being	_	
174-22	38033-38037	more	_	
174-23	38038-38040	or	_	
174-24	38041-38045	less	_	
174-25	38046-38054	variable	_	
174-26	38055-38061	within	_	
174-27	38062-38065	and	_	
174-28	38066-38072	across	_	
174-29	38073-38080	species	_	
174-30	38081-38088	remains	_	
174-31	38089-38096	unknown	_	
174-32	38096-38097	.	_	

#Text=We performed several post hoc analyses to make sure that effects could not simply be explained by global differences in fractional anisotropy and/or long-range connections being more difficult to trace in chimpanzees compared to humans (Supplementary material).
175-1	38098-38100	We	_	
175-2	38101-38110	performed	_	
175-3	38111-38118	several	_	
175-4	38119-38123	post	_	
175-5	38124-38127	hoc	_	
175-6	38128-38136	analyses	_	
175-7	38137-38139	to	_	
175-8	38140-38144	make	_	
175-9	38145-38149	sure	_	
175-10	38150-38154	that	_	
175-11	38155-38162	effects	_	
175-12	38163-38168	could	_	
175-13	38169-38172	not	_	
175-14	38173-38179	simply	_	
175-15	38180-38182	be	_	
175-16	38183-38192	explained	_	
175-17	38193-38195	by	_	
175-18	38196-38202	global	_	
175-19	38203-38214	differences	_	
175-20	38215-38217	in	_	
175-21	38218-38228	fractional	_	
175-22	38229-38239	anisotropy	_	
175-23	38240-38243	and	_	
175-24	38243-38244	/	_	
175-25	38244-38246	or	_	
175-26	38247-38257	long-range	_	
175-27	38258-38269	connections	_	
175-28	38270-38275	being	_	
175-29	38276-38280	more	_	
175-30	38281-38290	difficult	_	
175-31	38291-38293	to	_	
175-32	38294-38299	trace	_	
175-33	38300-38302	in	_	
175-34	38303-38314	chimpanzees	_	
175-35	38315-38323	compared	_	
175-36	38324-38326	to	_	
175-37	38327-38333	humans	_	
175-38	38334-38335	(	_	
175-39	38335-38348	Supplementary	_	
175-40	38349-38357	material	_	
175-41	38357-38358	)	_	
175-42	38358-38359	.	_	

#Text=Secondly, as in many primate comparative studies, our findings are not free from factors related to human behaviour.
176-1	38360-38368	Secondly	_	
176-2	38368-38369	,	_	
176-3	38370-38372	as	_	
176-4	38373-38375	in	_	
176-5	38376-38380	many	_	
176-6	38381-38388	primate	_	
176-7	38389-38400	comparative	_	
176-8	38401-38408	studies	_	
176-9	38408-38409	,	_	
176-10	38410-38413	our	_	
176-11	38414-38422	findings	_	
176-12	38423-38426	are	_	
176-13	38427-38430	not	_	
176-14	38431-38435	free	_	
176-15	38436-38440	from	_	
176-16	38441-38448	factors	_	
176-17	38449-38456	related	_	
176-18	38457-38459	to	_	
176-19	38460-38465	human	_	
176-20	38466-38475	behaviour	_	
176-21	38475-38476	.	_	

#Text=It remains difficult, for example, to assess the influence of aspects such as alcohol, illicit drug use, medication, etc. in the human population.
177-1	38477-38479	It	_	
177-2	38480-38487	remains	_	
177-3	38488-38497	difficult	_	
177-4	38497-38498	,	_	
177-5	38499-38502	for	_	
177-6	38503-38510	example	_	
177-7	38510-38511	,	_	
177-8	38512-38514	to	_	
177-9	38515-38521	assess	_	
177-10	38522-38525	the	_	
177-11	38526-38535	influence	_	
177-12	38536-38538	of	_	
177-13	38539-38546	aspects	_	
177-14	38547-38551	such	_	
177-15	38552-38554	as	_	
177-16	38555-38562	alcohol	_	
177-17	38562-38563	,	_	
177-18	38564-38571	illicit	_	
177-19	38572-38576	drug	_	
177-20	38577-38580	use	_	
177-21	38580-38581	,	_	
177-22	38582-38592	medication	_	
177-23	38592-38593	,	_	
177-24	38594-38597	etc	_	
177-25	38597-38598	.	_	
177-26	38599-38601	in	_	
177-27	38602-38605	the	_	
177-28	38606-38611	human	_	
177-29	38612-38622	population	_	
177-30	38622-38623	.	_	

#Text=In particular, considering consistent reports of white matter alterations with alcohol and cannabis use.
178-1	38624-38626	In	_	
178-2	38627-38637	particular	_	
178-3	38637-38638	,	_	
178-4	38639-38650	considering	_	
178-5	38651-38661	consistent	_	
178-6	38662-38669	reports	_	
178-7	38670-38672	of	_	
178-8	38673-38678	white	_	
178-9	38679-38685	matter	_	
178-10	38686-38697	alterations	_	
178-11	38698-38702	with	_	
178-12	38703-38710	alcohol	_	
178-13	38711-38714	and	_	
178-14	38715-38723	cannabis	_	
178-15	38724-38727	use	_	
178-16	38727-38728	.	_	

#Text=However, dysconnectivity effects in schizophrenia do not generally seem to strongly relate to medication effects.
179-1	38729-38736	However	_	
179-2	38736-38737	,	_	
179-3	38738-38753	dysconnectivity	_	
179-4	38754-38761	effects	_	
179-5	38762-38764	in	_	
179-6	38765-38778	schizophrenia	_	
179-7	38779-38781	do	_	
179-8	38782-38785	not	_	
179-9	38786-38795	generally	_	
179-10	38796-38800	seem	_	
179-11	38801-38803	to	_	
179-12	38804-38812	strongly	_	
179-13	38813-38819	relate	_	
179-14	38820-38822	to	_	
179-15	38823-38833	medication	_	
179-16	38834-38841	effects	_	
179-17	38841-38842	.	_	

#Text=Furthermore, our cross-condition analysis tends to suggest that it is unlikely that our schizophrenia results are primarily driven by these potential confounding factors, with brain dysconnectivity effects in other brain conditions not showing particular overlap with modifications in human brain connectivity.
180-1	38843-38854	Furthermore	_	
180-2	38854-38855	,	_	
180-3	38856-38859	our	_	
180-4	38860-38875	cross-condition	_	
180-5	38876-38884	analysis	_	
180-6	38885-38890	tends	_	
180-7	38891-38893	to	_	
180-8	38894-38901	suggest	_	
180-9	38902-38906	that	_	
180-10	38907-38909	it	_	
180-11	38910-38912	is	_	
180-12	38913-38921	unlikely	_	
180-13	38922-38926	that	_	
180-14	38927-38930	our	_	
180-15	38931-38944	schizophrenia	_	
180-16	38945-38952	results	_	
180-17	38953-38956	are	_	
180-18	38957-38966	primarily	_	
180-19	38967-38973	driven	_	
180-20	38974-38976	by	_	
180-21	38977-38982	these	_	
180-22	38983-38992	potential	_	
180-23	38993-39004	confounding	_	
180-24	39005-39012	factors	_	
180-25	39012-39013	,	_	
180-26	39014-39018	with	_	
180-27	39019-39024	brain	_	
180-28	39025-39040	dysconnectivity	_	
180-29	39041-39048	effects	_	
180-30	39049-39051	in	_	
180-31	39052-39057	other	_	
180-32	39058-39063	brain	_	
180-33	39064-39074	conditions	_	
180-34	39075-39078	not	_	
180-35	39079-39086	showing	_	
180-36	39087-39097	particular	_	
180-37	39098-39105	overlap	_	
180-38	39106-39110	with	_	
180-39	39111-39124	modifications	_	
180-40	39125-39127	in	_	
180-41	39128-39133	human	_	
180-42	39134-39139	brain	_	
180-43	39140-39152	connectivity	_	
180-44	39152-39153	.	_	

#Text=A third limitation is that our findings are inherently limited by the nature of the methodology used.
181-1	39154-39155	A	_	
181-2	39156-39161	third	_	
181-3	39162-39172	limitation	_	
181-4	39173-39175	is	_	
181-5	39176-39180	that	_	
181-6	39181-39184	our	_	
181-7	39185-39193	findings	_	
181-8	39194-39197	are	_	
181-9	39198-39208	inherently	_	
181-10	39209-39216	limited	_	
181-11	39217-39219	by	_	
181-12	39220-39223	the	_	
181-13	39224-39230	nature	_	
181-14	39231-39233	of	_	
181-15	39234-39237	the	_	
181-16	39238-39249	methodology	_	
181-17	39250-39254	used	_	
181-18	39254-39255	.	_	

#Text=Diffusion MRI may perhaps be the only methodology currently available to measure chimpanzee and human anatomical brain connectivity in vivo in relatively large numbers, but it has well-documented limitations, including difficulty reconstructing complex fibre orientations, an inability to resolve fibre direction, and a recognized underestimation of both long-range and short-range connectivity.
182-1	39256-39265	Diffusion	_	
182-2	39266-39269	MRI	_	
182-3	39270-39273	may	_	
182-4	39274-39281	perhaps	_	
182-5	39282-39284	be	_	
182-6	39285-39288	the	_	
182-7	39289-39293	only	_	
182-8	39294-39305	methodology	_	
182-9	39306-39315	currently	_	
182-10	39316-39325	available	_	
182-11	39326-39328	to	_	
182-12	39329-39336	measure	_	
182-13	39337-39347	chimpanzee	_	
182-14	39348-39351	and	_	
182-15	39352-39357	human	_	
182-16	39358-39368	anatomical	_	
182-17	39369-39374	brain	_	
182-18	39375-39387	connectivity	_	
182-19	39388-39390	in	_	
182-20	39391-39395	vivo	_	
182-21	39396-39398	in	_	
182-22	39399-39409	relatively	_	
182-23	39410-39415	large	_	
182-24	39416-39423	numbers	_	
182-25	39423-39424	,	_	
182-26	39425-39428	but	_	
182-27	39429-39431	it	_	
182-28	39432-39435	has	_	
182-29	39436-39451	well-documented	_	
182-30	39452-39463	limitations	_	
182-31	39463-39464	,	_	
182-32	39465-39474	including	_	
182-33	39475-39485	difficulty	_	
182-34	39486-39500	reconstructing	_	
182-35	39501-39508	complex	_	
182-36	39509-39514	fibre	_	
182-37	39515-39527	orientations	_	
182-38	39527-39528	,	_	
182-39	39529-39531	an	_	
182-40	39532-39541	inability	_	
182-41	39542-39544	to	_	
182-42	39545-39552	resolve	_	
182-43	39553-39558	fibre	_	
182-44	39559-39568	direction	_	
182-45	39568-39569	,	_	
182-46	39570-39573	and	_	
182-47	39574-39575	a	_	
182-48	39576-39586	recognized	_	
182-49	39587-39602	underestimation	_	
182-50	39603-39605	of	_	
182-51	39606-39610	both	_	
182-52	39611-39621	long-range	_	
182-53	39622-39625	and	_	
182-54	39626-39637	short-range	_	
182-55	39638-39650	connectivity	_	
182-56	39650-39651	.	_	

#Text=In a post hoc analysis we verified that there was no general (i.e. non-disease related) tendency to find random between-group effects in human-specific connections (Supplementary material).
183-1	39652-39654	In	_	
183-2	39655-39656	a	_	
183-3	39657-39661	post	_	
183-4	39662-39665	hoc	_	
183-5	39666-39674	analysis	_	
183-6	39675-39677	we	_	
183-7	39678-39686	verified	_	
183-8	39687-39691	that	_	
183-9	39692-39697	there	_	
183-10	39698-39701	was	_	
183-11	39702-39704	no	_	
183-12	39705-39712	general	_	
183-13	39713-39714	(	_	
183-14	39714-39717	i.e	_	
183-15	39717-39718	.	_	
183-16	39719-39730	non-disease	_	
183-17	39731-39738	related	_	
183-18	39738-39739	)	_	
183-19	39740-39748	tendency	_	
183-20	39749-39751	to	_	
183-21	39752-39756	find	_	
183-22	39757-39763	random	_	
183-23	39764-39777	between-group	_	
183-24	39778-39785	effects	_	
183-25	39786-39788	in	_	
183-26	39789-39803	human-specific	_	
183-27	39804-39815	connections	_	
183-28	39816-39817	(	_	
183-29	39817-39830	Supplementary	_	
183-30	39831-39839	material	_	
183-31	39839-39840	)	_	
183-32	39840-39841	.	_	

#Text=We further note that given the mentioned limitations of diffusion MRI, despite our rather strict selection of human-specific connections, we cannot fully rule out that some of the connections classified as human-specific could exist in the chimpanzee population.
184-1	39842-39844	We	_	
184-2	39845-39852	further	_	
184-3	39853-39857	note	_	
184-4	39858-39862	that	_	
184-5	39863-39868	given	_	
184-6	39869-39872	the	_	
184-7	39873-39882	mentioned	_	
184-8	39883-39894	limitations	_	
184-9	39895-39897	of	_	
184-10	39898-39907	diffusion	_	
184-11	39908-39911	MRI	_	
184-12	39911-39912	,	_	
184-13	39913-39920	despite	_	
184-14	39921-39924	our	_	
184-15	39925-39931	rather	_	
184-16	39932-39938	strict	_	
184-17	39939-39948	selection	_	
184-18	39949-39951	of	_	
184-19	39952-39966	human-specific	_	
184-20	39967-39978	connections	_	
184-21	39978-39979	,	_	
184-22	39980-39982	we	_	
184-23	39983-39989	cannot	_	
184-24	39990-39995	fully	_	
184-25	39996-40000	rule	_	
184-26	40001-40004	out	_	
184-27	40005-40009	that	_	
184-28	40010-40014	some	_	
184-29	40015-40017	of	_	
184-30	40018-40021	the	_	
184-31	40022-40033	connections	_	
184-32	40034-40044	classified	_	
184-33	40045-40047	as	_	
184-34	40048-40062	human-specific	_	
184-35	40063-40068	could	_	
184-36	40069-40074	exist	_	
184-37	40075-40077	in	_	
184-38	40078-40081	the	_	
184-39	40082-40092	chimpanzee	_	
184-40	40093-40103	population	_	
184-41	40103-40104	.	_	

#Text=These tracts could have a much lower microstructural organization in chimpanzees (e.g. lower axonal count, less myelination together resulting in low DWI signal), making them undetectable in this group.
185-1	40105-40110	These	_	
185-2	40111-40117	tracts	_	
185-3	40118-40123	could	_	
185-4	40124-40128	have	_	
185-5	40129-40130	a	_	
185-6	40131-40135	much	_	
185-7	40136-40141	lower	_	
185-8	40142-40157	microstructural	_	
185-9	40158-40170	organization	_	
185-10	40171-40173	in	_	
185-11	40174-40185	chimpanzees	_	
185-12	40186-40187	(	_	
185-13	40187-40190	e.g	_	
185-14	40190-40191	.	_	
185-15	40192-40197	lower	_	
185-16	40198-40204	axonal	_	
185-17	40205-40210	count	_	
185-18	40210-40211	,	_	
185-19	40212-40216	less	_	
185-20	40217-40228	myelination	_	
185-21	40229-40237	together	_	
185-22	40238-40247	resulting	_	
185-23	40248-40250	in	_	
185-24	40251-40254	low	_	
185-25	40255-40258	DWI	_	
185-26	40259-40265	signal	_	
185-27	40265-40266	)	_	
185-28	40266-40267	,	_	
185-29	40268-40274	making	_	
185-30	40275-40279	them	_	
185-31	40280-40292	undetectable	_	
185-32	40293-40295	in	_	
185-33	40296-40300	this	_	
185-34	40301-40306	group	_	
185-35	40306-40307	.	_	

#Text=Nevertheless, if that were the case, we reason that the observed effects reflect large enhancement of these cortico-cortical connections in humans, with our data suggesting that this evolutionary development co-varies with high involvement in psychosis.
186-1	40308-40320	Nevertheless	_	
186-2	40320-40321	,	_	
186-3	40322-40324	if	_	
186-4	40325-40329	that	_	
186-5	40330-40334	were	_	
186-6	40335-40338	the	_	
186-7	40339-40343	case	_	
186-8	40343-40344	,	_	
186-9	40345-40347	we	_	
186-10	40348-40354	reason	_	
186-11	40355-40359	that	_	
186-12	40360-40363	the	_	
186-13	40364-40372	observed	_	
186-14	40373-40380	effects	_	
186-15	40381-40388	reflect	_	
186-16	40389-40394	large	_	
186-17	40395-40406	enhancement	_	
186-18	40407-40409	of	_	
186-19	40410-40415	these	_	
186-20	40416-40432	cortico-cortical	_	
186-21	40433-40444	connections	_	
186-22	40445-40447	in	_	
186-23	40448-40454	humans	_	
186-24	40454-40455	,	_	
186-25	40456-40460	with	_	
186-26	40461-40464	our	_	
186-27	40465-40469	data	_	
186-28	40470-40480	suggesting	_	
186-29	40481-40485	that	_	
186-30	40486-40490	this	_	
186-31	40491-40503	evolutionary	_	
186-32	40504-40515	development	_	
186-33	40516-40525	co-varies	_	
186-34	40526-40530	with	_	
186-35	40531-40535	high	_	
186-36	40536-40547	involvement	_	
186-37	40548-40550	in	_	
186-38	40551-40560	psychosis	_	
186-39	40560-40561	.	_	

#Text=Our cross-species connectome comparison suggests that human specializations in brain connectivity may potentially be enriched for domains affected in schizophrenia.
187-1	40562-40565	Our	_	
187-2	40566-40579	cross-species	_	
187-3	40580-40590	connectome	_	
187-4	40591-40601	comparison	_	
187-5	40602-40610	suggests	_	
187-6	40611-40615	that	_	
187-7	40616-40621	human	_	
187-8	40622-40637	specializations	_	
187-9	40638-40640	in	_	
187-10	40641-40646	brain	_	
187-11	40647-40659	connectivity	_	
187-12	40660-40663	may	_	
187-13	40664-40675	potentially	_	
187-14	40676-40678	be	_	
187-15	40679-40687	enriched	_	
187-16	40688-40691	for	_	
187-17	40692-40699	domains	_	
187-18	40700-40708	affected	_	
187-19	40709-40711	in	_	
187-20	40712-40725	schizophrenia	_	
187-21	40725-40726	.	_	

#Text=Our findings suggest that the evolution of the human connectome in service of developing more complex brain function may be paralleled with higher risk for brain dysfunction.
188-1	40727-40730	Our	_	
188-2	40731-40739	findings	_	
188-3	40740-40747	suggest	_	
188-4	40748-40752	that	_	
188-5	40753-40756	the	_	
188-6	40757-40766	evolution	_	
188-7	40767-40769	of	_	
188-8	40770-40773	the	_	
188-9	40774-40779	human	_	
188-10	40780-40790	connectome	_	
188-11	40791-40793	in	_	
188-12	40794-40801	service	_	
188-13	40802-40804	of	_	
188-14	40805-40815	developing	_	
188-15	40816-40820	more	_	
188-16	40821-40828	complex	_	
188-17	40829-40834	brain	_	
188-18	40835-40843	function	_	
188-19	40844-40847	may	_	
188-20	40848-40850	be	_	
188-21	40851-40861	paralleled	_	
188-22	40862-40866	with	_	
188-23	40867-40873	higher	_	
188-24	40874-40878	risk	_	
188-25	40879-40882	for	_	
188-26	40883-40888	brain	_	
188-27	40889-40900	dysfunction	_	
188-28	40900-40901	.	_	

#Text=Supplementary Material
#Text=See Vértes and Seidlitz (doi:) for a scientific commentary on this article.
189-1	40902-40915	Supplementary	_	
189-2	40916-40924	Material	_	
189-3	40925-40928	See	_	
189-4	40929-40935	Vértes	_	
189-5	40936-40939	and	_	
189-6	40940-40948	Seidlitz	_	
189-7	40949-40950	(	_	
189-8	40950-40953	doi	_	
189-9	40953-40954	:	_	
189-10	40954-40955	)	_	
189-11	40956-40959	for	_	
189-12	40960-40961	a	_	
189-13	40962-40972	scientific	_	
189-14	40973-40983	commentary	_	
189-15	40984-40986	on	_	
189-16	40987-40991	this	_	
189-17	40992-40999	article	_	
189-18	40999-41000	.	_	

#Text=References
#Text=Abnormal white matter integrity in antipsychotic-naive first-episode psychosis patients assessed by a DTI principal component analysis
#Text=Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms
#Text=Evolutionary expansion of connectivity between multimodal association areas in the human brain compared to chimpanzees
#Text=A systematic review of diffusion weighted MRI studies of white matter microstructure in adolescent substance users
#Text=The basis of anisotropic water diffusion in the nervous system-a technical review
#Text=Longitudinal changes in white matter microstructure after heavy cannabis use
#Text=Neurobiology of human affiliative behaviour: implications for psychiatric disorders
#Text=Schizophrenia is a disease of general connectivity more than a specifically “social brain” network
#Text=The economy of brain network organization
#Text=
#Text=Thalamus and posterior temporal lobe show greater inter-network connectivity at rest and across sensory paradigms in schizophrenia
#Text=The anterior cingulate cortex: an integrative hub for human socially-driven interactions
#Text=Disruption of structure-function coupling in the schizophrenia connectome
#Text=The cognitive control network: Integrated cortical regions with dissociable functions
#Text=Assessing anxiety in nonhuman primates
#Text=Brain network analysis reveals affected connectome structure in bipolar I disorder
#Text=The genetics of schizophrenia and bipolar disorder: dissecting psychosis
#Text=Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
#Text=Is schizophrenia the price that Homo sapiens pays for language?
190-1	41001-41011	References	_	
190-2	41012-41020	Abnormal	_	
190-3	41021-41026	white	_	
190-4	41027-41033	matter	_	
190-5	41034-41043	integrity	_	
190-6	41044-41046	in	_	
190-7	41047-41066	antipsychotic-naive	_	
190-8	41067-41080	first-episode	_	
190-9	41081-41090	psychosis	_	
190-10	41091-41099	patients	_	
190-11	41100-41108	assessed	_	
190-12	41109-41111	by	_	
190-13	41112-41113	a	_	
190-14	41114-41117	DTI	_	
190-15	41118-41127	principal	_	
190-16	41128-41137	component	_	
190-17	41138-41146	analysis	_	
190-18	41147-41158	Ventricular	_	
190-19	41159-41170	enlargement	_	
190-20	41171-41173	in	_	
190-21	41174-41187	schizophrenia	_	
190-22	41187-41188	:	_	
190-23	41189-41201	relationship	_	
190-24	41202-41204	to	_	
190-25	41205-41213	positive	_	
190-26	41214-41217	and	_	
190-27	41218-41226	negative	_	
190-28	41227-41235	symptoms	_	
190-29	41236-41248	Evolutionary	_	
190-30	41249-41258	expansion	_	
190-31	41259-41261	of	_	
190-32	41262-41274	connectivity	_	
190-33	41275-41282	between	_	
190-34	41283-41293	multimodal	_	
190-35	41294-41305	association	_	
190-36	41306-41311	areas	_	
190-37	41312-41314	in	_	
190-38	41315-41318	the	_	
190-39	41319-41324	human	_	
190-40	41325-41330	brain	_	
190-41	41331-41339	compared	_	
190-42	41340-41342	to	_	
190-43	41343-41354	chimpanzees	_	
190-44	41355-41356	A	_	
190-45	41357-41367	systematic	_	
190-46	41368-41374	review	_	
190-47	41375-41377	of	_	
190-48	41378-41387	diffusion	_	
190-49	41388-41396	weighted	_	
190-50	41397-41400	MRI	_	
190-51	41401-41408	studies	_	
190-52	41409-41411	of	_	
190-53	41412-41417	white	_	
190-54	41418-41424	matter	_	
190-55	41425-41439	microstructure	_	
190-56	41440-41442	in	_	
190-57	41443-41453	adolescent	_	
190-58	41454-41463	substance	_	
190-59	41464-41469	users	_	
190-60	41470-41473	The	_	
190-61	41474-41479	basis	_	
190-62	41480-41482	of	_	
190-63	41483-41494	anisotropic	_	
190-64	41495-41500	water	_	
190-65	41501-41510	diffusion	_	
190-66	41511-41513	in	_	
190-67	41514-41517	the	_	
190-68	41518-41525	nervous	_	
190-69	41526-41534	system-a	_	
190-70	41535-41544	technical	_	
190-71	41545-41551	review	_	
190-72	41552-41564	Longitudinal	_	
190-73	41565-41572	changes	_	
190-74	41573-41575	in	_	
190-75	41576-41581	white	_	
190-76	41582-41588	matter	_	
190-77	41589-41603	microstructure	_	
190-78	41604-41609	after	_	
190-79	41610-41615	heavy	_	
190-80	41616-41624	cannabis	_	
190-81	41625-41628	use	_	
190-82	41629-41641	Neurobiology	_	
190-83	41642-41644	of	_	
190-84	41645-41650	human	_	
190-85	41651-41662	affiliative	_	
190-86	41663-41672	behaviour	_	
190-87	41672-41673	:	_	
190-88	41674-41686	implications	_	
190-89	41687-41690	for	_	
190-90	41691-41702	psychiatric	_	
190-91	41703-41712	disorders	_	
190-92	41713-41726	Schizophrenia	_	
190-93	41727-41729	is	_	
190-94	41730-41731	a	_	
190-95	41732-41739	disease	_	
190-96	41740-41742	of	_	
190-97	41743-41750	general	_	
190-98	41751-41763	connectivity	_	
190-99	41764-41768	more	_	
190-100	41769-41773	than	_	
190-101	41774-41775	a	_	
190-102	41776-41788	specifically	_	
190-103	41789-41790	“	_	
190-104	41790-41796	social	_	
190-105	41797-41802	brain	_	
190-106	41802-41803	”	_	
190-107	41804-41811	network	_	
190-108	41812-41815	The	_	
190-109	41816-41823	economy	_	
190-110	41824-41826	of	_	
190-111	41827-41832	brain	_	
190-112	41833-41840	network	_	
190-113	41841-41853	organization	_	
190-114	41855-41863	Thalamus	_	
190-115	41864-41867	and	_	
190-116	41868-41877	posterior	_	
190-117	41878-41886	temporal	_	
190-118	41887-41891	lobe	_	
190-119	41892-41896	show	_	
190-120	41897-41904	greater	_	
190-121	41905-41918	inter-network	_	
190-122	41919-41931	connectivity	_	
190-123	41932-41934	at	_	
190-124	41935-41939	rest	_	
190-125	41940-41943	and	_	
190-126	41944-41950	across	_	
190-127	41951-41958	sensory	_	
190-128	41959-41968	paradigms	_	
190-129	41969-41971	in	_	
190-130	41972-41985	schizophrenia	_	
190-131	41986-41989	The	_	
190-132	41990-41998	anterior	_	
190-133	41999-42008	cingulate	_	
190-134	42009-42015	cortex	_	
190-135	42015-42016	:	_	
190-136	42017-42019	an	_	
190-137	42020-42031	integrative	_	
190-138	42032-42035	hub	_	
190-139	42036-42039	for	_	
190-140	42040-42045	human	_	
190-141	42046-42061	socially-driven	_	
190-142	42062-42074	interactions	_	
190-143	42075-42085	Disruption	_	
190-144	42086-42088	of	_	
190-145	42089-42107	structure-function	_	
190-146	42108-42116	coupling	_	
190-147	42117-42119	in	_	
190-148	42120-42123	the	_	
190-149	42124-42137	schizophrenia	_	
190-150	42138-42148	connectome	_	
190-151	42149-42152	The	_	
190-152	42153-42162	cognitive	_	
190-153	42163-42170	control	_	
190-154	42171-42178	network	_	
190-155	42178-42179	:	_	
190-156	42180-42190	Integrated	_	
190-157	42191-42199	cortical	_	
190-158	42200-42207	regions	_	
190-159	42208-42212	with	_	
190-160	42213-42224	dissociable	_	
190-161	42225-42234	functions	_	
190-162	42235-42244	Assessing	_	
190-163	42245-42252	anxiety	_	
190-164	42253-42255	in	_	
190-165	42256-42264	nonhuman	_	
190-166	42265-42273	primates	_	
190-167	42274-42279	Brain	_	
190-168	42280-42287	network	_	
190-169	42288-42296	analysis	_	
190-170	42297-42304	reveals	_	
190-171	42305-42313	affected	_	
190-172	42314-42324	connectome	_	
190-173	42325-42334	structure	_	
190-174	42335-42337	in	_	
190-175	42338-42345	bipolar	_	
190-176	42346-42347	I	_	
190-177	42348-42356	disorder	_	
190-178	42357-42360	The	_	
190-179	42361-42369	genetics	_	
190-180	42370-42372	of	_	
190-181	42373-42386	schizophrenia	_	
190-182	42387-42390	and	_	
190-183	42391-42398	bipolar	_	
190-184	42399-42407	disorder	_	
190-185	42407-42408	:	_	
190-186	42409-42419	dissecting	_	
190-187	42420-42429	psychosis	_	
190-188	42430-42444	Identification	_	
190-189	42445-42447	of	_	
190-190	42448-42452	risk	_	
190-191	42453-42457	loci	_	
190-192	42458-42462	with	_	
190-193	42463-42469	shared	_	
190-194	42470-42477	effects	_	
190-195	42478-42480	on	_	
190-196	42481-42485	five	_	
190-197	42486-42491	major	_	
190-198	42492-42503	psychiatric	_	
190-199	42504-42513	disorders	_	
190-200	42513-42514	:	_	
190-201	42515-42516	a	_	
190-202	42517-42528	genome-wide	_	
190-203	42529-42537	analysis	_	
190-204	42538-42540	Is	_	
190-205	42541-42554	schizophrenia	_	
190-206	42555-42558	the	_	
190-207	42559-42564	price	_	
190-208	42565-42569	that	_	
190-209	42570-42574	Homo	_	
190-210	42575-42582	sapiens	_	
190-211	42583-42587	pays	_	
190-212	42588-42591	for	_	
190-213	42592-42600	language	_	
190-214	42600-42601	?	_	

#Text=Connectome-based patterns of first-episode medication-naive patients with schizophrenia
#Text=Shared vulnerability for connectome alterations across psychiatric and neurological brain disorders
#Text=Estimating false positives and negatives in brain networks
#Text=Enhancing studies of the connectome in autism using the autism brain imaging data exchange II
#Text=Mutations in human accelerated regions disrupt cognition and social behavior
#Text=Emotional processing in anterior cingulate and medial prefrontal cortex
#Text=The extended language network: a meta-analysis of neuroimaging studies on text comprehension
#Text=Patterns of brain structural changes in first-contact, antipsychotic drug-naive patients with schizophrenia
#Text=The connectomics of brain disorders
#Text=Schizophrenia, neuroimaging and connectomics
#Text=Evolution of the neural language network
#Text=Characterizing the connectome in schizophrenia with diffusion spectrum imaging
#Text=Mapping the structural core of human cerebral cortex
#Text=An anatomically comprehensive atlas of the adult human brain transcriptome
#Text=Evolution of the human brain: when bigger is better
#Text=Auditory hallucinations, network connectivity, and schizophrenia
#Text=Spatial embedding and wiring cost constrain the functional layout of the cortical network of rodents and primates
#Text=Neurobiology of the major psychoses: a translational perspective on brain structure and function-the FOR2107 consortium
#Text=White matter disruptions in schizophrenia are spatially widespread and topologically converge on brain network hubs
#Text=Reduced interhemispheric connectivity in schizophrenia-tractography based segmentation of the corpus callosum
#Text=Generation times in wild chimpanzees and gorillas suggest earlier divergence times in great ape and human evolution
#Text=Cognitive control deficits in schizophrenia: mechanisms and meaning
#Text=Mapping putative hubs in human, chimpanzee and rhesus macaque connectomes via diffusion tractography
#Text=Altered white matter connectivity in never-medicated patients with schizophrenia
#Text=Situating the default-mode network along a principal gradient of macroscale cortical organization
#Text=Models of stress in nonhuman primates and their relevance for human psychopathology and endocrine dysfunction
#Text=Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the cardiovascular health study
#Text=White matter microstructural recovery with abstinence and decline with relapse in alcohol dependence interacts with normal ageing: a controlled longitudinal DTI study
#Text=Connectomics-based structural network alterations in obsessive-compulsive disorder
#Text=A voxel-based diffusion tensor imaging study in unipolar and bipolar depression
#Text=Continuity, divergence, and the evolution of brain language pathways
#Text=The evolution of the arcuate fasciculus revealed with comparative DTI
#Text=Differential expansion of neural projection systems in primate brain evolution
#Text=Connectome disconnectivity and cortical gene expression in patients with schizophrenia
#Text=Schizophrenia: diverse approaches to a complex disease
#Text=Biological insights from 108 schizophrenia-associated genetic loci
#Text=Network-based substrate of cognitive reserve in Alzheimer's disease
#Text=Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence
#Text=Probing the association between early evolutionary markers and schizophrenia
#Text=Genetic markers of human evolution are enriched in schizophrenia
#Text=Toward a neural basis for social behavior
#Text=Obsessive-compulsive disorder: Insights from animal models
#Text=Magnetic resonance microimaging of intraaxonal water diffusion in live excised lamprey spinal cord
#Text=The characteristics of psychotic features in bipolar disorder
#Text=Comparative connectomics
#Text=Brain networks in schizophrenia
#Text=Hulshoff Pol HE.
191-1	42602-42618	Connectome-based	_	
191-2	42619-42627	patterns	_	
191-3	42628-42630	of	_	
191-4	42631-42644	first-episode	_	
191-5	42645-42661	medication-naive	_	
191-6	42662-42670	patients	_	
191-7	42671-42675	with	_	
191-8	42676-42689	schizophrenia	_	
191-9	42690-42696	Shared	_	
191-10	42697-42710	vulnerability	_	
191-11	42711-42714	for	_	
191-12	42715-42725	connectome	_	
191-13	42726-42737	alterations	_	
191-14	42738-42744	across	_	
191-15	42745-42756	psychiatric	_	
191-16	42757-42760	and	_	
191-17	42761-42773	neurological	_	
191-18	42774-42779	brain	_	
191-19	42780-42789	disorders	_	
191-20	42790-42800	Estimating	_	
191-21	42801-42806	false	_	
191-22	42807-42816	positives	_	
191-23	42817-42820	and	_	
191-24	42821-42830	negatives	_	
191-25	42831-42833	in	_	
191-26	42834-42839	brain	_	
191-27	42840-42848	networks	_	
191-28	42849-42858	Enhancing	_	
191-29	42859-42866	studies	_	
191-30	42867-42869	of	_	
191-31	42870-42873	the	_	
191-32	42874-42884	connectome	_	
191-33	42885-42887	in	_	
191-34	42888-42894	autism	_	
191-35	42895-42900	using	_	
191-36	42901-42904	the	_	
191-37	42905-42911	autism	_	
191-38	42912-42917	brain	_	
191-39	42918-42925	imaging	_	
191-40	42926-42930	data	_	
191-41	42931-42939	exchange	_	
191-42	42940-42942	II	_	
191-43	42943-42952	Mutations	_	
191-44	42953-42955	in	_	
191-45	42956-42961	human	_	
191-46	42962-42973	accelerated	_	
191-47	42974-42981	regions	_	
191-48	42982-42989	disrupt	_	
191-49	42990-42999	cognition	_	
191-50	43000-43003	and	_	
191-51	43004-43010	social	_	
191-52	43011-43019	behavior	_	
191-53	43020-43029	Emotional	_	
191-54	43030-43040	processing	_	
191-55	43041-43043	in	_	
191-56	43044-43052	anterior	_	
191-57	43053-43062	cingulate	_	
191-58	43063-43066	and	_	
191-59	43067-43073	medial	_	
191-60	43074-43084	prefrontal	_	
191-61	43085-43091	cortex	_	
191-62	43092-43095	The	_	
191-63	43096-43104	extended	_	
191-64	43105-43113	language	_	
191-65	43114-43121	network	_	
191-66	43121-43122	:	_	
191-67	43123-43124	a	_	
191-68	43125-43138	meta-analysis	_	
191-69	43139-43141	of	_	
191-70	43142-43154	neuroimaging	_	
191-71	43155-43162	studies	_	
191-72	43163-43165	on	_	
191-73	43166-43170	text	_	
191-74	43171-43184	comprehension	_	
191-75	43185-43193	Patterns	_	
191-76	43194-43196	of	_	
191-77	43197-43202	brain	_	
191-78	43203-43213	structural	_	
191-79	43214-43221	changes	_	
191-80	43222-43224	in	_	
191-81	43225-43238	first-contact	_	
191-82	43238-43239	,	_	
191-83	43240-43253	antipsychotic	_	
191-84	43254-43264	drug-naive	_	
191-85	43265-43273	patients	_	
191-86	43274-43278	with	_	
191-87	43279-43292	schizophrenia	_	
191-88	43293-43296	The	_	
191-89	43297-43309	connectomics	_	
191-90	43310-43312	of	_	
191-91	43313-43318	brain	_	
191-92	43319-43328	disorders	_	
191-93	43329-43342	Schizophrenia	_	
191-94	43342-43343	,	_	
191-95	43344-43356	neuroimaging	_	
191-96	43357-43360	and	_	
191-97	43361-43373	connectomics	_	
191-98	43374-43383	Evolution	_	
191-99	43384-43386	of	_	
191-100	43387-43390	the	_	
191-101	43391-43397	neural	_	
191-102	43398-43406	language	_	
191-103	43407-43414	network	_	
191-104	43415-43429	Characterizing	_	
191-105	43430-43433	the	_	
191-106	43434-43444	connectome	_	
191-107	43445-43447	in	_	
191-108	43448-43461	schizophrenia	_	
191-109	43462-43466	with	_	
191-110	43467-43476	diffusion	_	
191-111	43477-43485	spectrum	_	
191-112	43486-43493	imaging	_	
191-113	43494-43501	Mapping	_	
191-114	43502-43505	the	_	
191-115	43506-43516	structural	_	
191-116	43517-43521	core	_	
191-117	43522-43524	of	_	
191-118	43525-43530	human	_	
191-119	43531-43539	cerebral	_	
191-120	43540-43546	cortex	_	
191-121	43547-43549	An	_	
191-122	43550-43562	anatomically	_	
191-123	43563-43576	comprehensive	_	
191-124	43577-43582	atlas	_	
191-125	43583-43585	of	_	
191-126	43586-43589	the	_	
191-127	43590-43595	adult	_	
191-128	43596-43601	human	_	
191-129	43602-43607	brain	_	
191-130	43608-43621	transcriptome	_	
191-131	43622-43631	Evolution	_	
191-132	43632-43634	of	_	
191-133	43635-43638	the	_	
191-134	43639-43644	human	_	
191-135	43645-43650	brain	_	
191-136	43650-43651	:	_	
191-137	43652-43656	when	_	
191-138	43657-43663	bigger	_	
191-139	43664-43666	is	_	
191-140	43667-43673	better	_	
191-141	43674-43682	Auditory	_	
191-142	43683-43697	hallucinations	_	
191-143	43697-43698	,	_	
191-144	43699-43706	network	_	
191-145	43707-43719	connectivity	_	
191-146	43719-43720	,	_	
191-147	43721-43724	and	_	
191-148	43725-43738	schizophrenia	_	
191-149	43739-43746	Spatial	_	
191-150	43747-43756	embedding	_	
191-151	43757-43760	and	_	
191-152	43761-43767	wiring	_	
191-153	43768-43772	cost	_	
191-154	43773-43782	constrain	_	
191-155	43783-43786	the	_	
191-156	43787-43797	functional	_	
191-157	43798-43804	layout	_	
191-158	43805-43807	of	_	
191-159	43808-43811	the	_	
191-160	43812-43820	cortical	_	
191-161	43821-43828	network	_	
191-162	43829-43831	of	_	
191-163	43832-43839	rodents	_	
191-164	43840-43843	and	_	
191-165	43844-43852	primates	_	
191-166	43853-43865	Neurobiology	_	
191-167	43866-43868	of	_	
191-168	43869-43872	the	_	
191-169	43873-43878	major	_	
191-170	43879-43888	psychoses	_	
191-171	43888-43889	:	_	
191-172	43890-43891	a	_	
191-173	43892-43905	translational	_	
191-174	43906-43917	perspective	_	
191-175	43918-43920	on	_	
191-176	43921-43926	brain	_	
191-177	43927-43936	structure	_	
191-178	43937-43940	and	_	
191-179	43941-43953	function-the	_	
191-180	43954-43961	FOR2107	_	
191-181	43962-43972	consortium	_	
191-182	43973-43978	White	_	
191-183	43979-43985	matter	_	
191-184	43986-43997	disruptions	_	
191-185	43998-44000	in	_	
191-186	44001-44014	schizophrenia	_	
191-187	44015-44018	are	_	
191-188	44019-44028	spatially	_	
191-189	44029-44039	widespread	_	
191-190	44040-44043	and	_	
191-191	44044-44057	topologically	_	
191-192	44058-44066	converge	_	
191-193	44067-44069	on	_	
191-194	44070-44075	brain	_	
191-195	44076-44083	network	_	
191-196	44084-44088	hubs	_	
191-197	44089-44096	Reduced	_	
191-198	44097-44113	interhemispheric	_	
191-199	44114-44126	connectivity	_	
191-200	44127-44129	in	_	
191-201	44130-44156	schizophrenia-tractography	_	
191-202	44157-44162	based	_	
191-203	44163-44175	segmentation	_	
191-204	44176-44178	of	_	
191-205	44179-44182	the	_	
191-206	44183-44189	corpus	_	
191-207	44190-44198	callosum	_	
191-208	44199-44209	Generation	_	
191-209	44210-44215	times	_	
191-210	44216-44218	in	_	
191-211	44219-44223	wild	_	
191-212	44224-44235	chimpanzees	_	
191-213	44236-44239	and	_	
191-214	44240-44248	gorillas	_	
191-215	44249-44256	suggest	_	
191-216	44257-44264	earlier	_	
191-217	44265-44275	divergence	_	
191-218	44276-44281	times	_	
191-219	44282-44284	in	_	
191-220	44285-44290	great	_	
191-221	44291-44294	ape	_	
191-222	44295-44298	and	_	
191-223	44299-44304	human	_	
191-224	44305-44314	evolution	_	
191-225	44315-44324	Cognitive	_	
191-226	44325-44332	control	_	
191-227	44333-44341	deficits	_	
191-228	44342-44344	in	_	
191-229	44345-44358	schizophrenia	_	
191-230	44358-44359	:	_	
191-231	44360-44370	mechanisms	_	
191-232	44371-44374	and	_	
191-233	44375-44382	meaning	_	
191-234	44383-44390	Mapping	_	
191-235	44391-44399	putative	_	
191-236	44400-44404	hubs	_	
191-237	44405-44407	in	_	
191-238	44408-44413	human	_	
191-239	44413-44414	,	_	
191-240	44415-44425	chimpanzee	_	
191-241	44426-44429	and	_	
191-242	44430-44436	rhesus	_	
191-243	44437-44444	macaque	_	
191-244	44445-44456	connectomes	_	
191-245	44457-44460	via	_	
191-246	44461-44470	diffusion	_	
191-247	44471-44483	tractography	_	
191-248	44484-44491	Altered	_	
191-249	44492-44497	white	_	
191-250	44498-44504	matter	_	
191-251	44505-44517	connectivity	_	
191-252	44518-44520	in	_	
191-253	44521-44536	never-medicated	_	
191-254	44537-44545	patients	_	
191-255	44546-44550	with	_	
191-256	44551-44564	schizophrenia	_	
191-257	44565-44574	Situating	_	
191-258	44575-44578	the	_	
191-259	44579-44591	default-mode	_	
191-260	44592-44599	network	_	
191-261	44600-44605	along	_	
191-262	44606-44607	a	_	
191-263	44608-44617	principal	_	
191-264	44618-44626	gradient	_	
191-265	44627-44629	of	_	
191-266	44630-44640	macroscale	_	
191-267	44641-44649	cortical	_	
191-268	44650-44662	organization	_	
191-269	44663-44669	Models	_	
191-270	44670-44672	of	_	
191-271	44673-44679	stress	_	
191-272	44680-44682	in	_	
191-273	44683-44691	nonhuman	_	
191-274	44692-44700	primates	_	
191-275	44701-44704	and	_	
191-276	44705-44710	their	_	
191-277	44711-44720	relevance	_	
191-278	44721-44724	for	_	
191-279	44725-44730	human	_	
191-280	44731-44746	psychopathology	_	
191-281	44747-44750	and	_	
191-282	44751-44760	endocrine	_	
191-283	44761-44772	dysfunction	_	
191-284	44773-44780	Alcohol	_	
191-285	44781-44792	consumption	_	
191-286	44793-44796	and	_	
191-287	44797-44808	subclinical	_	
191-288	44809-44817	findings	_	
191-289	44818-44820	on	_	
191-290	44821-44829	magnetic	_	
191-291	44830-44839	resonance	_	
191-292	44840-44847	imaging	_	
191-293	44848-44850	of	_	
191-294	44851-44854	the	_	
191-295	44855-44860	brain	_	
191-296	44861-44863	in	_	
191-297	44864-44869	older	_	
191-298	44870-44876	adults	_	
191-299	44876-44877	:	_	
191-300	44878-44881	the	_	
191-301	44882-44896	cardiovascular	_	
191-302	44897-44903	health	_	
191-303	44904-44909	study	_	
191-304	44910-44915	White	_	
191-305	44916-44922	matter	_	
191-306	44923-44938	microstructural	_	
191-307	44939-44947	recovery	_	
191-308	44948-44952	with	_	
191-309	44953-44963	abstinence	_	
191-310	44964-44967	and	_	
191-311	44968-44975	decline	_	
191-312	44976-44980	with	_	
191-313	44981-44988	relapse	_	
191-314	44989-44991	in	_	
191-315	44992-44999	alcohol	_	
191-316	45000-45010	dependence	_	
191-317	45011-45020	interacts	_	
191-318	45021-45025	with	_	
191-319	45026-45032	normal	_	
191-320	45033-45039	ageing	_	
191-321	45039-45040	:	_	
191-322	45041-45042	a	_	
191-323	45043-45053	controlled	_	
191-324	45054-45066	longitudinal	_	
191-325	45067-45070	DTI	_	
191-326	45071-45076	study	_	
191-327	45077-45095	Connectomics-based	_	
191-328	45096-45106	structural	_	
191-329	45107-45114	network	_	
191-330	45115-45126	alterations	_	
191-331	45127-45129	in	_	
191-332	45130-45150	obsessive-compulsive	_	
191-333	45151-45159	disorder	_	
191-334	45160-45161	A	_	
191-335	45162-45173	voxel-based	_	
191-336	45174-45183	diffusion	_	
191-337	45184-45190	tensor	_	
191-338	45191-45198	imaging	_	
191-339	45199-45204	study	_	
191-340	45205-45207	in	_	
191-341	45208-45216	unipolar	_	
191-342	45217-45220	and	_	
191-343	45221-45228	bipolar	_	
191-344	45229-45239	depression	_	
191-345	45240-45250	Continuity	_	
191-346	45250-45251	,	_	
191-347	45252-45262	divergence	_	
191-348	45262-45263	,	_	
191-349	45264-45267	and	_	
191-350	45268-45271	the	_	
191-351	45272-45281	evolution	_	
191-352	45282-45284	of	_	
191-353	45285-45290	brain	_	
191-354	45291-45299	language	_	
191-355	45300-45308	pathways	_	
191-356	45309-45312	The	_	
191-357	45313-45322	evolution	_	
191-358	45323-45325	of	_	
191-359	45326-45329	the	_	
191-360	45330-45337	arcuate	_	
191-361	45338-45348	fasciculus	_	
191-362	45349-45357	revealed	_	
191-363	45358-45362	with	_	
191-364	45363-45374	comparative	_	
191-365	45375-45378	DTI	_	
191-366	45379-45391	Differential	_	
191-367	45392-45401	expansion	_	
191-368	45402-45404	of	_	
191-369	45405-45411	neural	_	
191-370	45412-45422	projection	_	
191-371	45423-45430	systems	_	
191-372	45431-45433	in	_	
191-373	45434-45441	primate	_	
191-374	45442-45447	brain	_	
191-375	45448-45457	evolution	_	
191-376	45458-45468	Connectome	_	
191-377	45469-45484	disconnectivity	_	
191-378	45485-45488	and	_	
191-379	45489-45497	cortical	_	
191-380	45498-45502	gene	_	
191-381	45503-45513	expression	_	
191-382	45514-45516	in	_	
191-383	45517-45525	patients	_	
191-384	45526-45530	with	_	
191-385	45531-45544	schizophrenia	_	
191-386	45545-45558	Schizophrenia	_	
191-387	45558-45559	:	_	
191-388	45560-45567	diverse	_	
191-389	45568-45578	approaches	_	
191-390	45579-45581	to	_	
191-391	45582-45583	a	_	
191-392	45584-45591	complex	_	
191-393	45592-45599	disease	_	
191-394	45600-45610	Biological	_	
191-395	45611-45619	insights	_	
191-396	45620-45624	from	_	
191-397	45625-45628	108	_	
191-398	45629-45653	schizophrenia-associated	_	
191-399	45654-45661	genetic	_	
191-400	45662-45666	loci	_	
191-401	45667-45680	Network-based	_	
191-402	45681-45690	substrate	_	
191-403	45691-45693	of	_	
191-404	45694-45703	cognitive	_	
191-405	45704-45711	reserve	_	
191-406	45712-45714	in	_	
191-407	45715-45726	Alzheimer's	_	
191-408	45727-45734	disease	_	
191-409	45735-45746	Genome-wide	_	
191-410	45747-45755	analysis	_	
191-411	45756-45763	reveals	_	
191-412	45764-45773	extensive	_	
191-413	45774-45781	genetic	_	
191-414	45782-45789	overlap	_	
191-415	45790-45797	between	_	
191-416	45798-45811	schizophrenia	_	
191-417	45811-45812	,	_	
191-418	45813-45820	bipolar	_	
191-419	45821-45829	disorder	_	
191-420	45829-45830	,	_	
191-421	45831-45834	and	_	
191-422	45835-45847	intelligence	_	
191-423	45848-45855	Probing	_	
191-424	45856-45859	the	_	
191-425	45860-45871	association	_	
191-426	45872-45879	between	_	
191-427	45880-45885	early	_	
191-428	45886-45898	evolutionary	_	
191-429	45899-45906	markers	_	
191-430	45907-45910	and	_	
191-431	45911-45924	schizophrenia	_	
191-432	45925-45932	Genetic	_	
191-433	45933-45940	markers	_	
191-434	45941-45943	of	_	
191-435	45944-45949	human	_	
191-436	45950-45959	evolution	_	
191-437	45960-45963	are	_	
191-438	45964-45972	enriched	_	
191-439	45973-45975	in	_	
191-440	45976-45989	schizophrenia	_	
191-441	45990-45996	Toward	_	
191-442	45997-45998	a	_	
191-443	45999-46005	neural	_	
191-444	46006-46011	basis	_	
191-445	46012-46015	for	_	
191-446	46016-46022	social	_	
191-447	46023-46031	behavior	_	
191-448	46032-46052	Obsessive-compulsive	_	
191-449	46053-46061	disorder	_	
191-450	46061-46062	:	_	
191-451	46063-46071	Insights	_	
191-452	46072-46076	from	_	
191-453	46077-46083	animal	_	
191-454	46084-46090	models	_	
191-455	46091-46099	Magnetic	_	
191-456	46100-46109	resonance	_	
191-457	46110-46122	microimaging	_	
191-458	46123-46125	of	_	
191-459	46126-46137	intraaxonal	_	
191-460	46138-46143	water	_	
191-461	46144-46153	diffusion	_	
191-462	46154-46156	in	_	
191-463	46157-46161	live	_	
191-464	46162-46169	excised	_	
191-465	46170-46177	lamprey	_	
191-466	46178-46184	spinal	_	
191-467	46185-46189	cord	_	
191-468	46190-46193	The	_	
191-469	46194-46209	characteristics	_	
191-470	46210-46212	of	_	
191-471	46213-46222	psychotic	_	
191-472	46223-46231	features	_	
191-473	46232-46234	in	_	
191-474	46235-46242	bipolar	_	
191-475	46243-46251	disorder	_	
191-476	46252-46263	Comparative	_	
191-477	46264-46276	connectomics	_	
191-478	46277-46282	Brain	_	
191-479	46283-46291	networks	_	
191-480	46292-46294	in	_	
191-481	46295-46308	schizophrenia	_	
191-482	46309-46317	Hulshoff	_	
191-483	46318-46321	Pol	_	
191-484	46322-46324	HE	_	
191-485	46324-46325	.	_	

#Text=Aberrant frontal and temporal complex network structure in schizophrenia: a graph theoretical analysis
#Text=Associated microscale spine density and macroscale connectivity disruptions in schizophrenia
#Text=Multi-scale neuroscience of psychiatric disorders
#Text=A cross-disorder connectome landscape of brain dysconnectivity
#Text=The WU-Minn human connectome project: an overview
#Text=SchizConnect: mediating neuroimaging databases on schizophrenia and related disorders for large-scale integration
#Text=Genetic mapping and evolutionary analysis of human-expanded cognitive network
#Text=Impaired cognitive inhibition in schizophrenia: a meta-analysis of the Stroop interference effect
#Text=Genomic and network patterns of schizophrenia genetic variation in human evolutionary accelerated regions
#Text=Large-scale automated synthesis of human functional neuroimaging data
#Text=Single-neuron and genetic correlates of autistic behavior in macaque
#Text=Connectome sensitivity or specificity: which is more important?
192-1	46326-46334	Aberrant	_	
192-2	46335-46342	frontal	_	
192-3	46343-46346	and	_	
192-4	46347-46355	temporal	_	
192-5	46356-46363	complex	_	
192-6	46364-46371	network	_	
192-7	46372-46381	structure	_	
192-8	46382-46384	in	_	
192-9	46385-46398	schizophrenia	_	
192-10	46398-46399	:	_	
192-11	46400-46401	a	_	
192-12	46402-46407	graph	_	
192-13	46408-46419	theoretical	_	
192-14	46420-46428	analysis	_	
192-15	46429-46439	Associated	_	
192-16	46440-46450	microscale	_	
192-17	46451-46456	spine	_	
192-18	46457-46464	density	_	
192-19	46465-46468	and	_	
192-20	46469-46479	macroscale	_	
192-21	46480-46492	connectivity	_	
192-22	46493-46504	disruptions	_	
192-23	46505-46507	in	_	
192-24	46508-46521	schizophrenia	_	
192-25	46522-46533	Multi-scale	_	
192-26	46534-46546	neuroscience	_	
192-27	46547-46549	of	_	
192-28	46550-46561	psychiatric	_	
192-29	46562-46571	disorders	_	
192-30	46572-46573	A	_	
192-31	46574-46588	cross-disorder	_	
192-32	46589-46599	connectome	_	
192-33	46600-46609	landscape	_	
192-34	46610-46612	of	_	
192-35	46613-46618	brain	_	
192-36	46619-46634	dysconnectivity	_	
192-37	46635-46638	The	_	
192-38	46639-46646	WU-Minn	_	
192-39	46647-46652	human	_	
192-40	46653-46663	connectome	_	
192-41	46664-46671	project	_	
192-42	46671-46672	:	_	
192-43	46673-46675	an	_	
192-44	46676-46684	overview	_	
192-45	46685-46697	SchizConnect	_	
192-46	46697-46698	:	_	
192-47	46699-46708	mediating	_	
192-48	46709-46721	neuroimaging	_	
192-49	46722-46731	databases	_	
192-50	46732-46734	on	_	
192-51	46735-46748	schizophrenia	_	
192-52	46749-46752	and	_	
192-53	46753-46760	related	_	
192-54	46761-46770	disorders	_	
192-55	46771-46774	for	_	
192-56	46775-46786	large-scale	_	
192-57	46787-46798	integration	_	
192-58	46799-46806	Genetic	_	
192-59	46807-46814	mapping	_	
192-60	46815-46818	and	_	
192-61	46819-46831	evolutionary	_	
192-62	46832-46840	analysis	_	
192-63	46841-46843	of	_	
192-64	46844-46858	human-expanded	_	
192-65	46859-46868	cognitive	_	
192-66	46869-46876	network	_	
192-67	46877-46885	Impaired	_	
192-68	46886-46895	cognitive	_	
192-69	46896-46906	inhibition	_	
192-70	46907-46909	in	_	
192-71	46910-46923	schizophrenia	_	
192-72	46923-46924	:	_	
192-73	46925-46926	a	_	
192-74	46927-46940	meta-analysis	_	
192-75	46941-46943	of	_	
192-76	46944-46947	the	_	
192-77	46948-46954	Stroop	_	
192-78	46955-46967	interference	_	
192-79	46968-46974	effect	_	
192-80	46975-46982	Genomic	_	
192-81	46983-46986	and	_	
192-82	46987-46994	network	_	
192-83	46995-47003	patterns	_	
192-84	47004-47006	of	_	
192-85	47007-47020	schizophrenia	_	
192-86	47021-47028	genetic	_	
192-87	47029-47038	variation	_	
192-88	47039-47041	in	_	
192-89	47042-47047	human	_	
192-90	47048-47060	evolutionary	_	
192-91	47061-47072	accelerated	_	
192-92	47073-47080	regions	_	
192-93	47081-47092	Large-scale	_	
192-94	47093-47102	automated	_	
192-95	47103-47112	synthesis	_	
192-96	47113-47115	of	_	
192-97	47116-47121	human	_	
192-98	47122-47132	functional	_	
192-99	47133-47145	neuroimaging	_	
192-100	47146-47150	data	_	
192-101	47151-47164	Single-neuron	_	
192-102	47165-47168	and	_	
192-103	47169-47176	genetic	_	
192-104	47177-47187	correlates	_	
192-105	47188-47190	of	_	
192-106	47191-47199	autistic	_	
192-107	47200-47208	behavior	_	
192-108	47209-47211	in	_	
192-109	47212-47219	macaque	_	
192-110	47220-47230	Connectome	_	
192-111	47231-47242	sensitivity	_	
192-112	47243-47245	or	_	
192-113	47246-47257	specificity	_	
192-114	47257-47258	:	_	
192-115	47259-47264	which	_	
192-116	47265-47267	is	_	
192-117	47268-47272	more	_	
192-118	47273-47282	important	_	
192-119	47282-47283	?	_	

#Text=Abbreviation
#Text=DWI = 
#Text=diffusion-weighted imaging
193-1	47284-47296	Abbreviation	_	
193-2	47297-47300	DWI	_	
193-3	47301-47302	=	_	
193-4	47304-47322	diffusion-weighted	_	
193-5	47323-47330	imaging	_	
